Notes_NN
to_PIN
the_DT
financial_JJ
statements_NOMZ
1_CD
Segmental_JJ
analysis_NN
by_PIN
business_NOMZ
sector_NN
12_CD
months_NN
to_PIN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
m_FW
m_FW
Sales_NN
Amersham_NN
Health_NN
947.7_CD
922.0_CD
Amersham_NN
Biosciences_NN
670.5_CD
680.5_CD
1,618.2_CD
1,602.5_CD
Included_VBN
within_PIN
Amersham_NN
Health_NN
is_VPRT [BEMA]
the_DT
groups_NN
share_NN
of_PIN
Nihon_NN
Medi-Physics_NN
NMP_NN
joint_JJ
venture_NN
sales_NN
during_PIN
the_DT
year_NN
of_PIN
80.5_CD
m_NN [BEMA]
2001_CD
87.3_CD
m._NN
Total_JJ
operating_GER
profit_NN
before_IN
exceptional_JJ
items_NN
and_PHC
goodwill_NN
amortisation_NOMZ
Amersham_NN
Health_NN
255.6_CD
240.9_CD
Amersham_NN
Biosciences_NN
75.3_CD
72.4_CD
Corporate_JJ
and_PHC
other_JJ
21.1_CD
20.8_CD
309.8_CD
292.5_CD
The_DT
following_VBG
table_NN
shows_NN
operating_VBG [WZPRES]
profit_NN
after_IN
allocation_NOMZ
of_PIN
exceptional_JJ
items_NN
and_PHC
goodwill_NN
amortisation_NOMZ
._.
The_DT
exceptional_JJ
items_NN
charged_VBN [WZPAST]
in_PIN
2002_CD
relate_VPRT
nil_NN
2001_CD
8.5_CD
m_NN [BEMA]
to_PIN
Amersham_NN
Health_NN
,_,
nil_NN
2001_CD
2.6_CD
m_NN [BEMA]
to_PIN
Amersham_NN
Biosciences_NN
and_PHC
nil_NN
2001_CD
2.4_CD
m_NN
income_NN
to_PIN
Corporate_JJ
and_PHC
other_JJ
._.
Amortisation_NOMZ
charged_VBD
on_PIN
goodwill_NN
in_PIN
2002_CD
relates_VPRT
0.9_CD
m_NN [BEMA]
2001_CD
1.4_CD
m_NN [BEMA]
to_PIN
Amersham_NN
Health_NN
,_,
and_ANDC
35.7_CD
m_NN [BEMA]
2001_CD
10.3_CD
m_NN [BEMA]
to_PIN
Amersham_NN
Biosciences_NN
._.
Total_JJ
operating_GER
profit_NN
after_IN
exceptional_JJ
items_NN
and_PHC
goodwill_NN
amortisation_NOMZ
Amersham_NN
Health_NN
254.7_CD
231.0_CD
Amersham_NN
Biosciences_NN
39.6_CD
59.5_CD
Corporate_JJ
and_PHC
other_JJ
21.1_CD
18.4_CD
273.2_CD
272.1_CD
Included_VBN
within_PIN
Amersham_NN
Health_NN
is_VPRT [BEMA]
the_DT
groups_NN
share_NN
of_PIN
the_DT
NMP_NN
joint_JJ
venture_NN
profit_NN
before_IN
interest_NN
and_PHC
tax_NN
for_PIN
the_DT
year_NN
of_PIN
23.2_CD
m_NN [BEMA]
2001_CD
26.1_CD
m._FW
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Restated_VBN
m_FW
m_FW [BEMA]
Net_JJ
assets_NN
Amersham_NN
Health_NN
559.9_CD
451.5_CD
Amersham_NN
Biosciences_NN
1,032.6_CD
413.2_CD
Corporate_JJ
and_PHC
other_JJ
33.7_CD
20.2_CD
Net_NN
operating_VBG [WZPRES]
assets_NN
1,558.8_CD
844.5_CD
Unallocated_JJ
net_JJ
liabilities_NOMZ
Current_JJ
and_PHC
deferred_JJ
taxation_NOMZ
163.6_CD
129.9_CD
Dividends_NN
payable_JJ
36.0_CD
30.3_CD
Net_JJ
debt_NN
182.3_CD
25.4_CD
1,176.9_CD
658.9_CD
The_DT
net_JJ
assets_NN
of_PIN
Amersham_NN
Biosciences_NN
include_VPRT
goodwill_NN
at_PIN
a_DT
net_JJ
book_NN
value_NN
of_PIN
630.6_CD
m_NN [BEMA]
at_PIN
31_CD
December_NN
2002_CD
arising_VBG
from_PIN
the_DT
purchase_NN
of_PIN
the_DT
45_CD
%_NN
minority_NOMZ
interest_NN
in_PIN
Amersham_NN
Biosciences_NN
._.
Included_VBN [PASTP]
within_PIN
the_DT
net_JJ
operating_GER
assets_NN
of_PIN
Amersham_NN
Health_NN
is_VPRT [BEMA]
the_DT
groups_NN
share_NN
of_PIN
the_DT
NMP_NN
joint_JJ
venture_NN
assets_NN
of_PIN
73.0_CD
m_NN
,_,
2001_CD
67.1_CD
m._NN
58_CD
Amersham_NN
plc_NN
Annual_JJ
Report_NN
&_CC
Accounts_NN
2002_CD
2_CD
Segmental_JJ
analysis_NN
by_PIN
geographical_JJ
sector_NN
12_CD
months_NN
to_PIN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
By_PIN
origin_NN
m_NN
m_NN
Sales_NN
Europe_NN
903.9_CD
722.1_CD
North_NN
America_NN
871.8_CD
853.7_CD
Japan_NN
187.8_CD
202.1_CD
Asia_NN
Pacic_NN
84.0_CD
77.5_CD
Rest_VPRT
of_PIN
the_DT
world_NN
5.2_CD
6.7_CD
2,052.7_CD
1,862.1_CD
Less_RB
inter-segment_JJ
sales_NN
434.5_CD
259.6_CD
1,618.2_CD
1,602.5_CD
Included_VBN
within_PIN
Japan_NN
is_VPRT [BEMA]
the_DT
groups_NN
share_NN
of_PIN
NMP_NN
joint_JJ
venture_NN
sales_NN
of_PIN
80.5_CD
m_NN [BEMA]
2001_CD
87.3_CD
m._NN
Total_JJ
operating_GER
profit_NN
before_IN
exceptional_JJ
items_NN
and_PHC
goodwill_NN
amortisation_NOMZ
Europe_NN
219.3_CD
193.0_CD
North_NN
America_NN
80.3_CD
89.7_CD
Japan_NN
31.9_CD
30.4_CD
Asia_NN
Pacic_NN
0.9_CD
0.3_CD
Rest_VPRT
of_PIN
the_DT
world_NN
0.3_CD
0.5_CD
Corporate_JJ
and_PHC
other_JJ
21.1_CD
20.8_CD
309.8_CD
292.5_CD
The_DT
following_VBG
table_NN
shows_NN
operating_VBG [WZPRES]
profit_NN
after_IN
allocation_NOMZ
of_PIN
exceptional_JJ
items_NN
and_PHC
goodwill_NN
amortisation_NOMZ
._.
The_DT
exceptional_JJ
items_NN
charged_VBN [WZPAST]
in_PIN
2002_CD
relate_VPRT
nil_NN
2001_CD
1.1_CD
m_NN [BEMA]
to_PIN
North_NN
America_NN
,_,
nil_NN
2001_CD
10.0_CD
m_NN [BEMA]
to_PIN
Europe_NN
and_CC
nil_JJ
2001_CD
2.4_CD
m_NN
income_NN
to_PIN
Corporate_JJ
and_PHC
other_JJ
._.
Total_JJ
operating_GER
profit_NN
after_IN
exceptional_JJ
items_NN
and_PHC
goodwill_NN
amortisation_NOMZ
Europe_NN
210.4_CD
182.7_CD
North_NN
America_NN
57.6_CD
77.2_CD
Japan_NN
26.9_CD
30.4_CD
Asia_NN
Pacic_NN
0.9_CD
0.3_CD
Rest_VPRT
of_PIN
the_DT
world_NN
0.3_CD
0.5_CD
Corporate_JJ
and_PHC
other_JJ
21.1_CD
18.4_CD
273.2_CD
272.1_CD
Included_VBN
within_PIN
Japan_NN
is_VPRT [BEMA]
the_DT
groups_NN
share_NN
of_PIN
NMP_NN
joint_JJ
venture_NN
profit_NN
before_IN
interest_NN
and_PHC
tax_NN
for_PIN
the_DT
year_NN
of_PIN
23.2_CD
m_NN [BEMA]
2001_CD
26.1_CD
m._FW
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Restated_VBN
m_FW
m_FW [BEMA]
Net_JJ
assets_NN
Europe_NN
709.3_CD
383.1_CD
North_NN
America_NN
603.0_CD
322.4_CD
Japan_NN
228.9_CD
107.8_CD
Asia_NN
Pacic_NN
49.5_CD
49.8_CD
Rest_VPRT
of_PIN
the_DT
world_NN
1.8_CD
1.6_CD
Corporate_JJ
and_PHC
other_JJ
33.7_CD
20.2_CD
Net_NN
operating_VBG [WZPRES]
assets_NN
1,558.8_CD
844.5_CD
Unallocated_JJ
net_JJ
liabilities_NOMZ
Current_JJ
and_PHC
deferred_JJ
taxation_NOMZ
163.6_CD
129.9_CD
Dividends_NN
payable_JJ
36.0_CD
30.3_CD
Net_JJ
debt_NN
182.3_CD
25.4_CD
1,176.9_CD
658.9_CD
The_DT
net_JJ
assets_NN
include_VPRT
goodwill_NN
at_PIN
a_DT
net_JJ
book_NN
value_NN
of_PIN
630.6_CD
m_NN [BEMA]
at_PIN
31_CD
December_NN
2002_CD
arising_VBG
from_PIN
the_DT
purchase_NN
of_PIN
the_DT
45_CD
%_NN
minority_NOMZ
interest_NN
in_PIN
Amersham_NN
Biosciences_NN
._.
The_DT
goodwill_NN
is_VPRT [PASS]
allocated_VBN
to_PIN
Europe_NN
207.1_CD
m_NN
,_,
North_NN
America_NN
304.1_CD
m_NN
and_PHC
Japan_NN
119.4_CD
m_NN
,_,
based_VBN [PASTP]
on_PIN
expected_VBN [PRIV] [THATD]
revenues_NN
arising_VBG [WZPRES]
in_PIN
those_DEMO
territories_NN
._.
Included_VBN [PASTP]
within_PIN
the_DT
net_JJ
operating_GER
assets_NN
of_PIN
Japan_NN
is_VPRT [BEMA]
the_DT
groups_NN
share_NN
of_PIN
the_DT
NMP_NN
joint_JJ
venture_NN
assets_NN
of_PIN
73.0_CD
m_NN
,_,
2001_CD
67.1_CD
m._NN
Amersham_NN
plc_NN
59_CD
Notes_NN
to_PIN
the_DT
financial_JJ
statements_NOMZ
continued_VBD
2_CD
Segmental_JJ
analysis_NN
by_PIN
geographical_JJ
sector_NN
continued_VBD
12_CD
months_NN
to_PIN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
By_PIN
destination_NOMZ
m_NN
m_NN
Sales_NN
Europe_NN
427.8_CD
392.0_CD
North_NN
America_NN
798.5_CD
767.7_CD
Japan_NN
264.1_CD
290.7_CD
Asia_NN
Pacic_NN
80.6_CD
80.4_CD
Rest_VPRT
of_PIN
the_DT
world_NN
47.2_CD
71.7_CD
1,618.2_CD
1,602.5_CD
Included_VBN
within_PIN
Japan_NN
is_VPRT [BEMA]
the_DT
groups_NN
share_NN
of_PIN
NMP_NN
joint_JJ
venture_NN
sales_NN
during_PIN
the_DT
year_NN
of_PIN
80.5_CD
m_NN [BEMA]
2001_CD
87.3_CD
m._NN
3_CD
Exceptional_JJ
items_NN
12_CD
months_NN
to_PIN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
m_FW
m_FW
Cost_NN
of_PIN
the_DT
proposed_VBN [SUAV]
otation_NOMZ
of_PIN
Amersham_NN
Biosciences_NN
3.4_CD
Transfer_NN
of_PIN
pension_NN
assets_NN
9.0_CD
Costs_NN
of_PIN
exiting_VBG
the_DT
disease_NN
proling_VBG [WZPRES]
project_NN
5.8_CD
Costs_NN
of_PIN
exiting_VBG
Harwell_NN
site_NN
8.5_CD
Charged_VBN
to_TO
operating_VBG
profit_NN
8.7_CD
profit_NN
on_PIN
disposal_NN
of_PIN
29_CD
%_NN
of_PIN
Nycomed_NN
Pharma_NN
55.3_CD
profit_NN
on_PIN
sale_NN
of_PIN
xed_JJ
asset_NN
investment_NOMZ
55.3_CD
Tax_NN
credit_NN
relating_VBG [WZPRES]
to_PIN
group_NN
reorganisation_NOMZ
9.2_CD
Total_JJ
exceptional_JJ
items_NN
9.2_CD
46.6_CD
Tax_NN
credit_NN
related_VBN [WZPAST]
to_PIN
exceptional_JJ
items_NN
0.5_CD
As_CONJ
a_NULL
result_NULL
of_PIN
the_DT
formation_NOMZ
of_PIN
a_DT
consolidated_JJ
tax_NN
group_NN
in_PIN
the_DT
US_FPP1
on_PIN
31_CD
July_NN
2002_CD
,_,
the_DT
group_NN
has_VPRT [PEAS]
recognized_VBN [PRIV]
a_DT
deferred_VBN
taxation_NOMZ
asset_NN
of_PIN
9.2_CD
m_NN [SPAU] [PASS]
primarily_RB
related_VBN
to_PIN
the_DT
future_JJ
utilisation_NOMZ
of_PIN
tax_NN
losses_NN
arising_VBG [WZPRES]
from_PIN
prior_JJ
periods_NN
._.
During_PIN
2001_CD
,_,
costs_NN
of_PIN
3.4_CD
m_NN [PASS]
were_VBD [PASS]
incurred_VBN
in_PIN
relation_NOMZ
to_PIN
the_DT
proposed_VBN [SUAV]
partial_JJ
otation_NOMZ
of_PIN
Amersham_NN
Biosciences_NN
._.
The_DT
costs_NN
related_VBN [WZPAST]
primarily_RB
to_PIN
adviser_NN
fees_NN
and_CC
other_JJ
similar_JJ
costs_NN
in_PIN
preparing_VBG
the_DT
prospectus_NN
for_PIN
otation_NOMZ
and_CC
in_PIN
relocating_VBG
the_DT
business_NOMZ
to_PIN
the_DT
US_FPP1
._.
During_PIN
2001_CD
,_,
the_DT
company_NN
received_VBD
22.5_CD
m_NN [PASS]
related_VBN [WZPAST]
to_PIN
a_DT
transfer_NN
of_PIN
assets_NN
from_PIN
former_JJ
pension_NN
plans_NN
._.
Of_PIN
this_DEMO
amount_NN
,_,
13.5_CD
m_NN [PASS]
was_VBD [PASS]
applied_VBN
against_PIN
ongoing_JJ
liabilities_NOMZ
primarily_RB
for_PIN
employees_NN
who_WP [WHSUB]
have_VPRT [PEAS]
transferred_VBN
into_PIN
Amersham_NN
pension_NN
schemes_NN
and_CC
the_DT
balance_NN
of_PIN
9.0_CD
m_NN [PASS]
was_VBD [PASS]
recognized_VBN [PRIV]
as_IN
exceptional_JJ
income_NN
,_,
where_RB
the_DT
company_NN
has_VPRT
no_SYNE
further_JJ
liability_NOMZ
._.
Cash_NN
costs_NN
of_PIN
4.1_CD
m_NN
and_CC
non-cash_JJ
write_VB [PUBV]
offs_NN
of_PIN
1.7_CD
m_NN [PASS]
were_VBD [PASS]
incurred_VBN
in_PIN
the_DT
second_JJ
half_NN
of_PIN
2001_CD
in_PIN
concluding_VBG [PRIV]
research_NN
on_PIN [STPR]
,_,
and_ANDC
winding_VBG
up_RP
the_DT
operation_NOMZ
of_PIN
an_DT
early_TIME
stage_NN
investment_NOMZ
in_PIN [STPR]
,_,
disease_NN
proling_GER
._.
An_DT
investment_NOMZ
of_PIN
4.0_CD
m_NN [PASS]
was_VBD [PASS]
made_VBN
in_PIN
the_DT
research_NN
project_NN
in_PIN
the_DT
first_JJ
half_NN
of_PIN
2001_CD
,_,
which_WDT [SERE]
has_VPRT [PEAS]
been_VBN [PASS]
charged_VBN
to_TO
operating_VBG
activities_NOMZ
._.
In_PIN
2001_CD
,_,
costs_NN
of_PIN
8.5_CD
m_NN [PASS]
were_VBD [PASS]
accrued_VBN
in_PIN
relation_NOMZ
to_PIN
the_DT
decision_NN
to_TO
terminate_VB
the_DT
groups_NN
lease_NN
at_PIN
the_DT
Harwell_NN
site_NN
following_VBG [WZPRES]
a_DT
complete_JJ
cessation_NOMZ
of_PIN
the_DT
groups_NN
activities_NOMZ
at_PIN
this_DEMO
location_NOMZ
._.
The_DT
costs_NN
relate_VPRT
primarily_RB
to_PIN
asset_NN
write_VB [PUBV]
offs_NN
and_CC
decommissioning_VBG
costs_NN
._.
During_PIN
2001_CD
,_,
the_DT
group_NN
sold_VBD
its_PIT
29_CD
%_NN
interest_NN
in_PIN
Nycomed_NN
Pharma_NN
._.
The_DT
group_NN
recorded_VBD
a_DT
profit_NN
on_PIN
the_DT
transaction_NOMZ
of_PIN
55.3_CD
m_NN
after_IN
charging_VBG
costs_NN
associated_VBN [WZPAST]
with_PIN
the_DT
disposal_NN
._.
In_PIN
2001_CD
,_,
the_DT
minority_NOMZ
impact_NN
was_VBD [BEMA]
2.0_CD
m_NN
relating_VBG [WZPRES]
to_PIN
exceptional_JJ
items_NN
charged_VBN
to_TO
operating_VBG
profit_NN
._.
In_PIN
2002_CD
,_,
no_SYNE
exceptional_JJ
items_NN
have_VPRT [PEAS]
been_VBN [PASS]
charged_VBN
to_TO
operating_VBG
profit_NN
._.
60_CD
Amersham_NN
plc_NN
Annual_JJ
Report_NN
&_CC
Accounts_NN
2002_CD
4_CD
Total_JJ
operating_GER
profit_NN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2001_CD
Before_IN
Before_IN
exceptional_JJ
Exceptional_JJ
exceptional_JJ
Exceptional_JJ
items_NN
items_NN
Total_JJ
items_NN
items_NN
Total_JJ
m_NN
m_FW
m_FW
m_FW
m_FW
m_FW
Group_NN
turnover_NN
1,537.7_CD
1,537.7_CD
1,515.2_CD
1,515.2_CD
Cost_NN
of_PIN
sales_NN
481.0_CD
481.0_CD
500.1_CD
0.5_CD
499.6_CD
Gross_NN
profit_NN
1,056.7_CD
1,056.7_CD
1,015.1_CD
0.5_CD
1,015.6_CD
Distribution_NOMZ
and_PHC
selling_GER
costs_NN
419.7_CD
419.7_CD
401.8_CD
401.8_CD
Administrative_JJ
expenses_NN
387.0_CD
387.0_CD
358.6_CD
9.2_CD
367.8_CD
Group_NN
operating_GER
profit_NN
250.0_CD
250.0_CD
254.7_CD
8.7_CD
246.0_CD
Share_NN
of_PIN
operating_VBG
profits_NN
of_PIN
joint_JJ
venture_NN
and_PHC
associates_NN
23.2_CD
23.2_CD
26.1_CD
26.1_CD
Total_JJ
operating_GER
profit_NN
273.2_CD
273.2_CD
280.8_CD
8.7_CD
272.1_CD
Research_NN
and_PHC
development_NOMZ
costs_NN
included_VBD
in_PIN
administrative_JJ
expenses_NN
relate_VPRT
to_PIN
Amersham_NN
Health_NN
95.1_CD
m_NN [BEMA]
2001_CD
83.0_CD
m_NN
,_,
Amersham_NN
Biosciences_NN
88.0_CD
m_NN [BEMA]
2001_CD
86.4_CD
m_NN
,_,
and_ANDC
Corporate_JJ
and_PHC
other_JJ
1.1_CD
m_NN [BEMA]
2001_CD
4.4_CD
m._NN
Total_JJ
research_NN
and_PHC
development_NOMZ
costs_NN
amounted_VBD
to_PIN
184.2_CD
m_NN [BEMA]
2001_CD
173.8_CD
m._FW
Goodwill_NN
amortisation_NOMZ
charged_VBD
to_PIN
administrative_JJ
expenses_NN
in_PIN
2002_CD
is_VPRT [BEMA]
36.6_CD
m_NN [BEMA]
2001_CD
11.7_CD
m._FW
12_CD
months_NN
to_PIN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
m_NN
m_NN [BEMA]
Total_JJ
operating_GER
profit_NN
is_VPRT [PASS]
arrived_VBN
at_PIN
after_IN
charging_VBG
:_:
Remuneration_NOMZ
of_PIN
the_DT
groups_NN
auditors_NN
Audit_NN
fees_NN
company_NN
0.1_CD
m_NN
:_:
2001_CD
0.1_CD
m_NN [BEMA]
1.6_CD
1.3_CD
Other_JJ
services_NN
to_PIN
the_DT
group_NN
in_PIN
the_DT
UK_NN
0.1_CD
0.2_CD
in_PIN
the_DT
rest_NN
of_PIN
the_DT
world_NN
primarily_RB
related_VBN
to_PIN
taxation_NOMZ
0.4_CD
0.2_CD
Operating_GER
lease_NN
rentals_NN
Hire_VPRT
of_PIN
plant_NN
and_PHC
machinery_NN
14.5_CD
13.9_CD
Hire_NN
of_PIN
land_NN
and_PHC
buildings_GER
and_CC
other_JJ
xed_JJ
assets_NN
15.1_CD
14.3_CD
Amortisation_NOMZ
of_PIN
government_NOMZ
grants_NN
0.2_CD
0.2_CD
Depreciation_NOMZ
of_PIN
tangible_JJ
xed_JJ
assets_NN
Owned_VBN
72.0_CD
61.1_CD
Held_VBN [PRIV]
under_IN
finance_NN
leases_VPRT
0.3_CD
0.4_CD
Amortisation_NOMZ
of_PIN
intangible_JJ
xed_JJ
assets_NN
Goodwill_NN
36.6_CD
11.7_CD
Other_JJ
intangibles_NN
7.7_CD
6.8_CD
Loss_NN
on_PIN
disposal_NN
of_PIN
tangible_JJ
xed_JJ
assets_NN
1.5_CD
0.3_CD
5_CD
Directors_NN
emoluments_VPRT
12_CD
months_NN
to_PIN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
m_FW
m_FW [BEMA]
Basic_JJ
salary_NN
2.2_CD
1.4_CD
Fees_NN
0.5_CD
0.4_CD
Benets_NN
0.4_CD
0.3_CD
Annual_JJ
bonuses_NN
1.2_CD
1.1_CD
Payments_NOMZ
of_PIN
pension_NN
contributions_NOMZ
0.2_CD
0.2_CD
Compensation_NOMZ
for_PIN
loss_NN
of_PIN
ofce_NN
0.8_CD
Payments_NOMZ
to_PIN
past_JJ
Directors_NN
0.4_CD
0.4_CD
5.7_CD
3.8_CD
Gains_NN
made_VBN [WZPAST]
on_PIN
exercise_NN
of_PIN
share_NN
options_NOMZ
and_CC
long_JJ
term_NN
incentive_NN
shares_NN
1.4_CD
5.7_CD
5.2_CD
Detailed_JJ
disclosures_NN
of_PIN
Directors_NN
individual_JJ
remuneration_NOMZ
,_,
pension_NN
entitlements_NOMZ
,_,
share_NN
options_NOMZ
and_CC
long_JJ
term_NN
incentives_NN
are_VPRT [PASS]
given_VBN
in_PIN
the_DT
Remuneration_NOMZ
report_NN
on_PIN
pages_NN
43_CD
to_PIN
50_CD
._.
Amersham_NN
plc_NN
61_CD
Notes_NN
to_PIN
the_DT
financial_JJ
statements_NOMZ
continued_VBD
6_CD
Employee_NN
information_NOMZ
The_DT
weighted_JJ
average_JJ
number_NN
of_PIN
persons_NN
including_VBG [WZPRES]
Executive_NN
Directors_NN
employed_VBN [WZPAST]
by_PIN
the_DT
group_NN
during_PIN
the_DT
year_NN
is_VPRT [BYPA]
analyzed_VBN
by_PIN
type_NN
of_PIN
work_NN
below_PLACE
._.
12_CD
months_NN
to_PIN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Number_NN
Number_NN
Production_NOMZ
and_PHC
development_NOMZ
4,962_CD
4,587_CD
Distribution_NOMZ
and_CC
selling_VBG
3,262_CD
3,140_CD
Administration_NOMZ
1,827_CD
1,792_CD
10,051_CD
9,519_CD
12_CD
months_NN
to_PIN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
m_FW
m_FW
Staff_NN
costs_NN
Aggregate_JJ
gross_JJ
wages_NN
and_PHC
salaries_NN
376.2_CD
337.3_CD
Employers_NN
National_NN
Insurance_NN
contributions_NOMZ
or_CC
foreign_JJ
equivalents_NN
72.5_CD
55.3_CD
Employers_NN
pension_NN
costs_NN
under_IN
group_NN
pension_NN
schemes_NN
27.1_CD
20.9_CD
Total_JJ
direct_JJ
costs_NN
of_PIN
employment_NOMZ
475.8_CD
413.5_CD
7_CD
Net_JJ
interest_NN
payable_JJ
12_CD
months_NN
to_PIN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
m_FW
m_FW
Interest_NN
payable_JJ
and_PHC
similar_JJ
charges_NN
On_PIN
bank_NN
loans_NN
and_PHC
overdrafts_NN
1.9_CD
3.5_CD
On_PIN
other_JJ
loans_NN
6.9_CD
13.3_CD
Unwinding_GER
of_PIN
discount_NN
on_PIN
decommissioning_VBG
provision_NN
2.8_CD
2.1_CD
11.6_CD
18.9_CD
Interest_NN
receivable_NN
and_CC
similar_JJ
income_NN
Interest_NN
on_PIN
short_JJ
term_NN
deposits_NN
and_PHC
interest_NN
bearing_GER
investments_NOMZ
4.5_CD
10.2_CD
Net_JJ
interest_NN
payable_JJ
7.1_CD
8.7_CD
Included_VBN
within_PIN
interest_NN
payable_JJ
and_PHC
similar_JJ
charges_NN
,_,
relating_VBG [PRESP]
to_PIN
the_DT
unwinding_VBG
of_PIN
the_DT
discount_NN
on_PIN
the_DT
decommissioning_VBG
provision_NN
,_,
is_VPRT [BEMA]
0.6_CD
m_NN [BEMA]
2001_CD
0.6_CD
m_NN [BEMA]
attributable_PRED
to_PIN
the_DT
groups_NN
joint_JJ
venture_NN
in_PIN
NMP_NN
._.
8_CD
Tax_NN
on_PIN
profit_NN
on_PIN
ordinary_JJ
activities_NOMZ
12_CD
months_NN
to_PIN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Restated_NN
Note_NN
m_NN
m_NN
UK_NN
corporation_NOMZ
tax_NN
at_PIN
30_CD
%_NN
2001_CD
30_CD
%_NN
Current_JJ
4.0_CD
23.0_CD
Double_RB
tax_NN
relief_NN
8.2_CD
15.4_CD
4.2_CD
7.6_CD
Overseas_PLACE
taxation_NOMZ
83.9_CD
69.3_CD
Over-provision_NN
in_PIN
respect_NN
of_PIN
prior_JJ
years_NN
18.6_CD
0.6_CD
Share_NN
of_PIN
joint_JJ
venture_NN
and_PHC
associates_NN
10.1_CD
11.7_CD
Total_JJ
current_JJ
tax_NN
71.2_CD
88.0_CD
Deferred_JJ
tax_NN
Origination_NOMZ
and_PHC
reversal_NN
of_PIN
timing_NN
differences_NN
7.1_CD
13.8_CD
Prior_RB
year_NN
deferred_VBN
tax_NN
movement_NOMZ
16.0_CD
4.8_CD
Total_JJ
deferred_JJ
tax_NN
23.1_CD
9.0_CD
Tax_NN
before_IN
exceptional_JJ
items_NN
94.3_CD
97.0_CD
Exceptional_JJ
items_NN
3_CD
9.2_CD
0.5_CD
85.1_CD
96.5_CD
The_DT
groups_NN
tax_NN
charge_NN
has_VPRT [PEAS]
benefited_VBN
from_PIN
a_DT
net_JJ
over-provision_NN
in_PIN
respect_NN
of_PIN
prior_JJ
years_NN
of_PIN
2.6_CD
m_NN [BEMA]
net_JJ
movement_NOMZ
between_PIN
current_JJ
and_PHC
deferred_JJ
tax_NN
._.
This_DEMP
is_VPRT
principally_RB
as_CONJ
a_NULL
result_NULL
of_PIN
the_DT
favourable_JJ
settlement_NOMZ
of_PIN
earlier_TIME
years_NN
taxation_NOMZ
issues_NN
._.
Furthermore_CONJ
,_,
as_CONJ
a_NULL
result_NULL
of_PIN
the_DT
purchase_NN
of_PIN
the_DT
45_CD
%_NN
minority_NOMZ
interest_NN
in_PIN
Amersham_NN
Biosciences_NN
in_PIN
the_DT
year_NN
and_CC
the_DT
subsequent_JJ
formation_NOMZ
of_PIN
a_DT
US_FPP1
consolidated_JJ
tax_NN
group_NN
,_,
it_PIT
has_VPRT [PEAS]
been_VBN [BEMA]
possible_PRED
to_TO
recognize_VB [PRIV]
certain_JJ
tax_NN
losses_NN
in_PIN
the_DT
US_FPP1
._.
The_DT
deferred_JJ
tax_NN
benefit_NN
arising_VBG [WZPRES]
has_VPRT [PEAS]
been_VBN [PASS]
treated_VBN
as_IN
an_DT
exceptional_JJ
item_NN
._.
62_CD
Amersham_NN
plc_NN
Annual_JJ
Report_NN
&_CC
Accounts_NN
2002_CD
8_CD
Tax_NN
on_PIN
profit_NN
on_PIN
ordinary_JJ
activities_NOMZ
continued_VBD
The_DT
current_JJ
tax_NN
charge_NN
for_PIN
the_DT
period_NN
is_VPRT [BEMA]
lower_PRED
2001_CD
higher_JJ
than_PIN
the_DT
standard_JJ
rate_NN
of_PIN
corporation_NOMZ
tax_NN
in_PIN
the_DT
UK_NN
of_PIN
30_CD
%_NN
._.
The_DT
differences_NN
are_VPRT [PASS]
explained_VBN [PUBV]
below_PLACE
:_:
12_CD
months_NN
to_PIN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Restated_VBN
m_NN
m_NN
profit_NN
on_PIN
ordinary_JJ
activities_NOMZ
before_IN
tax_NN
before_IN
exceptional_JJ
items_NN
263.7_CD
267.7_CD
profit_NN
on_PIN
ordinary_JJ
activities_NOMZ
multiplied_VBN [WZPAST]
by_PIN
the_DT
standard_JJ
rate_NN
of_PIN
corporation_NOMZ
tax_NN
in_PIN
the_DT
UK_NN
of_PIN
30_CD
%_NN
2001_CD
:_:
30_CD
%_NN
79.1_CD
80.3_CD
Effects_NN
of_PIN
:_:
Adjustments_NOMZ
in_PIN
respect_NN
of_PIN
prior_JJ
period_NN
18.6_CD
0.6_CD
Adjustments_NOMZ
in_PIN
respect_NN
of_PIN
foreign_JJ
tax_NN
rates_NN
7.4_CD
4.6_CD
Expenses_NN
not_XX0
deductible_JJ
for_PIN
tax_NN
purposes_NN
:_:
Non_NN
tax_NN
deductible_JJ
goodwill_NN
11.7_CD
5.1_CD
Other_JJ
1.7_CD
0.8_CD
Timing_NN
differences_NN
:_:
Capital_NN
allowances_NN
in_PIN
excess_NN
of_PIN
depreciation_NOMZ
8.0_CD
0.8_CD
Tax_NN
deductible_JJ
goodwill_NN
3.8_CD
3.8_CD
Unrealised_JJ
stock_NN
profit_NN
4.8_CD
0.1_CD
Research_NN
and_PHC
development_NOMZ
credits_NN
3.9_CD
3.9_CD
Unutilised_JJ
tax_NN
losses_NN
0.8_CD
6.4_CD
71.2_CD
88.0_CD
Exceptional_JJ
items_NN
0.5_CD
71.2_CD
87.5_CD
9_CD
Dividends_NN
paid_VBN
and_PHC
proposed_VBN [SUAV]
12_CD
months_NN
to_PIN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
m_NN [PASS]
m_NN [PASS]
Paid_VBD
interim_JJ
dividend_NN
of_PIN
2.65_CD
p_NN
per_PIN
share_NN
2001_CD
2.35_CD
p_NN
per_PIN
share_NN
21.3_CD
14.9_CD
Proposed_VBN [SUAV]
final_JJ
dividend_NN
of_PIN
5.15_CD
p_NN
per_PIN
share_NN
2001_CD
4.75_CD
p_NN
per_PIN
share_NN
36.0_CD
30.3_CD
57.3_CD
45.2_CD
Dividends_NN
paid_VBN [WZPAST]
of_PIN
21.3_CD
m_NN
contains_VPRT
2.9_CD
m_NN
relating_VBG [WZPRES]
to_PIN
the_DT
final_JJ
2001_CD
dividend_NN
paid_VBN [WZPAST]
to_PIN
holders_NN
of_PIN
the_DT
57.5_CD
m_NN [BEMA]
new_JJ
ordinary_JJ
shares_NN
which_WDT [WHSUB]
were_VBD [BYPA]
issued_VBN
by_PIN
means_NN
of_PIN
a_DT
placing_GER
on_PIN
18_CD
March_NN
2002_CD
._.
A_DT
final_JJ
dividend_NN
of_PIN
5.15_CD
p_NN
per_PIN
share_NN
is_VPRT [PASS]
proposed_VBN [SUAV]
,_,
bringing_VBG [PRESP]
the_DT
total_JJ
dividend_NN
for_PIN
the_DT
year_NN
to_PIN
7.80_CD
p._NN
10_CD
Earnings_GER
per_PIN
ordinary_JJ
share_NN
Basic_JJ
earnings_GER
per_PIN
ordinary_JJ
share_NN
is_VPRT [BYPA]
calculated_VBN [PRIV]
by_PIN
dividing_VBG
the_DT
earnings_GER
attributable_JJ
to_PIN
ordinary_JJ
shareholders_NN
by_PIN
the_DT
weighted_JJ
average_JJ
number_NN
of_PIN
ordinary_JJ
shares_NN
in_PIN
issue_NN
in_PIN
the_DT
year_NN
,_,
excluding_VBG [PRESP]
those_DEMP
held_VBN [PRIV]
by_PIN
employee_NN
share_NN
trusts_NN
._.
For_PIN
diluted_VBN
earnings_GER
per_PIN
ordinary_JJ
share_NN
,_,
the_DT
weighted_JJ
average_JJ
number_NN
of_PIN
ordinary_JJ
shares_NN
is_VPRT [PASS]
adjusted_VBN
to_TO
assume_VB [PRIV]
conversion_NN
of_PIN
all_QUAN
potentially_RB
dilutive_JJ
ordinary_JJ
shares_NN
._.
Amersham_NN
plc_NN
63_CD
Notes_NN
to_PIN
the_DT
financial_JJ
statements_NOMZ
continued_VBD
10_CD
Earnings_GER
per_PIN
ordinary_JJ
share_NN
continued_VBN
The_DT
calculation_NOMZ
of_PIN
earnings_GER
per_PIN
ordinary_JJ
share_NN
is_VPRT [PASS]
based_VBN
on_PIN
the_DT
following_VBG
attributable_JJ
profit_NN
and_CC
weighted_JJ
average_JJ
number_NN
of_PIN
shares_NN
._.
12_CD
months_NN
to_PIN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Restated_VBN
m_FW
p_FW
m_FW
p_FW
Attributable_JJ
profit_NN
profit_NN
attributable_JJ
to_PIN
shareholders_NN
basic_JJ
178.7_CD
26.1_CD
210.7_CD
33.2_CD
Add_VB [PUBV]
back_RP
the_DT
following_VBG
items_NN
Exceptional_JJ
items_NN
46.6_CD
7.3_CD
Goodwill_NN
amortisation_NOMZ
36.6_CD
5.3_CD
11.7_CD
1.9_CD
Adjust_VB
for_PIN
related_JJ
amounts_NN
of_PIN
Taxation_NOMZ
9.2_CD
1.3_CD
0.5_CD
0.1_CD
Minority_NOMZ
interest_NN
1.3_CD
0.2_CD
6.7_CD
1.1_CD
profit_NN
attributable_JJ
to_PIN
shareholders_NN
before_IN
exceptional_JJ
items_NN
and_PHC
goodwill_NN
amortisation_NOMZ
204.8_CD
29.9_CD
168.6_CD
26.6_CD
Average_JJ
number_NN
of_PIN
ordinary_JJ
shares_NN
Basic_JJ
684.7_CD
m_NN [BEMA]
634.4_CD
m_NN
Dilution_NOMZ
effect_NN
of_PIN
outstanding_JJ
share_NN
options_NOMZ
4.0_CD
m_NN [BEMA]
4.3_CD
m_NN
Diluted_NN
688.7_CD
m_NN [BEMA]
638.7_CD
m_NN
Earnings_GER
per_PIN
ordinary_JJ
share_NN
basic_JJ
26.1_CD
p_NN
33.2_CD
p_NN
before_IN
exceptional_JJ
items_NN
and_PHC
goodwill_NN
amortisation_NOMZ
29.9_CD
p_VPRT
26.6_CD
p_JJ
diluted_VBN
after_IN
exceptional_JJ
items_NN
and_PHC
goodwill_NN
amortisation_NOMZ
25.9_CD
p_VPRT
33.0_CD
p_JJ
Earnings_GER
per_PIN
ordinary_JJ
share_NN
before_IN
exceptional_JJ
items_NN
and_PHC
goodwill_NN
amortisation_NOMZ
is_VPRT [PASS]
presented_VBN
in_PIN
order_NN
to_TO
show_VB [PRIV]
the_DT
impact_NN
on_PIN
earnings_GER
of_PIN
non-recurring_JJ
items_NN
and_PHC
goodwill_NN
._.
11_CD
Intangible_NN
xed_VBD
assets_NN
Group_NN
Company_NN
Other_JJ
Other_JJ
Goodwill_NN
intangibles_VPRT
Total_JJ
intangibles_NN
m_VPRT
m_FW
m_FW
m_FW
Cost_NN
At_PIN
1_CD
January_NN
2002_CD
146.9_CD
73.0_CD
219.9_CD
1.8_CD
Foreign_JJ
currency_NN
translation_NOMZ
54.6_CD
11.5_CD
43.1_CD
Acquisition_NOMZ
of_PIN
subsidiaries_NN
3.9_CD
3.9_CD
Goodwill_NN
subsumed_VBN [WZPAST]
on_PIN
purchase_NN
of_PIN
45_CD
%_NN
minority_NOMZ
in_PIN
Amersham_NN
Biosciences_NN
79.3_CD
79.3_CD
Additions_NOMZ
744.5_CD
6.4_CD
750.9_CD
Disposals_NN
6.3_CD
6.3_CD
At_PIN
31_CD
December_NN
2002_CD
757.5_CD
88.5_CD
846.0_CD
1.8_CD
Amortisation_NOMZ
At_PIN
1_CD
January_NN
2002_CD
35.3_CD
31.9_CD
67.2_CD
1.0_CD
Foreign_JJ
currency_NN
translation_NOMZ
3.2_CD
6.4_CD
3.2_CD
Amortisation_NOMZ
subsumed_VBN [WZPAST]
on_PIN
purchase_NN
of_PIN
45_CD
%_NN
minority_NOMZ
in_PIN
Amersham_NN
Biosciences_NN
15.4_CD
15.4_CD
Disposals_NN
4.5_CD
4.5_CD
Charge_NN
for_PIN
the_DT
year_NN
36.6_CD
7.7_CD
44.3_CD
0.2_CD
At_PIN
31_CD
December_NN
2002_CD
53.3_CD
41.5_CD
94.8_CD
1.2_CD
Net_JJ
book_NN
value_NN
At_PIN
31_CD
December_NN
2002_CD
704.2_CD
47.0_CD
751.2_CD
0.6_CD
At_PIN
31_CD
December_NN
2001_CD
111.6_CD
41.1_CD
152.7_CD
0.8_CD
Additions_NOMZ
to_PIN
goodwill_NN
during_PIN
the_DT
year_NN
amounted_VBD
to_PIN
744.5_CD
m_NN
:_:
692.3_CD
m_NN [PASS]
arose_VBD
on_PIN
the_DT
purchase_NN
of_PIN
the_DT
45_CD
%_NN
minority_NOMZ
interest_NN
in_PIN
Amersham_NN
Biosciences_NN
,_,
including_VBG [PRESP]
45_CD
%_NN
of_PIN
Amersham_NN
Biosciences_NN
goodwill_NN
of_PIN
63.9_CD
m_NN
,_,
and_ANDC
52.2_CD
m_NN [PASS]
arose_VBD
on_PIN
other_JJ
acquisitions_NOMZ
,_,
see_VPRT [PRIV]
note_NN
24_CD
._.
Additions_NOMZ
to_PIN
other_JJ
intangibles_NN
of_PIN
6.4_CD
m_NN [BEMA]
during_PIN
the_DT
year_NN
comprise_VPRT
a_DT
number_NN
of_PIN
license_NN
agreements_NOMZ
entered_VBD
into_PIN
by_PIN
the_DT
group_NN
._.
Included_VBN [PASTP]
in_PIN
the_DT
cost_NN
of_PIN
land_NN
and_PHC
buildings_GER
is_VPRT [BEMA]
3.2_CD
m_NN [BEMA]
2001_CD
3.0_CD
m_NN
,_,
plant_NN
and_PHC
machinery_NN
nil_NN
2001_CD
nil_NN
,_,
and_ANDC
xtures_NN
,_,
ttings_NN
,_,
tools_NN
and_PHC
equipment_NOMZ
0.8_CD
m_NN [BEMA]
2001_CD
0.8_CD
m_NN
,_,
in_PIN
respect_NN
of_PIN
assets_NN
held_VBN [PRIV]
under_IN
finance_NN
leases_NN
for_PIN
the_DT
group_NN
,_,
and_ANDC
nil_NN
2001_CD
nil_NN
for_PIN
the_DT
company_NN
._.
Depreciation_NOMZ
on_PIN
assets_NN
held_VBN [PRIV]
under_IN
finance_NN
leases_NN
during_PIN
the_DT
year_NN
amounted_VBD
to_PIN
0.3_CD
m_NN [BEMA]
2001_CD
0.4_CD
m._FW
Included_VBN
in_PIN
the_DT
net_JJ
book_NN
value_NN
of_PIN
land_NN
and_PHC
buildings_GER
is_VPRT [BEMA]
2.2_CD
m_NN [BEMA]
2001_CD
2.3_CD
m_NN
,_,
plant_NN
and_PHC
machinery_NN
nil_NN
,_,
2001_CD
nil_NN
and_PHC
xtures_NN
,_,
ttings_NN
,_,
tools_NN
and_PHC
equipment_NOMZ
0.3_CD
m_NN [BEMA]
2001_CD
0.5_CD
m_NN
,_,
in_PIN
respect_NN
of_PIN
assets_NN
held_VBN [PRIV]
under_IN
finance_NN
leases_NN
for_PIN
the_DT
group_NN
,_,
and_ANDC
nil_NN
2001_CD
nil_NN
for_PIN
the_DT
company_NN
._.
The_DT
0.9_CD
m_NN [PASS]
transferred_VBN [WZPAST]
to_PIN
current_JJ
assets_NN
relates_VPRT
to_PIN
demonstration_NOMZ
equipment_NOMZ
reclassied_VBD
to_PIN
within_PIN
nished_VBN
goods_NN
stock_NN
._.
Amersham_NN
plc_NN
65_CD
Notes_NN
to_PIN
the_DT
financial_JJ
statements_NOMZ
continued_VBD
13_CD
Fixed_VBN
asset_NN
investments_NOMZ
Investment_NOMZ
in_PIN
own_JJ
Joint_NN
Trade_NN
shares_NN
venture_NN
Associates_NN
investments_NOMZ
Total_NN
Group_NN
m_FW
m_FW
m_FW
m_FW
m_FW
Cost_NN
or_CC
valuation_NOMZ
At_PIN
1_CD
January_NN
2002_CD
21.3_CD
67.1_CD
3.7_CD
19.4_CD
111.5_CD
Foreign_JJ
currency_NN
translation_NOMZ
0.9_CD
0.6_CD
0.9_CD
2.4_CD
Transfer_NN
to_PIN
subsidiary_NN
2.6_CD
2.6_CD
Fair_NN
value_NN
adjustments_NOMZ
relating_VBG [WZPRES]
to_PIN
the_DT
purchase_NN
of_PIN
Amersham_NN
Biosciences_NN
1.2_CD
1.2_CD
Additions_NOMZ
1.8_CD
3.4_CD
5.2_CD
Disposals_NN
5.3_CD
5.3_CD
Transfer_NN
to_PIN
employees_NN
3.9_CD
3.9_CD
Share_NN
of_PIN
retained_VBN
profit_NN
6.5_CD
6.5_CD
At_PIN
31_CD
December_NN
2002_CD
18.3_CD
73.0_CD
3.7_CD
12.8_CD
107.8_CD
Provision_NN
At_PIN
1_CD
January_NN
2002_CD
1.5_CD
2.7_CD
5.2_CD
9.4_CD
Foreign_JJ
currency_NN
translation_NOMZ
0.2_CD
0.2_CD
Charge_NN
to_TO
profit_VB
and_CC
loss_NN
0.4_CD
1.0_CD
1.0_CD
2.4_CD
Disposals_NN
3.2_CD
3.2_CD
At_PIN
31_CD
December_NN
2002_CD
1.9_CD
3.7_CD
2.8_CD
8.4_CD
Net_JJ
book_NN
value_NN
At_PIN
31_CD
December_NN
2002_CD
16.4_CD
73.0_CD
10.0_CD
99.4_CD
At_PIN
31_CD
December_NN
2001_CD
19.8_CD
67.1_CD
1.0_CD
14.2_CD
102.1_CD
Investment_NOMZ
in_PIN
own_JJ
shares_NN
group_NN
and_PHC
company_NN
Investment_NOMZ
in_PIN
own_JJ
shares_NN
is_VPRT [PASS]
held_VBN [PRIV]
through_PIN
a_DT
Qualifying_VBG
Employee_NN
Share_NN
Ownership_NN
Trust_NN
QUEST_NN
,_,
through_PIN
the_DT
Amersham_NN
ESOP_NN
Trust_NN
A_NN
ESOP_NN
,_,
and_ANDC
by_PIN
the_DT
Amersham_NN
US_FPP1
Stock_NN
Option_NOMZ
Plan_NN
Trust_NN
2000_CD
._.
Shares_NN
held_VBN [PRIV] [WZPAST]
by_PIN
the_DT
QUEST_NN
are_VPRT [BYPA]
issued_VBN
by_PIN
the_DT
company_NN
and_CC
held_VBN [PRIV]
on_PIN
trust_NN
for_PIN
employees_NN
._.
The_DT
shares_NN
are_VPRT [PASS]
transferred_VBN
to_PIN
employees_NN
on_PIN
the_DT
exercise_NN
of_PIN
options_NOMZ
under_IN
an_DT
authorised_JJ
Save_NN
As_IN
You_SPP2
Earn_VPRT
Scheme_NN
SAYE_NN
._.
Shares_NN
held_VBN [PRIV] [WZPAST]
by_PIN
A_DT
ESOP_NN
and_CC
the_DT
Amersham_NN
US_FPP1
Stock_NN
Option_NOMZ
Plan_NN
Trust_NN
2000_CD
are_VPRT [PASS]
purchased_VBN
in_PIN
the_DT
market_NN
using_VBG [WZPRES]
funds_NN
advanced_VBN [WZPAST]
by_PIN
the_DT
company_NN
and_CC
are_VPRT [PASS]
held_VBN [PRIV]
on_PIN
trust_NN
for_PIN
the_DT
employees_NN
eligible_JJ
under_IN
the_DT
companys_NN
long_JJ
term_NN
incentive_NN
plan_NN
,_,
cash_NN
options_NOMZ
under_IN
the_DT
Amersham_NN
Executive_NN
Share_NN
Option_NOMZ
Scheme_NN
1993_CD
and_CC
options_NOMZ
under_IN
the_DT
Amersham_NN
US_FPP1
Stock_NN
Option_NOMZ
Plan_NN
2000_CD
._.
The_DT
cost_NN
of_PIN
the_DT
funds_NN
advanced_VBD
to_PIN
A_DT
ESOP_NN
that_TSUB
relate_VPRT
to_PIN
the_DT
companys_NN
long_JJ
term_NN
incentive_NN
plans_VPRT
LTIP_NN
is_VPRT [PASS]
amortised_VBN
in_PIN
the_DT
profit_NN
and_PHC
loss_NN
account_NN
over_IN
the_DT
three_CD
year_NN
life_NN
of_PIN
the_DT
scheme_NN
._.
770,057_CD
shares_NN
are_VPRT [BYPA]
held_VBN [PRIV]
by_PIN
the_DT
QUEST_NN
,_,
with_PIN
a_DT
market_NN
value_NN
at_PIN
31_CD
December_NN
2002_CD
of_PIN
4.3_CD
m_NN
and_CC
a_DT
nominal_JJ
value_NN
of_PIN
0.04_CD
m._FW
545,282_CD
shares_NN
are_VPRT [BYPA]
held_VBN [PRIV]
by_PIN
the_DT
A_NN
ESOP_NN
,_,
with_PIN
a_DT
market_NN
valuation_NOMZ
at_PIN
31_CD
December_NN
2002_CD
of_PIN
3.0_CD
m_NN
and_CC
a_DT
nominal_JJ
value_NN
of_PIN
0.03_CD
m._FW
2,251,315_CD
shares_NN
are_VPRT [BYPA]
held_VBN [PRIV]
by_PIN
the_DT
Amersham_NN
US_FPP1
Stock_NN
Option_NOMZ
Plan_NN
Trust_NN
2000_CD
with_PIN
a_DT
market_NN
valuation_NOMZ
at_PIN
31_CD
December_NN
2002_CD
of_PIN
12.5_CD
m_NN
and_CC
a_DT
nominal_JJ
value_NN
of_PIN
0.1_CD
m._FW
Dividends_NN
have_VPRT [PEAS]
been_VBN [SPAU] [PASS]
partially_DWNT
waived_VBN
for_PIN
all_QUAN
schemes_NN
._.
100_CD
%_NN
of_PIN
the_DT
shares_NN
held_VBN [PRIV] [WZPAST]
by_PIN
the_DT
A_NN
ESOP_NN
and_CC
the_DT
Amersham_NN
US_FPP1
Stock_NN
Option_NOMZ
Plan_NN
Trust_NN
2000_CD
are_VPRT
under_IN
option_NOMZ
to_PIN
employees_NN
._.
None_INPR
of_PIN
the_DT
QUEST_NN
shares_NN
are_VPRT
under_IN
option_NOMZ
to_PIN
employees_NN
._.
Transfer_NN
to_PIN
subsidiary_NN
The_DT
2.6_CD
m_NN
transfer_NN
to_PIN
subsidiary_NN
relates_VPRT
to_PIN
the_DT
existing_VBG
trade_NN
investment_NOMZ
in_PIN
Cimarron_NN
Software_NN
Inc_NN
,_,
which_WDT [SERE]
became_VBD
a_DT
subsidiary_NN
undertaking_GER
in_PIN
the_DT
year_NN
._.
Market_NN
value_NN
of_PIN
listed_VBN
investments_NOMZ
The_DT
market_NN
value_NN
of_PIN
listed_VBN
investments_NOMZ
at_PIN
31_CD
December_NN
2002_CD
is_VPRT [BEMA]
3.6_CD
m_NN
,_,
2001_CD
4.9_CD
m_NN
,_,
and_ANDC
the_DT
carrying_VBG
value_NN
after_IN
provisions_NN
is_VPRT [BEMA]
5.5_CD
m_NN
,_,
2001_CD
6.3_CD
m._NN
66_CD
Amersham_NN
plc_NN
Annual_JJ
Report_NN
&_CC
Accounts_NN
2002_CD
13_CD
Fixed_VBN
asset_NN
investments_NOMZ
continued_VBD
Investments_NOMZ
Investments_NOMZ
in_PIN
own_JJ
in_PIN
group_NN
shares_NN
undertakings_GER
Total_JJ
Company_NN
Note_NN
m_FW
m_FW
m_FW
Cost_NN
or_CC
valuation_NOMZ
At_PIN
1_CD
January_NN
2002_CD
5.1_CD
204.1_CD
209.2_CD
Foreign_JJ
currency_NN
translation_NOMZ
27.2_CD
27.2_CD
Revaluation_NOMZ
of_PIN
investments_NOMZ
26_CD
3.6_CD
3.6_CD
Additions_NOMZ
0.5_CD
1,260.8_CD
1,261.3_CD
Disposals_NN
559.4_CD
559.4_CD
Transfer_NN
to_PIN
employees_NN
1.5_CD
1.5_CD
At_PIN
31_CD
December_NN
2002_CD
4.1_CD
881.9_CD
886.0_CD
Provision_NN
At_PIN
1_CD
January_NN
2002_CD
1.2_CD
1.2_CD
Charge_NN
to_TO
profit_VB
and_CC
loss_NN
0.4_CD
0.4_CD
At_PIN
31_CD
December_NN
2002_CD
1.6_CD
1.6_CD
Net_JJ
book_NN
value_NN
At_PIN
31_CD
December_NN
2002_CD
2.5_CD
881.9_CD
884.4_CD
At_PIN
31_CD
December_NN
2001_CD
3.9_CD
204.1_CD
208.0_CD
Additions_NOMZ
in_PIN
the_DT
company_NN
primarily_RB
relate_VPRT
to_PIN
the_DT
708.6_CD
m_NN
purchase_NN
of_PIN
the_DT
45_CD
%_NN
minority_NOMZ
interest_NN
in_PIN
Amersham_NN
Biosciences_NN
._.
Following_VBG [PRESP]
the_DT
purchase_NN
,_,
the_DT
group_NN
undertook_VBD
a_DT
reorganisation_NOMZ
which_WDT [WHSUB]
involved_VBD
the_DT
acquisition_NOMZ
and_PHC
disposal_NN
of_PIN
shares_NN
between_PIN
the_DT
company_NN
and_CC
its_PIT
subsidiaries_NN
._.
14_CD
Stocks_NN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Group_NN
Group_NN
Company_NN
Company_NN
m_FW
m_FW
m_FW
m_FW
Raw_FW
materials_NN
and_PHC
consumables_NN
53.0_CD
46.5_CD
6.9_CD
7.9_CD
Work_NN
in_PIN
progress_NN
56.7_CD
45.5_CD
6.9_CD
7.6_CD
Finished_VBN
goods_NN
and_PHC
goods_NN
for_PIN
resale_NN
98.3_CD
88.6_CD
4.0_CD
1.9_CD
208.0_CD
180.6_CD
17.8_CD
17.4_CD
The_DT
replacement_NOMZ
cost_NN
of_PIN
stocks_NN
is_VPRT
not_XX0
materially_RB
different_PRED
from_PIN
original_JJ
cost_NN
._.
15_CD
Debtors_NN
amounts_NN
due_JJ
within_PIN
one_CD
year_NN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Group_NN
Group_NN
Company_NN
Company_NN
Restated_NN
m_FW
m_FW
m_FW
m_FW
Trade_NN
debtors_NN
301.7_CD
298.2_CD
8.2_CD
7.9_CD
Amounts_NN
owed_VBN [WZPAST]
by_PIN
group_NN
undertakings_GER
535.4_CD
555.6_CD
Amounts_NN
owed_VBN [WZPAST]
by_PIN
joint_JJ
venture_NN
and_PHC
associates_NN
1.0_CD
1.3_CD
1.0_CD
1.3_CD
Other_JJ
debtors_NN
21.2_CD
34.7_CD
4.2_CD
6.7_CD
Prepayments_NOMZ
and_CC
accrued_VBN
income_NN
25.3_CD
26.6_CD
4.2_CD
4.9_CD
349.2_CD
360.8_CD
553.0_CD
576.4_CD
16_CD
Debtors_NN
amounts_NN
due_RB
after_IN
one_CD
year_NN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Group_NN
Group_NN
Company_NN
Company_NN
Restated_NN
m_FW
m_FW
m_FW
m_FW [BYPA]
Amounts_NN
owed_VBN [WZPAST]
by_PIN
group_NN
undertakings_GER
201.9_CD
Other_JJ
debtors_NN
17.3_CD
16.7_CD
2.9_CD
Prepayments_NOMZ
and_CC
accrued_VBN
income_NN
11.1_CD
8.7_CD
10.7_CD
8.7_CD
Deferred_JJ
taxation_NOMZ
assets_NN
32.9_CD
30.0_CD
61.3_CD
55.4_CD
212.6_CD
11.6_CD
Amersham_NN
plc_NN
67_CD
Notes_NN
to_PIN
the_DT
financial_JJ
statements_NOMZ
continued_VBD
17_CD
Short_JJ
term_NN
deposits_NN
and_PHC
investments_NOMZ
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Group_NN
Group_NN
Company_NN
Company_NN
m_FW
m_FW
m_FW
m_FW [BEMA]
Short_JJ
term_NN
deposits_NN
included_VBD
in_PIN
net_JJ
debt_NN
see_VPRT [PRIV]
note_NN
32_CD
22.1_CD
96.5_CD
21.6_CD
92.5_CD
Loan_NN
notes_VPRT [PRIV]
2.9_CD
2.9_CD
22.1_CD
99.4_CD
21.6_CD
95.4_CD
18_CD
Creditors_NN
amounts_NN
due_JJ
within_PIN
one_CD
year_NN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Group_NN
Group_NN
Company_NN
Company_NN
m_FW
m_FW
m_FW
m_FW
Loans_NN
Short_NN
term_NN
loans_NN
from_PIN
group_NN
undertakings_GER
857.6_CD
532.5_CD
Short_JJ
term_NN
loan_NN
from_PIN
joint_JJ
venture_NN
and_PHC
associates_NN
26.2_CD
26.2_CD
Bank_NN
loans_NN
and_PHC
overdrafts_NN
16.2_CD
14.8_CD
0.9_CD
4.4_CD
Finance_NN
lease_NN
obligations_NOMZ
0.3_CD
0.3_CD
Unsecured_JJ
loan_NN
notes_VPRT [PRIV]
1.9_CD
15.7_CD
13.8_CD
44.6_CD
30.8_CD
884.7_CD
550.7_CD
Other_JJ
creditors_NN
Trade_NN
creditors_NN
71.2_CD
86.4_CD
11.5_CD
13.9_CD
Amounts_NN
owed_VBN [WZPAST]
to_PIN
group_NN
undertakings_GER
18.2_CD
15.8_CD
Amounts_NN
owed_VBN [WZPAST]
to_PIN
joint_JJ
venture_NN
and_PHC
associates_NN
0.1_CD
0.1_CD
0.1_CD
0.1_CD
United_NN
Kingdom_NN
corporation_NOMZ
tax_NN
6.1_CD
9.9_CD
4.8_CD
9.9_CD
Overseas_PLACE
subsidiary_NN
taxation_NOMZ
128.9_CD
108.1_CD
Other_JJ
taxes_NN
and_CC
social_JJ
security_NOMZ
27.0_CD
19.7_CD
2.6_CD
2.1_CD
Other_JJ
creditors_NN
63.0_CD
42.9_CD
9.8_CD
6.4_CD
Accruals_NN
and_CC
deferred_JJ
income_NN
149.9_CD
155.1_CD
51.2_CD
47.6_CD
Dividends_NN
payable_JJ
36.0_CD
30.3_CD
36.0_CD
30.3_CD
482.2_CD
452.5_CD
134.2_CD
126.1_CD
526.8_CD
483.3_CD
1,018.9_CD
676.8_CD
19_CD
Creditors_NN
amounts_NN
due_RB
after_IN
one_CD
year_NN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Group_NN
Group_NN
Company_NN
Company_NN
m_FW
m_FW
m_FW
m_FW
Loans_NN
Bank_NN
loans_NN
and_PHC
overdrafts_NN
68.5_CD
8.7_CD
61.6_CD
Finance_NN
lease_NN
obligations_NOMZ
2.5_CD
2.7_CD
Unsecured_JJ
loan_NN
notes_NN
121.5_CD
136.6_CD
119.9_CD
133.1_CD
192.5_CD
148.0_CD
181.5_CD
133.1_CD
Other_JJ
creditors_NN
11.5_CD
6.4_CD
3.7_CD
6.7_CD
204.0_CD
154.4_CD
185.2_CD
139.8_CD
Repayments_NOMZ
are_VPRT [BEMA]
due_PRED
as_IN
follows_VPRT
:_:
Between_PIN
one_CD
and_CC
two_CD
years_NN
108.6_CD
7.9_CD
103.9_CD
3.0_CD
Between_PIN
two_CD
and_CC
five_CD
years_NN
84.3_CD
134.3_CD
71.6_CD
125.8_CD
In_PIN
five_CD
years_NN
or_CC
more_EMPH
11.1_CD
12.2_CD
9.7_CD
11.0_CD
204.0_CD
154.4_CD
185.2_CD
139.8_CD
The_DT
company_NN
has_VPRT
$_$
193.0_CD
m_NN
,_,
2001_CD
$_$
213.0_CD
m_NN
,_,
equivalent_JJ
to_PIN
123.4_CD
m_NN
,_,
2001_CD
152.3_CD
m_NN
,_,
of_PIN
private_JJ
placement_NOMZ
unsecured_JJ
loan_NN
notes_NN
see_VPRT [PRIV]
note_NN
20_CD
._.
The_DT
carrying_VBG
value_NN
of_PIN
these_DEMO
notes_NN
includes_VPRT
a_DT
fair_JJ
value_NN
adjustment_NOMZ
of_PIN
3.5_CD
m_NN
,_,
2001_CD
5.4_CD
m._NN
The_DT
fair_JJ
value_NN
adjustment_NOMZ
arose_VBD
on_PIN
the_DT
acquisition_NOMZ
of_PIN
the_DT
notes_NN
at_PIN
the_DT
time_NN
of_PIN
the_DT
merger_NN
with_PIN
Nycomed_NN
._.
Of_PIN
the_DT
carrying_VBG
value_NN
,_,
1.9_CD
m_NN
,_,
2001_CD
15.7_CD
m_NN
,_,
is_VPRT [PASS]
reported_VBN [PUBV]
in_PIN
amounts_NN
due_JJ
within_PIN
one_CD
year_NN
._.
68_CD
Amersham_NN
plc_NN
Annual_JJ
Report_NN
&_CC
Accounts_NN
2002_CD
20_CD
Derivatives_NN
and_CC
other_JJ
financial_JJ
instruments_NOMZ
A_DT
discussion_NN
of_PIN
the_DT
groups_NN
objectives_NN
and_PHC
policies_NN
with_PIN
regard_NN
to_PIN
the_DT
use_NN
of_PIN
financial_JJ
instruments_NOMZ
is_VPRT [PASS]
found_VBN [PRIV]
in_PIN
the_DT
Treasury_NN
Policy_NN
and_PHC
Liquidity_NOMZ
section_NOMZ
of_PIN
the_DT
Financial_NN
review_NN
on_PIN
page_NN
33_CD
._.
Where_RB
permitted_VBN
by_PIN
FRS13_CD
,_,
disclosures_NN
in_PIN
this_DEMO
note_NN
exclude_VPRT
short_JJ
term_NN
debtors_NN
and_PHC
creditors_NN
._.
a_DT
Currency_NN
and_PHC
interest_NN
rate_NN
composition_NOMZ
of_PIN
financial_JJ
liabilities_NOMZ
of_PIN
the_DT
group_NN
The_DT
following_VBG
table_NN
analyses_VPRT
the_DT
currency_NN
and_PHC
interest_NN
rate_NN
composition_NOMZ
of_PIN
the_DT
groups_NN
financial_JJ
liabilities_NOMZ
at_PIN
31_CD
December_NN
after_IN
taking_VBG
into_PIN
account_NN
interest_NN
rate_NN
and_PHC
currency_NN
swaps_NN
._.
The_DT
financial_JJ
liabilities_NOMZ
comprise_VPRT
bank_NN
loans_NN
and_PHC
overdrafts_NN
plus_PIN
any_QUAN
long_JJ
term_NN
contractual_JJ
obligations_NOMZ
to_TO
deliver_VB
cash_NN
or_CC
other_JJ
financial_JJ
assets_NN
to_PIN
third_JJ
parties_NN
._.
In_CONJ
addition_NULL
a_DT
short_JJ
term_NN
loan_NN
from_PIN
the_DT
groups_NN
joint_JJ
venture_NN
of_PIN
26.2_CD
m_NN [BEMA]
2001_CD
nil_NN
is_VPRT [PASS]
included_VBN
within_PIN
the_DT
analysis_NN
of_PIN
net_JJ
debt_NN
._.
The_DT
average_JJ
interest_NN
rates_NN
for_PIN
the_DT
financial_JJ
liabilities_NOMZ
of_PIN
the_DT
group_NN
at_PIN
31_CD
December_NN
,_,
together_RB
with_PIN
the_DT
periods_NN
for_PIN
which_WDT [PIRE]
the_DT
rates_NN
were_VBD [PASS]
xed_VBN
,_,
are_VPRT [PASS]
set_VBN
out_PIN
in_PIN
the_DT
table_NN
below_PLACE
:_:
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Average_JJ
Average_JJ
Average_JJ
Average_JJ
interest_NN
rate_NN
years_NN
to_PIN
Average_JJ
years_NN
to_PIN
interest_NN
rate_NN
years_NN
to_PIN
Average_JJ
years_NN
to_PIN
of_PIN
xed_JJ
rate_NN
maturity_NOMZ
of_PIN
maturity_NOMZ
of_PIN
nonof_JJ
xed_JJ
rate_NN
maturity_NOMZ
of_PIN
maturity_NOMZ
of_PIN
nonliabilities_NOMZ
xed_VBN
rate_NN
interest_NN
bearing_VBG [WZPRES]
liabilities_NOMZ
xed_VBN
rate_NN
interest_NN
bearing_VBG [WZPRES]
%_NN
liabilities_NOMZ
financial_JJ
liabilities_NOMZ
%_NN
liabilities_NOMZ
financial_JJ
liabilities_NOMZ
Sterling_GER
5.0_CD
0.0_CD
1.5_CD
8.0_CD
n_NN
a_DT
US_FPP1
dollars_NN
8.6_CD
2.4_CD
0.0_CD
7.3_CD
3.2_CD
0.0_CD
Euro_NN
3.4_CD
6.4_CD
0.5_CD
1.3_CD
Danish_JJ
kroner_NN
6.0_CD
1.2_CD
2.7_CD
6.0_CD
0.5_CD
3.7_CD
Norwegian_JJ
kroner_NN
3.9_CD
1.5_CD
2.4_CD
4.3_CD
1.1_CD
Other_JJ
currencies_NN
5.5_CD
1.2_CD
5.9_CD
2.3_CD
4.2_CD
1.5_CD
0.9_CD
7.3_CD
2.4_CD
0.5_CD
Financial_NN
liabilities_NOMZ
are_VPRT [PASS]
analyzed_VBN
as_IN
:_:
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
NonNonFixed_NN
Floating_VBG [WZPRES]
interest_NN
Fixed_VBN
Floating_VBG
interest_NN
rate_NN
rate_NN
bearing_VBG [WZPRES]
Total_JJ
rate_NN
rate_NN
bearing_VBG [WZPRES]
Total_JJ
m_NN
m_FW
m_FW
m_FW
m_FW
m_FW
m_FW
m_FW
Bank_NN
loans_NN
and_PHC
overdrafts_NN
15.3_CD
62.8_CD
6.6_CD
84.7_CD
12.2_CD
5.7_CD
5.6_CD
23.5_CD
Finance_NN
lease_NN
obligations_NOMZ
2.8_CD
2.8_CD
3.0_CD
3.0_CD
Unsecured_JJ
loan_NN
notes_NN
123.4_CD
123.4_CD
152.3_CD
152.3_CD
Currency_NN
and_PHC
interest_NN
rate_NN
swaps_NN
31.1_CD
31.1_CD
17.2_CD
17.2_CD
Other_JJ
financial_JJ
liabilities_NOMZ
7.8_CD
2.4_CD
10.2_CD
3.6_CD
0.8_CD
4.4_CD
Non-equity_JJ
minority_NOMZ
interest_NN
42.6_CD
42.6_CD
115.4_CD
96.7_CD
9.0_CD
221.1_CD
193.5_CD
25.9_CD
6.4_CD
225.8_CD
Floating_VBG
rate_NN
interest_NN
on_PIN
bank_NN
loans_NN
and_PHC
overdrafts_NN
is_VPRT [PASS]
based_VBN
on_PIN
local_JJ
bank_NN
base_NN
rates_NN
,_,
and_ANDC
the_DT
oating_NN
rate_NN
interest_NN
on_PIN
swaps_NN
is_VPRT [PASS]
based_VBN
on_PIN
LIBOR_NN
._.
Amersham_NN
plc_NN
69_CD
Notes_NN
to_PIN
the_DT
financial_JJ
statements_NOMZ
continued_VBD
20_CD
Derivatives_NN
and_CC
other_JJ
financial_JJ
instruments_NOMZ
continued_VBD
The_DT
groups_NN
principal_JJ
xed_VBN
rate_NN
debt_NN
obligations_NOMZ
are_VPRT [BEMA]
three_CD
series_NN
of_PIN
US_FPP1
private_JJ
placement_NOMZ
unsecured_JJ
loan_NN
notes_NN
with_PIN
the_DT
following_JJ
rates_NN
and_PHC
maturities_NOMZ
:_:
Amount_NN
Interest_NN
rate_NN
Series_NN
$_$
m_CD
%_NN
Maturity_NOMZ
Series_NN
B_NN
15_CD
8.79_CD
February_NN
2005_CD
Series_NN
C_NN
163_CD
8.77_CD
November_NN
2004_CD
Series_NN
D_NN
15_CD
8.97_CD
November_NN
2009_CD
The_DT
carrying_GER
value_NN
of_PIN
Series_NN
C_NN
and_PHC
D_NN
notes_VPRT [PRIV]
includes_VPRT
a_DT
fair_JJ
value_NN
adjustment_NOMZ
of_PIN
3.5_CD
m_NN [BEMA]
2001_CD
5.4_CD
m_NN
,_,
which_WDT [SERE]
arose_VBD
on_PIN
the_DT
acquisition_NOMZ
of_PIN
the_DT
debt_NN
instruments_NOMZ
at_PIN
the_DT
time_NN
of_PIN
the_DT
merger_NN
with_PIN
Nycomed_NN
._.
The_DT
interest_NN
rate_NN
of_PIN
US_FPP1
dollar_NN
xed_VBD
rate_NN
liabilities_NOMZ
is_VPRT [PASS]
adjusted_VBN
for_PIN
the_DT
partial_JJ
unwinding_VBG
of_PIN
this_DEMO
fair_JJ
value_NN
adjustment_NOMZ
during_PIN
the_DT
periods_NN
reported_VBD [PUBV]
._.
b_NN
Currency_NN
and_PHC
interest_NN
rate_NN
composition_NOMZ
of_PIN
financial_JJ
assets_NN
of_PIN
the_DT
group_NN
The_DT
following_JJ
tables_NN
analyze_VPRT
the_DT
currency_NN
and_PHC
interest_NN
rate_NN
composition_NOMZ
of_PIN
the_DT
groups_NN
financial_JJ
assets_NN
at_PIN
31_CD
December_NN
._.
The_DT
financial_JJ
assets_NN
comprise_VPRT
cash_NN
at_PIN
bank_NN
,_,
short_JJ
term_NN
deposits_NN
,_,
trade_NN
investments_NOMZ
and_PHC
interest_NN
bearing_GER
investments_NOMZ
plus_PIN
any_QUAN
long_JJ
term_NN
contractual_JJ
rights_NN
to_TO
receive_VB
cash_NN
or_CC
other_JJ
financial_JJ
assets_NN
from_PIN
third_JJ
parties_NN
._.
The_DT
interest_NN
rates_NN
on_PIN
the_DT
majority_NOMZ
of_PIN
oating_NN
rate_NN
financial_JJ
assets_NN
are_VPRT [PASS]
based_VBN
on_PIN
local_JJ
market_NN
oating_NN
rates_NN
._.
The_DT
average_JJ
interest_NN
rates_NN
for_PIN
the_DT
financial_JJ
assets_NN
of_PIN
the_DT
group_NN
at_PIN
31_CD
December_NN
,_,
together_RB
with_PIN
the_DT
period_NN
for_PIN
which_WDT [PIRE]
the_DT
rates_NN
were_VBD [PASS]
xed_VBN
,_,
are_VPRT
as_IN
follows_VPRT
:_:
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2001_CD
Average_JJ
years_NN
to_PIN
Average_JJ
years_NN
Average_JJ
Average_JJ
maturity_NOMZ
of_PIN
Average_JJ
Average_JJ
to_PIN
maturity_NOMZ
of_PIN
interest_NN
rate_NN
years_NN
to_PIN
non-interest_JJ
interest_NN
rate_NN
years_NN
to_PIN
non-interest_JJ
of_PIN
xed_JJ
rate_NN
maturity_NOMZ
of_PIN
bearing_GER
of_PIN
xed_JJ
rate_NN
maturity_NOMZ
of_PIN
bearing_VBG
assets_NN
xed_VBN
rate_NN
financial_JJ
assets_NN
xed_VBD
rate_NN
financial_JJ
%_NN
assets_NN
assets_NN
%_NN
assets_NN
assets_NN
Sterling_GER
3.7_CD
0.0_CD
0.0_CD
3.7_CD
0.1_CD
0.1_CD
US_FPP1
dollars_NN
3.9_CD
0.3_CD
0.4_CD
8.2_CD
1.8_CD
0.6_CD
Japanese_JJ
yen_NN
0.0_CD
Euro_NN
2.0_CD
0.0_CD
0.2_CD
6.8_CD
4.3_CD
0.0_CD
Norwegian_JJ
kroner_NN
2.8_CD
0.3_CD
0.8_CD
6.7_CD
0.1_CD
Danish_JJ
kroner_NN
1.9_CD
8.9_CD
0.0_CD
Swedish_JJ
kronor_NN
0.2_CD
0.0_CD
0.0_CD
Other_JJ
currencies_NN
3.8_CD
0.0_CD
0.0_CD
1.8_CD
0.1_CD
0.0_CD
3.3_CD
0.1_CD
0.1_CD
6.4_CD
1.0_CD
0.4_CD
70_CD
Amersham_NN
plc_NN
Annual_JJ
Report_NN
&_CC
Accounts_NN
2002_CD
20_CD
Derivatives_NN
and_CC
other_JJ
financial_JJ
instruments_NOMZ
continued_VBD
Financial_JJ
assets_NN
are_VPRT [PASS]
analyzed_VBN
as_IN
follows_VPRT
:_:
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
NonNonFixed_NN
Floating_VBG [WZPRES]
interest_NN
Fixed_VBN
Floating_VBG
interest_NN
rate_NN
rate_NN
bearing_VBG [WZPRES]
Total_JJ
rate_NN
rate_NN
bearing_VBG [WZPRES]
Total_JJ
m_NN
m_FW
m_FW
m_FW
m_FW
m_FW
m_FW
m_FW
Cash_NN
at_PIN
bank_NN
and_CC
in_PIN
hand_NN
1.7_CD
24.3_CD
6.7_CD
32.7_CD
1.2_CD
43.3_CD
12.4_CD
56.9_CD
Short_JJ
term_NN
deposits_NN
0.4_CD
4.4_CD
17.3_CD
22.1_CD
20.0_CD
74.4_CD
2.1_CD
96.5_CD
Interest_NN
bearing_GER
investments_NOMZ
2.9_CD
2.9_CD
Equity_NOMZ
investments_NOMZ
8.1_CD
8.1_CD
12.8_CD
12.8_CD
Other_JJ
financial_JJ
assets_NN
0.4_CD
4.7_CD
5.1_CD
0.8_CD
5.6_CD
6.4_CD
2.5_CD
28.7_CD
36.8_CD
68.0_CD
24.9_CD
117.7_CD
32.9_CD
175.5_CD
In_CONJ
addition_NULL
to_PIN
the_DT
financial_JJ
liabilities_NOMZ
and_CC
financial_JJ
assets_NN
disclosed_VBN [PUBV]
above_PLACE
,_,
the_DT
group_NN
has_VPRT [PEAS]
granted_VBN [SUAV]
put_JJ
options_NOMZ
over_IN
shares_NN
in_PIN
Corixa_NN
Corporation_NOMZ
,_,
Cimarron_NN
Software_NN
Inc._NN
and_PHC
Imaging_GER
Research_NN
Inc._NN
and_CC
holds_VPRT [PRIV]
call_JJ
options_NOMZ
over_IN
shares_NN
in_PIN
Cimarron_NN
Software_NN
Inc._NN
._.
Imaging_GER
Research_NN
Inc._NN
and_PHC
Analytica_NN
of_PIN
Branford_NN
which_WDT [WHSUB]
meet_VPRT
the_DT
denition_NOMZ
of_PIN
financial_JJ
instruments_NOMZ
._.
The_DT
maximum_NN
potential_JJ
aggregate_JJ
cash_NN
consideration_NOMZ
under_IN
these_DEMO
contracts_NN
is_VPRT
US$_$
71.5_CD
m._FW
These_DEMO
options_NOMZ
expire_VPRT
by_PIN
2006_CD
._.
c_NN
Maturity_NOMZ
of_PIN
financial_JJ
liabilities_NOMZ
The_DT
maturity_NOMZ
of_PIN
the_DT
groups_NN
financial_JJ
liabilities_NOMZ
at_PIN
31_CD
December_NN
is_VPRT [PASS]
analyzed_VBN
as_IN
follows_VPRT
:_:
Bank_NN
Finance_NN
Other_JJ
Non-equity_JJ
loans_NN
and_PHC
lease_NN
Unsecured_JJ
financial_JJ
minority_NOMZ
overdrafts_NN
obligations_NOMZ
loan_NN
notes_VPRT [PRIV]
liabilities_NOMZ
interest_NN
Total_JJ
31_CD
December_NN
2002_CD
m_FW
m_FW
m_FW
m_FW
m_FW
m_FW
Analysis_NN
by_PIN
year_NN
of_PIN
repayment_NOMZ
Due_JJ
within_PIN
one_CD
year_NN
or_CC
on_PIN
demand_NN
16.2_CD
0.3_CD
1.9_CD
1.5_CD
19.9_CD
Between_PIN
one_CD
and_CC
two_CD
years_NN
3.0_CD
0.3_CD
102.9_CD
1.5_CD
107.7_CD
Between_PIN
two_CD
and_CC
five_CD
years_NN
65.2_CD
0.6_CD
9.8_CD
7.2_CD
82.8_CD
In_PIN
five_CD
years_NN
or_CC
more_EMPH
0.3_CD
1.6_CD
8.8_CD
10.7_CD
Due_JJ
after_IN
more_EMPH
than_PIN
one_CD
year_NN
68.5_CD
2.5_CD
121.5_CD
8.7_CD
201.2_CD
Total_JJ
repayments_NOMZ
84.7_CD
2.8_CD
123.4_CD
10.2_CD
221.1_CD
Bank_NN
Finance_NN
Other_JJ
Non-equity_JJ
loans_NN
and_PHC
lease_NN
Unsecured_JJ
financial_JJ
minority_NOMZ
overdrafts_NN
obligations_NOMZ
loan_NN
notes_VPRT [PRIV]
liabilities_NOMZ
interest_NN
Total_JJ
31_CD
December_NN
2001_CD
m_FW
m_FW
m_FW
m_FW
m_FW
m_FW
Analysis_NN
by_PIN
year_NN
of_PIN
repayment_NOMZ
Due_JJ
within_PIN
one_CD
year_NN
or_CC
on_PIN
demand_NN
14.8_CD
0.3_CD
15.7_CD
2.2_CD
33.0_CD
Between_PIN
one_CD
and_CC
two_CD
years_NN
2.0_CD
0.3_CD
2.0_CD
0.7_CD
5.0_CD
Between_PIN
two_CD
and_CC
five_CD
years_NN
6.7_CD
0.7_CD
124.7_CD
1.5_CD
133.6_CD
In_PIN
five_CD
years_NN
or_CC
more_EMPH
1.7_CD
9.9_CD
42.6_CD
54.2_CD
Due_JJ
after_IN
more_EMPH
than_PIN
one_CD
year_NN
8.7_CD
2.7_CD
136.6_CD
2.2_CD
42.6_CD
192.8_CD
Total_JJ
repayments_NOMZ
23.5_CD
3.0_CD
152.3_CD
4.4_CD
42.6_CD
225.8_CD
The_DT
group_NN
has_VPRT
undrawn_JJ
committed_JJ
borrowing_GER
facilities_NOMZ
available_JJ
to_PIN
it_PIT
at_PIN
31_CD
December_NN
as_IN
follows_VPRT
:_:
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
m_NN
m_NN
Expiring_VBG [WZPRES]
within_PIN
one_CD
year_NN
430.0_CD
Expiring_VBG
between_PIN
four_CD
years_NN
and_CC
five_CD
years_NN
404.3_CD
404.3_CD
430.0_CD
Amersham_NN
plc_NN
71_CD
Notes_NN
to_PIN
the_DT
financial_JJ
statements_NOMZ
continued_VBD
20_CD
Derivatives_NN
and_CC
other_JJ
financial_JJ
instruments_NOMZ
continued_VBD
d_SYM
Currency_NN
risk_NN
exposure_NN
The_DT
following_VBG
table_NN
shows_VPRT [PRIV]
the_DT
currency_NN
exposure_NN
of_PIN
the_DT
net_JJ
monetary_JJ
assets_NN
and_PHC
liabilities_NOMZ
of_PIN
group_NN
companies_NN
at_PIN
31_CD
December_NN
._.
The_DT
exposures_NN
arise_VPRT
where_RB
monetary_JJ
assets_NN
and_PHC
liabilities_NOMZ
are_VPRT [PASS]
denominated_VBN
in_PIN
currencies_NN
other_JJ
than_PIN
the_DT
functional_JJ
currency_NN
of_PIN
the_DT
operating_VBG
company_NN
in_PIN
which_WDT [PIRE]
they_TPP3
are_VPRT [PASS]
held_VBN [PRIV]
._.
The_DT
gains_NN
or_CC
losses_NN
on_PIN
these_DEMO
monetary_JJ
assets_NN
and_PHC
liabilities_NOMZ
are_VPRT [PASS]
recorded_VBN
in_PIN
the_DT
profit_NN
and_PHC
loss_NN
account_NN
._.
Japanese_JJ
Norwegian_JJ
Swedish_JJ
Sterling_GER
US_FPP1
dollars_NN
yen_NN
Euro_NN
kroner_NN
kronor_NN
Other_JJ
Total_NN
31_CD
December_NN
2002_CD
m_FW
m_FW
m_FW
m_FW
m_FW
m_FW
m_FW
m_FW [BEMA]
Functional_JJ
currency_NN
of_PIN
operating_VBG
company_NN
Sterling_GER
8.9_CD
1.8_CD
1.8_CD
7.6_CD
0.6_CD
3.2_CD
12.7_CD
US_FPP1
dollars_NN
0.1_CD
0.1_CD
Japanese_JJ
yen_NN
0.3_CD
1.6_CD
1.3_CD
Euro_NN
0.9_CD
5.6_CD
1.2_CD
0.3_CD
5.6_CD
Norwegian_JJ
kroner_NN
7.5_CD
1.8_CD
16.1_CD
6.5_CD
0.1_CD
9.4_CD
22.8_CD
Swedish_JJ
kronor_NN
3.8_CD
9.8_CD
1.8_CD
7.4_CD
0.2_CD
7.8_CD
Other_JJ
currencies_NN
0.1_CD
13.5_CD
0.7_CD
5.0_CD
0.1_CD
19.4_CD
4.2_CD
5.4_CD
16.1_CD
1.6_CD
1.4_CD
0.8_CD
12.2_CD
30.5_CD
Japanese_JJ
Norwegian_JJ
Swedish_JJ
Sterling_GER
US_FPP1
dollars_NN
yen_NN
Euro_NN
kroner_NN
kronor_NN
Other_JJ
Total_NN
31_CD
December_NN
2001_CD
m_FW
m_FW
m_FW
m_FW
m_FW
m_FW
m_FW
m_FW [BEMA]
Functional_JJ
currency_NN
of_PIN
operating_VBG
company_NN
Sterling_GER
15.3_CD
0.9_CD
11.9_CD
7.0_CD
9.7_CD
3.0_CD
16.2_CD
US_FPP1
dollars_NN
3.4_CD
1.6_CD
5.0_CD
Japanese_JJ
yen_NN
1.7_CD
1.7_CD
Euro_NN
0.4_CD
3.7_CD
0.1_CD
0.3_CD
0.1_CD
3.8_CD
Norwegian_JJ
kroner_NN
3.0_CD
5.5_CD
2.7_CD
4.5_CD
0.1_CD
0.4_CD
5.0_CD
Swedish_JJ
kronor_NN
4.0_CD
11.6_CD
3.9_CD
3.3_CD
0.3_CD
1.8_CD
2.5_CD
Other_JJ
currencies_NN
3.2_CD
4.0_CD
0.8_CD
10.0_CD
3.0_CD
5.7_CD
4.1_CD
10.8_CD
9.9_CD
2.7_CD
26.6_CD
e_SYM
Fair_NN
values_NN
and_PHC
disclosures_NN
The_DT
estimated_VBN [PRIV]
book_NN
values_NN
and_CC
fair_JJ
values_NN
of_PIN
the_DT
groups_NN
financial_JJ
instruments_NOMZ
at_PIN
31_CD
December_NN
are_VPRT [PASS]
set_VBN
out_PIN
below_PLACE
:_:
Primary_JJ
financial_JJ
instruments_NOMZ
held_VBN [PRIV]
or_CC
issued_VBN
to_TO
finance_VB
the_DT
groups_NN
operations_NOMZ
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Book_NN
value_NN
Fair_NN
value_NN
Book_NN
value_NN
Fair_NN
value_NN
m_NN
m_FW
m_FW
m_FW [BEMA]
1_CD
Cash_NN
at_PIN
bank_NN
32.7_CD
32.7_CD
56.9_CD
56.9_CD
1_CD
Short_JJ
term_NN
deposits_NN
22.1_CD
22.1_CD
96.5_CD
96.5_CD
1_CD
Interest_NN
bearing_GER
investments_NOMZ
2.9_CD
2.9_CD
2_CD
Equity_NOMZ
investments_NOMZ
8.1_CD
6.2_CD
12.8_CD
11.4_CD
3_CD
Other_JJ
financial_JJ
assets_NN
5.1_CD
5.1_CD
6.4_CD
6.6_CD
1_CD
Bank_NN
loans_NN
and_PHC
overdrafts_NN
84.7_CD
84.7_CD
23.5_CD
23.5_CD
4_CD
Non-equity_NOMZ
minority_NOMZ
interest_NN
42.6_CD
42.6_CD
1_CD
Finance_NN
lease_NN
obligations_NOMZ
2.8_CD
2.8_CD
3.0_CD
3.0_CD
5_CD
Other_JJ
financial_JJ
liabilities_NOMZ
10.2_CD
10.2_CD
4.4_CD
4.4_CD
6_CD
Unsecured_JJ
loan_NN
notes_NN
123.4_CD
140.0_CD
152.3_CD
171.0_CD
1_CD
The_DT
fair_JJ
values_NN
of_PIN
cash_NN
,_,
short_JJ
term_NN
deposits_NN
,_,
interest_NN
bearing_GER
investments_NOMZ
excluding_VBG [WZPRES]
subordinated_JJ
loan_NN
notes_NN
and_PHC
overdrafts_NN
approximate_JJ
to_TO
carrying_VBG
values_NN
due_JJ
to_PIN
the_DT
short_JJ
maturity_NOMZ
period_NN
of_PIN
these_DEMO
financial_JJ
assets_NN
._.
The_DT
difference_NN
between_PIN
carrying_VBG
value_NN
and_CC
fair_JJ
value_NN
is_VPRT [SPAU] [PASS]
also_RB
considered_VBN [PRIV]
to_TO
be_VB [BEMA]
immaterial_PRED
for_PIN
oating_VBG
rate_NN
bank_NN
loans_NN
and_PHC
finance_NN
lease_NN
obligations_NOMZ
._.
Interest_NN
bearing_GER
investments_NOMZ
included_VBD
subordinated_JJ
loan_NN
notes_NN
that_TSUB
were_VBD [BYPA]
valued_VBN
by_PIN
discounting_VBG
the_DT
associated_VBN
future_JJ
cash_NN
ows_VPRT
to_PIN
31_CD
December_NN
2001_CD
._.
The_DT
difference_NN
between_PIN
carrying_VBG
value_NN
and_CC
fair_JJ
value_NN
was_VBD [PASS]
considered_VBN [PRIV]
immaterial_JJ
._.
2_CD
Equity_NOMZ
investments_NOMZ
represent_VPRT
equity_NOMZ
holdings_GER
in_PIN
trade_NN
investments_NOMZ
._.
The_DT
fair_JJ
value_NN
of_PIN
listed_VBN
investments_NOMZ
is_VPRT [BEMA]
equal_PRED
to_PIN
the_DT
year_NN
end_NN
market_NN
price_NN
._.
3_CD
Other_JJ
financial_JJ
assets_NN
include_VPRT
investments_NOMZ
in_PIN
unit_NN
trusts_NN
and_PHC
capital_NN
funds_NN
that_TSUB
are_VPRT [PASS]
valued_VBN
at_PIN
market_NN
value_NN
._.
4_CD
The_DT
non-equity_JJ
minority_NOMZ
interest_NN
represents_VPRT
45_CD
%_NN
of_PIN
the_DT
8_CD
%_NN
non-equity_JJ
redeemable_JJ
cumulative_JJ
preference_NN
shares_NN
of_PIN
Amersham_NN
Biosciences_NN
,_,
which_WDT [SERE]
was_VBD [PASS]
extinguished_VBN
in_PIN
2002_CD
on_PIN
the_DT
purchase_NN
of_PIN
the_DT
45_CD
%_NN
minority_NOMZ
in_PIN
Amersham_NN
Biosciences_NN
._.
5_CD
Other_JJ
financial_JJ
liabilities_NOMZ
largely_RB
comprise_VPRT
discounted_JJ
deferred_VBN
consideration_NOMZ
on_PIN
acquisitions_NOMZ
,_,
for_PIN
which_WDT [PIRE]
book_NN
value_NN
is_VPRT
not_XX0
materially_RB
different_PRED
to_PIN
fair_JJ
value_NN
._.
6_CD
The_DT
book_NN
value_NN
of_PIN
the_DT
unsecured_JJ
loan_NN
notes_NN
includes_VPRT
a_DT
fair_JJ
value_NN
adjustment_NOMZ
of_PIN
3.5_CD
m_NN [BEMA]
2001_CD
5.4_CD
m_NN
,_,
that_DEMP
arose_VBD
as_CONJ
a_NULL
result_NULL
of_PIN
the_DT
acquisition_NOMZ
of_PIN
the_DT
notes_NN
at_PIN
the_DT
time_NN
of_PIN
the_DT
merger_NN
with_PIN
Nycomed_NN
._.
The_DT
fair_JJ
value_NN
quoted_VBN [WZPAST]
at_PIN
31_CD
December_NN
is_VPRT [PASS]
based_VBN
on_PIN
the_DT
present_JJ
value_NN
of_PIN
future_JJ
cash_NN
ows_NN
of_PIN
the_DT
notes_NN
._.
72_CD
Amersham_NN
plc_NN
Annual_JJ
Report_NN
&_CC
Accounts_NN
2002_CD
20_CD
Derivatives_NN
and_CC
other_JJ
financial_JJ
instruments_NOMZ
continued_VBD
7_CD
Derivative_JJ
financial_JJ
instruments_NOMZ
held_VBN [PRIV]
to_TO
manage_VB
interest_NN
rate_NN
and_PHC
currency_NN
exposures_NN
Assets_NN
Liabilities_NOMZ
Assets_NN
Liabilities_NOMZ
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
31_CD
Dec_NN
2001_CD
Notional_NN
Fair_NN
Notional_NN
Fair_NN
Notional_NN
Fair_NN
Notional_NN
Fair_NN
principal_JJ
value_NN
principal_NN
value_NN
principal_JJ
value_NN
principal_JJ
value_NN
m_NN
m_FW
m_FW
m_FW
m_FW
m_FW
m_FW
m_FW
Interest_NN
rate_NN
swaps_NN
31.1_CD
31.1_CD
3.2_CD
51.7_CD
3.2_CD
34.5_CD
1.3_CD
Forward_RB
foreign_JJ
exchange_NN
contracts_NN
923.4_CD
26.5_CD
890.6_CD
3.1_CD
900.6_CD
17.7_CD
873.1_CD
8.1_CD
Total_JJ
for_PIN
financial_JJ
assets_NN
954.5_CD
26.5_CD
952.3_CD
20.9_CD
Total_JJ
for_PIN
financial_JJ
liabilities_NOMZ
921.7_CD
6.3_CD
907.6_CD
9.4_CD
7_CD
Interest_NN
rate_NN
swaps_NN
and_CC
forward_RB
foreign_JJ
exchange_NN
contracts_NN
are_VPRT [PASS]
stated_VBN [PUBV]
at_PIN
current_JJ
market_NN
values_NN
._.
f_LS
Hedges_NN
As_IN
explained_VBN [PUBV]
in_PIN
the_DT
Financial_NN
review_NN
on_PIN
page_NN
33_CD
,_,
the_DT
groups_NN
policy_NN
is_VPRT
to_TO
hedge_VB
exposures_NN
to_PIN
interest_NN
rate_NN
risk_NN
and_PHC
currency_NN
exposures_NN
using_VBG [WZPRES]
a_DT
variety_NN
of_PIN
derivative_JJ
financial_JJ
instruments_NOMZ
._.
Gains_NN
and_PHC
losses_NN
on_PIN
these_DEMO
instruments_NOMZ
are_VPRT [PASS]
not_XX0
recognized_VBN [PRIV]
until_IN
the_DT
exposure_NN
that_DEMP
is_VPRT
being_VBG [PASS]
hedged_VBN
is_VPRT [BEMA] [PASS]
itself_PIT
recognized_VBN [PRIV]
._.
Gains_NN
or_CC
losses_NN
on_PIN
the_DT
fair_JJ
value_NN
of_PIN
financial_JJ
instruments_NOMZ
are_VPRT [PASS]
classied_VBN
as_IN
unrecognised_JJ
where_RB
they_TPP3
have_VPRT [PEAS]
not_XX0
yet_RB
been_VBN [PASS]
recorded_VBN
in_PIN
the_DT
financial_JJ
statements_NOMZ
._.
Where_RB
gains_NN
or_CC
losses_NN
have_VPRT [PEAS]
crystallised_VBN
,_,
but_CC
are_VPRT [PASS]
carried_VBN
forward_RB
in_PIN
the_DT
balance_NN
sheet_NN
pending_VBG [WZPRES]
their_TPP3
recognition_NOMZ
in_PIN
the_DT
profit_NN
and_PHC
loss_NN
account_NN
in_PIN
a_DT
future_JJ
period_NN
,_,
they_TPP3
are_VPRT [PASS]
treated_VBN
as_IN
deferred_VBN
._.
The_DT
following_JJ
table_NN
analyses_VPRT
the_DT
movement_NOMZ
in_PIN
unrecognised_JJ
and_PHC
deferred_JJ
gains_NN
or_CC
losses_NN
on_PIN
hedge_NN
instruments_NOMZ
during_PIN
the_DT
year_NN
to_PIN
31_CD
December_NN
2002_CD
._.
31_CD
Dec_NN
2002_CD
Unrecognised_NN
Deferred_NN
Net_JJ
Net_NN
gains_VPRT
gains_NN
Gains_NN
Losses_NN
losses_NN
Gains_NN
Losses_NN
losses_NN
m_VPRT
m_FW
m_FW
m_FW
m_FW
m_FW [BEMA]
Unrecognised_JJ
gains_NN
losses_NN
on_PIN
hedges_NN
At_PIN
1_CD
January_NN
2002_CD
13.8_CD
8.3_CD
5.5_CD
21.9_CD
10.8_CD
11.1_CD
Gains_NN
losses_NN
arising_VBG [WZPRES]
in_PIN
previous_JJ
years_NN
that_TSUB
were_VBD [PASS]
recognized_VBN [PRIV]
in_PIN
2002_CD
12.0_CD
8.3_CD
3.7_CD
12.7_CD
6.0_CD
6.7_CD
Gains_NN
losses_NN
arising_VBG [WZPRES]
before_IN
1_CD
January_NN
2003_CD
that_DEMP
were_VBD [PASS]
not_XX0
recognized_VBN [PRIV]
in_PIN
2002_CD
1.8_CD
1.8_CD
9.2_CD
4.8_CD
4.4_CD
Gains_NN
losses_NN
arising_VBG [WZPRES]
in_PIN
2002_CD
that_DEMP
were_VBD [PASS]
not_XX0
recognized_VBN [PRIV]
in_PIN
2002_CD
17.5_CD
1.0_CD
16.5_CD
14.2_CD
1.0_CD
15.2_CD
Unrecognised_JJ
gains_NN
losses_NN
on_PIN
hedges_NN
at_PIN
31_CD
December_NN
2002_CD
19.3_CD
1.0_CD
18.3_CD
23.4_CD
3.8_CD
19.6_CD
Of_PIN
which_WDT [PIRE]
Gains_NN
losses_NN
expected_VBN [PRIV]
to_TO
be_VB [PASS]
recognized_VBN [PRIV]
in_PIN
2003_CD
17.9_CD
1.0_CD
16.9_CD
15.5_CD
3.8_CD
11.7_CD
Gains_NN
losses_NN
expected_VBN [PRIV]
to_TO
be_VB [PASS]
recognized_VBN [PRIV]
in_PIN
2004_CD
or_CC
later_TIME
1.4_CD
1.4_CD
7.9_CD
7.9_CD
As_IN
at_PIN
31_CD
December_NN
2002_CD
the_DT
company_NN
has_VPRT
outstanding_JJ
foreign_JJ
exchange_NN
contracts_NN
with_PIN
commercial_JJ
banks_NN
,_,
as_IN
set_VBN
out_PIN
in_PIN
the_DT
following_VBG
table_NN
:_:
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Principal_NN
Principal_NN
Principal_NN
Principal_NN
receivable_JJ
payable_JJ
Total_JJ
receivable_NN
payable_JJ
Total_JJ
m_NN
m_FW
m_FW
m_FW
m_FW
m_FW
Held_FW
to_TO
manage_VB
assets_NN
and_PHC
liabilities_NOMZ
525.4_CD
507.9_CD
17.5_CD
425.8_CD
416.9_CD
8.9_CD
Held_VBN [PRIV]
to_TO
manage_VB
transaction_NOMZ
exposures_NN
398.0_CD
382.7_CD
15.3_CD
474.8_CD
456.2_CD
18.6_CD
923.4_CD
890.6_CD
32.8_CD
900.6_CD
873.1_CD
27.5_CD
Amersham_NN
plc_NN
73_CD
Notes_NN
to_PIN
the_DT
financial_JJ
statements_NOMZ
continued_VBD
20_CD
Derivatives_NN
and_CC
other_JJ
financial_JJ
instruments_NOMZ
continued_VBD
The_DT
contracts_NN
held_VBD [PRIV]
to_TO
manage_VB
assets_NN
and_PHC
liabilities_NOMZ
at_PIN
31_CD
December_NN
2002_CD
,_,
can_POMD
be_VB [PASS]
analyzed_VBN
as_IN
follows_VPRT
:_:
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Principal_NN
Principal_NN
Principal_NN
Principal_NN
receivable_JJ
payable_JJ
Total_JJ
receivable_NN
payable_JJ
Total_JJ
m_NN
m_FW
m_FW
m_FW
m_FW
m_FW [BEMA]
US_FPP1
dollars_NN
43.5_CD
250.1_CD
206.6_CD
41.5_CD
197.8_CD
156.3_CD
Japanese_JJ
yen_NN
2.9_CD
79.2_CD
76.3_CD
5.2_CD
99.9_CD
94.7_CD
Sterling_GER
58.2_CD
110.1_CD
51.9_CD
52.3_CD
35.7_CD
16.6_CD
Euros_NN
36.0_CD
15.1_CD
20.9_CD
99.7_CD
44.4_CD
55.3_CD
Norwegian_JJ
kroner_NN
372.6_CD
11.9_CD
360.7_CD
154.3_CD
15.3_CD
139.0_CD
Other_JJ
currencies_NN
12.2_CD
41.5_CD
29.3_CD
72.1_CD
23.8_CD
48.3_CD
525.4_CD
507.9_CD
17.5_CD
425.1_CD
416.9_CD
8.2_CD
21_CD
Financial_NN
commitments_NOMZ
The_DT
group_NN
has_VPRT
commitments_NOMZ
to_TO
make_VB
research_NN
and_PHC
development_NOMZ
milestone_NN
payments_NOMZ
and_PHC
payments_NOMZ
under_IN
licence_NN
agreements_NOMZ
to_PIN
third_JJ
parties_NN
subject_JJ
to_PIN
achievement_NOMZ
of_PIN
agreed_VBN [SUAV] [PUBV]
stages_NN
of_PIN
product_NN
development_NOMZ
._.
At_PIN
31_CD
December_NN
2002_CD
the_DT
maximum_NN
amounts_VPRT
payable_JJ
under_IN
these_DEMO
agreements_NOMZ
was_VBD [BEMA]
10.2_CD
m_NN [BEMA]
2001_CD
24.2_CD
m._NN
22_CD
Provisions_NN
for_PIN
liabilities_NOMZ
and_PHC
charges_NN
Pensions_NN
Deferred_NN
Decommissioning_GER
and_CC
similar_JJ
Disposal_NN
Other_JJ
tax_NN
and_CC
efuent_JJ
costs_NN
obligations_NOMZ
costs_NN
provisions_NN
Total_JJ
m_NN
m_FW
m_FW
m_FW
m_FW
m_FW
Group_NN
At_PIN
1_CD
January_NN
2002_CD
as_IN
previously_TIME
stated_VBN [PUBV]
21.1_CD
63.2_CD
88.2_CD
19.7_CD
27.8_CD
220.0_CD
Prior_RB
year_NN
adjustment_NOMZ
20.8_CD
20.8_CD
At_PIN
1_CD
January_NN
2002_CD
as_IN
restated_VBN
41.9_CD
63.2_CD
88.2_CD
19.7_CD
27.8_CD
240.8_CD
Foreign_JJ
currency_NN
translation_NOMZ
0.5_CD
1.1_CD
0.2_CD
1.0_CD
0.2_CD
Transfer_NN
of_PIN
deferred_JJ
tax_NN
assets_NN
2.9_CD
2.9_CD
Transfer_NN
to_PIN
current_JJ
tax_NN
creditor_NN
2.1_CD
2.1_CD
Adjustment_NOMZ
relating_VBG [WZPRES]
to_PIN
fair_JJ
value_NN
0.3_CD
0.3_CD
Charge_NN
to_TO
profit_VB
and_CC
loss_NN
23.1_CD
5.1_CD
14.7_CD
0.2_CD
2.3_CD
45.4_CD
Charge_NN
to_PIN
statement_NOMZ
of_PIN
total_JJ
recognized_VBN [PRIV]
gains_NN
and_PHC
losses_NN
5.4_CD
5.4_CD
Utilised_VBN
during_PIN
the_DT
year_NN
3.9_CD
11.3_CD
9.3_CD
4.9_CD
29.4_CD
Exceptional_JJ
item_NN
9.2_CD
9.2_CD
At_PIN
31_CD
December_NN
2002_CD
61.5_CD
65.5_CD
91.5_CD
9.6_CD
25.4_CD
253.5_CD
Company_NN
At_PIN
1_CD
January_NN
2002_CD
51.9_CD
8.6_CD
6.7_CD
67.2_CD
Charged_VBN
to_TO
profit_VB
and_CC
loss_NN
7.5_CD
2.0_CD
0.3_CD
2.9_CD
12.7_CD
Utilised_VBN
during_PIN
the_DT
year_NN
1.1_CD
1.0_CD
4.4_CD
6.5_CD
At_PIN
31_CD
December_NN
2002_CD
7.5_CD
52.8_CD
7.9_CD
5.2_CD
73.4_CD
A_DT
further_JJ
analysis_NN
of_PIN
the_DT
deferred_VBN
taxation_NOMZ
provision_NN
is_VPRT [PASS]
given_VBN
in_PIN
note_NN
23_CD
._.
The_DT
prior_JJ
year_NN
adjustment_NOMZ
relates_VPRT
to_PIN
the_DT
introduction_NOMZ
of_PIN
FRS19_NN
,_,
Deferred_NN
Taxation_NOMZ
,_,
as_IN
explained_VBN [PUBV]
in_PIN
note_NN
36_CD
._.
Provisions_NN
for_PIN
decommissioning_VBG
and_CC
efuent_JJ
costs_NN
relate_VPRT
to_PIN
the_DT
costs_NN
,_,
determined_VBN [SUAV] [PRIV] [PASTP]
on_PIN
a_DT
going_VBG
concern_NN
basis_NN
,_,
associated_VBN [PASTP]
with_PIN
decommissioning_VBG
radioactive_JJ
facilities_NOMZ
and_CC
with_PIN
the_DT
eventual_JJ
disposal_NN
of_PIN
the_DT
groups_NN
intermediate_JJ
level_NN
waste_NN
which_WDT [WHSUB]
arises_VPRT
from_PIN
operations_NOMZ
._.
Decommissioning_VBG
costs_NN
will_PRMD
be_VB [PASS]
incurred_VBN
after_IN
the_DT
facilities_NOMZ
are_VPRT [PASS]
withdrawn_VBN
from_PIN
use_NN
in_PIN
radioactive_JJ
operations_NOMZ
and_CC
extend_VB
out_PIN
to_PIN
2036_CD
._.
Total_JJ
decommissioning_GER
and_CC
efuent_JJ
costs_NN
to_TO
be_VB [PASS]
incurred_VBN
in_PIN
the_DT
next_JJ
10_CD
years_NN
amount_NN
to_TO
approximately_RB
37.4_CD
m._FW
The_DT
provisions_NN
are_VPRT [PASS]
based_VBN
on_PIN
the_DT
latest_JJ
technical_JJ
assessment_NOMZ
of_PIN
the_DT
process_NN
and_PHC
methods_NN
likely_JJ
to_TO
be_VB [PASS]
used_VBN
,_,
and_ANDC
are_VPRT [PASS]
stated_VBN [PUBV]
at_PIN
current_JJ
prices_NN
and_CC
discounted_VBN
using_VBG
a_DT
real_JJ
discount_NN
rate_NN
of_PIN
4_CD
%_NN
._.
The_DT
provisions_NN
for_PIN
pensions_NN
and_CC
similar_JJ
obligations_NOMZ
primarily_RB
relate_VPRT
to_PIN
pension_NN
schemes_NN
,_,
details_NN
of_PIN
which_WDT [PIRE]
are_VPRT [PASS]
given_VBN
in_PIN
note_NN
29_CD
._.
The_DT
9.6_CD
m_NN
provision_NN
for_PIN
disposal_NN
costs_NN
related_VBN [WZPAST]
to_PIN
sale_NN
of_PIN
businesses_NOMZ
comprises_VPRT
0.8_CD
m_NN [BEMA]
for_PIN
the_DT
disposal_NN
of_PIN
the_DT
Tomojet_NN
business_NOMZ
in_PIN
2002_CD
,_,
0.8_CD
m_NN [BEMA]
for_PIN
the_DT
closure_NN
of_PIN
the_DT
disease_NN
proling_GER
project_NN
in_PIN
2001_CD
,_,
7.3_CD
m_NN [BEMA]
for_PIN
the_DT
disposal_NN
of_PIN
Nycomed_NN
Pharma_NN
in_PIN
2001_CD
,_,
0.3_CD
m_NN [BEMA]
for_PIN
the_DT
sale_NN
of_PIN
Puerto_NN
Rico_NN
Plant_NN
in_PIN
1998_CD
and_CC
0.4_CD
m_NN [BEMA]
for_PIN
the_DT
sale_NN
of_PIN
Puridec_NN
arising_VBG [WZPRES]
in_PIN
1996_CD
._.
These_DEMO
provisions_NN
are_VPRT [BEMA]
for_PIN
legal_JJ
or_CC
constructive_JJ
obligations_NOMZ
arising_VBG [WZPRES]
from_PIN
the_DT
sale_NN
of_PIN
businesses_NOMZ
and_CC
are_VPRT [PASS]
expected_VBN [PRIV]
to_TO
be_VB [PASS]
incurred_VBN
within_PIN
the_DT
next_JJ
five_CD
years_NN
._.
Other_JJ
provisions_NN
are_VPRT
principally_RB
insurance_NN
claims_NN
,_,
warranties_NN
and_PHC
costs_NN
associated_VBN [WZPAST]
with_PIN
the_DT
rationalisation_NOMZ
of_PIN
radiopharmaceutical_JJ
production_NOMZ
within_PIN
Amersham_NN
Health_NN
._.
The_DT
provision_NN
at_PIN
31_CD
December_NN
2002_CD
of_PIN
25.4_CD
m_NN [BEMA]
2001_CD
27.8_CD
m_NN
is_VPRT [PASS]
made_VBN
up_IN
of_PIN
8.0_CD
m_NN [BEMA]
2001_CD
5.5_CD
m_NN
relating_VBG [WZPRES]
to_PIN
insurance_NN
reserves_NN
,_,
2.4_CD
m_NN [BEMA]
2001_CD
3.0_CD
m_NN
relating_VBG [WZPRES]
to_PIN
warranties_NN
,_,
3.8_CD
m_NN [BEMA]
2001_CD
4.5_CD
m_NN
relating_VBG [WZPRES]
to_PIN
radiopharmaceutical_JJ
rationalisation_NOMZ
costs_NN
and_CC
11.2_CD
m_NN [BEMA]
2001_CD
14.8_CD
m_NN [BEMA]
of_PIN
legal_JJ
and_PHC
other_JJ
provisions_NN
._.
74_CD
Amersham_NN
plc_NN
Annual_JJ
Report_NN
&_CC
Accounts_NN
2002_CD
23_CD
Deferred_JJ
taxation_NOMZ
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Group_NN
Group_NN
Company_NN
Company_NN
Restated_NN
Note_NN
m_NN
m_FW
m_FW
m_FW
Provision_NN
for_PIN
deferred_JJ
tax_NN
comprises_VPRT
:_:
Accelerated_JJ
capital_NN
allowances_NN
22.4_CD
10.7_CD
7.0_CD
Tax_NN
deductible_JJ
goodwill_NN
26.2_CD
25.2_CD
Capital_NN
gains_NN
held_VBN [PRIV]
over_IN
6.6_CD
2.2_CD
4.3_CD
Unrealised_JJ
stock_NN
profit_NN
22.2_CD
18.1_CD
Other_JJ
short_JJ
term_NN
timing_NN
differences_NN
4.4_CD
8.1_CD
3.8_CD
28.6_CD
11.9_CD
7.5_CD
Transfer_NN
to_TO
deferred_VBN
taxation_NOMZ
assets_NN
16_CD
32.9_CD
30.0_CD
22_CD
61.5_CD
41.9_CD
7.5_CD
The_DT
group_NN
has_VPRT
a_DT
potential_JJ
deferred_JJ
tax_NN
asset_NN
of_PIN
28.8_CD
m_NN [BEMA]
in_PIN
the_DT
US_FPP1
Biosciences_NN
business_NOMZ
of_PIN
which_WDT [PIRE]
9.2_CD
m_NN
has_VPRT [PEAS]
been_VBN [PASS]
recognized_VBN [PRIV]
,_,
as_IN
an_DT
exceptional_JJ
item_NN
,_,
based_VBN [PASTP]
on_PIN
future_JJ
financial_JJ
projections_NOMZ
which_WDT [WHSUB]
forecast_VPRT [PUBV]
future_JJ
taxable_JJ
profits_NN
in_PIN
excess_NN
of_PIN
those_DEMP
arising_VBG
from_PIN
the_DT
reversal_NN
of_PIN
deferred_JJ
tax_NN
liabilities_NOMZ
._.
The_DT
remaining_VBG
19.6_CD
m_NN
is_VPRT [PASS]
not_XX0
recognized_VBN [PRIV]
as_IN
there_EX
is_VPRT
insufficient_JJ
evidence_NN
,_,
at_PIN
this_DEMO
time_NN
,_,
that_THVC
the_DT
asset_NN
will_PRMD
be_VB [BEMA]
recoverable_PRED
in_PIN
the_DT
foreseeable_JJ
future_NN
._.
In_CONJ
addition_NULL
,_,
the_DT
group_NN
has_VPRT
further_JJ
unrecognised_JJ
deferred_JJ
tax_NN
assets_NN
of_PIN
13.5_CD
m_NN
arising_VBG [WZPRES]
in_PIN
other_JJ
territories_NN
._.
These_DEMP
relate_VPRT
primarily_RB
to_PIN
tax_NN
losses_NN
in_PIN
those_DEMO
territories_NN
._.
There_EX
is_VPRT
insufficient_JJ
evidence_NN
,_,
at_PIN
this_DEMO
time_NN
,_,
that_THVC
these_DEMO
assets_NN
will_PRMD
be_VB [BEMA]
recoverable_PRED
._.
The_DT
unrecognised_JJ
assets_NN
will_PRMD
be_VB [BEMA]
recoverable_PRED
when_RB
sufficient_JJ
evidence_NN
becomes_VPRT
available_JJ
to_TO
support_VB
that_DEMO
recoverability_NOMZ
._.
Deferred_JJ
tax_NN
is_VPRT [PASS]
measured_VBN
on_PIN
a_DT
non-discounted_JJ
basis_NN
at_PIN
the_DT
tax_NN
rates_NN
that_TSUB
are_VPRT [PASS]
expected_VBN [PRIV]
to_TO
apply_VB
in_PIN
the_DT
periods_NN
in_PIN
which_WDT [PIRE]
timing_NN
differences_NN
reverse_RB
,_,
based_VBN [PASTP]
on_PIN
tax_NN
rates_NN
and_PHC
laws_NN
substantively_RB
enacted_VBN
at_PIN
the_DT
balance_NN
sheet_NN
date_NN
._.
24_CD
Acquisitions_NOMZ
During_PIN
the_DT
year_NN
the_DT
group_NN
made_VBD
acquisitions_NOMZ
with_PIN
a_DT
total_JJ
consideration_NOMZ
of_PIN
767.9_CD
m_NN
,_,
of_PIN
which_WDT [PIRE]
708.6_CD
m_NN [PASS]
related_VBN [WZPAST]
to_PIN
the_DT
purchase_NN
of_PIN
the_DT
45_CD
%_NN
minority_NOMZ
interest_NN
in_PIN
Amersham_NN
Biosciences_NN
from_PIN
Pharmacia_NN
Corp._NN
a_DT
Purchase_NN
of_PIN
45_CD
%_NN
minority_NOMZ
interest_NN
holding_VBG [PRIV] [WZPRES]
in_PIN
Amersham_NN
Biosciences_NN
On_PIN
21_CD
March_NN
2002_CD
the_DT
group_NN
completed_VBD
the_DT
purchase_NN
of_PIN
the_DT
45_CD
%_NN
minority_NOMZ
interest_NN
holding_VBG [PRIV] [WZPRES]
in_PIN
Amersham_NN
Biosciences_NN
that_TOBJ
it_PIT
did_VBD
not_XX0
already_RB
own_VB
._.
The_DT
purchase_NN
consideration_NOMZ
was_VBD [BEMA]
704.1_CD
m_NN [BEMA]
of_PIN
cash_NN
,_,
plus_PIN
costs_NN
associated_VBN [WZPAST]
with_PIN
the_DT
purchase_NN
of_PIN
4.5_CD
m._FW
The_DT
purchase_NN
was_VBD [BYPA]
nanced_VBN
by_PIN
a_DT
placing_GER
of_PIN
57.5_CD
m_FW [BEMA]
new_JJ
ordinary_JJ
shares_NN
on_PIN
18_CD
March_NN
2002_CD
,_,
which_WDT [SERE]
generated_VBD
397.0_CD
m_NN
after_IN
costs_NN
of_PIN
issue_NN
,_,
together_RB
with_PIN
the_DT
use_NN
of_PIN
existing_VBG
cash_NN
resources_NN
and_PHC
drawings_GER
under_IN
the_DT
groups_NN
committed_VBN
bank_NN
facilities_NOMZ
._.
The_DT
transaction_NOMZ
was_VBD [PASS]
accounted_VBN
for_PIN
using_VBG
acquisition_NOMZ
accounting_GER
._.
Goodwill_NN
of_PIN
692.3_CD
m_NN [PASS]
arose_VBD
on_PIN
the_DT
transaction_NOMZ
,_,
and_ANDC
will_PRMD
be_VB [PASS]
amortised_VBN
over_IN
20_CD
years_NN
from_PIN
the_DT
date_NN
of_PIN
the_DT
purchase_NN
._.
The_DT
20_CD
year_NN
useful_JJ
life_NN
reects_VPRT
the_DT
continuing_VBG
investment_NOMZ
in_PIN
the_DT
development_NOMZ
of_PIN
the_DT
business_NOMZ
._.
The_DT
values_NN
ascribed_VBD
to_PIN
the_DT
net_JJ
assets_NN
acquired_VBN [WZPAST]
in_PIN
Amersham_NN
Biosciences_NN
,_,
and_ANDC
details_NN
of_PIN
the_DT
fair_JJ
value_NN
adjustments_NOMZ
,_,
which_WDT [SERE]
are_VPRT [BEMA]
provisional_PRED
,_,
are_VPRT [PASS]
set_VBN
out_PIN
below_PLACE
:_:
Book_NN
value_NN
Fair_NN
value_NN
at_PIN
21_CD
Mar_NN
at_PIN
21_CD
Mar_NN
2002_CD
Revaluation_NOMZ
Other_JJ
2002_CD
m_FW
m_FW
m_FW
m_FW [BEMA]
Tangible_JJ
xed_JJ
assets_NN
including_VBG [WZPRES]
investments_NOMZ
205.0_CD
27.2_CD
232.2_CD
Intangible_NN
xed_VBD
assets_NN
146.9_CD
142.0_CD
4.9_CD
351.9_CD
27.2_CD
142.0_CD
237.1_CD
Current_JJ
assets_NN
including_VBG [WZPRES]
intra-group_JJ
deposits_NN
of_PIN
60m_JJ
353.4_CD
353.4_CD
Current_JJ
liabilities_NOMZ
including_VBG [WZPRES]
intra-group_JJ
loans_NN
of_PIN
339m_CD
482.1_CD
482.1_CD
Net_JJ
current_JJ
liabilities_NOMZ
128.7_CD
128.7_CD
Total_JJ
assets_NN
less_RB
current_JJ
liabilities_NOMZ
223.2_CD
27.2_CD
142.0_CD
108.4_CD
Non-current_JJ
liabilities_NOMZ
25.2_CD
25.2_CD
Provisions_NN
for_PIN
liabilities_NOMZ
and_PHC
charges_NN
47.6_CD
0.6_CD
47.0_CD
150.4_CD
27.8_CD
142.0_CD
36.2_CD
Net_JJ
assets_NN
acquired_VBN
45_CD
%_NN
16.3_CD
Cost_NN
of_PIN
acquisition_NOMZ
cash_NN
consideration_NOMZ
704.1_CD
Acquisition_NOMZ
expenses_NN
professional_JJ
fees_NN
and_PHC
tax_NN
costs_NN
4.5_CD
Goodwill_NN
arising_VBG [WZPRES]
on_PIN
acquisition_NOMZ
692.3_CD
Amersham_NN
plc_NN
75_CD
Notes_NN
to_PIN
the_DT
financial_JJ
statements_NOMZ
continued_VBD
24_CD
Acquisitions_NOMZ
continued_VBD
The_DT
other_JJ
adjustment_NOMZ
relates_VPRT
to_PIN
goodwill_NN
in_PIN
the_DT
Amersham_NN
Biosciences_NN
balance_NN
sheet_NN
eliminated_VBN [WZPAST]
on_PIN
the_DT
purchase_NN
of_PIN
the_DT
minority_NOMZ
interest_NN
._.
No_SYNE
accounting_GER
policy_NN
alignment_NOMZ
adjustments_NOMZ
are_VPRT [PASS]
required_VBN [SUAV]
as_IN
Amersham_NN
Biosciences_NN
accounting_GER
policies_NN
are_VPRT [BEMA]
consistent_PRED
with_PIN
those_DEMO
of_PIN
the_DT
Amersham_NN
group_NN
._.
Tangible_JJ
xed_JJ
assets_NN
have_VPRT [PEAS]
been_VBN [PASS]
revalued_VBN
to_PIN
their_TPP3
fair_JJ
value_NN
and_CC
listed_VBN
investments_NOMZ
have_VPRT [PEAS]
been_VBN [PASS]
written_VBN [PUBV]
down_RP
to_PIN
their_TPP3
market_NN
value_NN
._.
Adjustments_NOMZ
within_PIN
provisions_NN
for_PIN
liabilities_NOMZ
and_PHC
charges_NN
relate_VPRT
to_PIN
the_DT
funded_JJ
status_NN
of_PIN
pensions_NN
,_,
primarily_RB
unrecognised_JJ
actuarial_JJ
gains_NN
._.
A_DT
45_CD
%_NN
share_NN
of_PIN
the_DT
revaluation_NOMZ
and_CC
other_JJ
adjustment_NOMZ
has_VPRT [PEAS]
been_VBN [PASS]
recognized_VBN [PRIV]
in_PIN
the_DT
group_NN
accounts_VPRT
._.
As_IN
the_DT
purchase_NN
of_PIN
Amersham_NN
Biosciences_NN
is_VPRT [BEMA]
an_DT
increase_NN
in_PIN
stake_NN
,_,
the_DT
profits_NN
and_PHC
cash_NN
ows_NN
of_PIN
Amersham_NN
Biosciences_NN
are_VPRT [SPAU] [PASS]
already_RB
contained_VBN
within_PIN
the_DT
consolidated_JJ
profit_NN
and_PHC
loss_NN
account_NN
and_PHC
cash_NN
ow_NN
statement_NOMZ
of_PIN
the_DT
Amersham_NN
group_NN
for_PIN
the_DT
current_JJ
and_PHC
prior_JJ
year_NN
._.
The_DT
minority_NOMZ
interest_NN
for_PIN
the_DT
period_NN
to_PIN
21_CD
March_NN
2002_CD
was_VBD [BEMA]
0.8_CD
m_NN
credit_NN
,_,
represented_VBN [PASTP]
by_PIN
a_DT
0.6_CD
m_NN
charge_NN
for_PIN
non-equity_JJ
minority_NOMZ
interests_NN
and_CC
1.4_CD
m_NN
credit_NN
for_PIN
equity_NOMZ
minority_NOMZ
interests_NN
._.
The_DT
purchase_NN
of_PIN
the_DT
45_CD
%_NN
minority_NOMZ
interest_NN
was_VBD [SPAU] [BYPA]
partly_DWNT
achieved_VBN
by_PIN
the_DT
group_NN
acquiring_VBG [WZPRES]
a_DT
100_CD
%_NN
interest_NN
in_PIN
Pharmacia_NN
Biosystems_NN
AB_NN
,_,
now_DPAR
known_VBN [PRIV]
as_IN
Amersham_NN
Biosystems_NN
AB_NN
,_,
a_DT
former_JJ
trading_GER
company_NN
in_PIN
the_DT
Pharmacia_NN
Corporation_NOMZ
group_NN
._.
At_PIN
the_DT
date_NN
of_PIN
the_DT
purchase_NN
this_DEMO
company_NN
had_VBD
no_SYNE
assets_NN
or_CC
liabilities_NOMZ
,_,
apart_RB
from_PIN
the_DT
investment_NOMZ
in_PIN
Amersham_NN
Biosciences_NN
._.
Full_JJ
warranties_NN
and_PHC
indemnities_NOMZ
were_VBD [PASS]
received_VBN
from_PIN
Pharmacia_NN
Corporation_NOMZ
in_PIN
respect_NN
of_PIN
this_DEMO
company_NN
._.
b_NN
Other_JJ
acquisitions_NOMZ
On_PIN
31_CD
January_NN
2002_CD
,_,
the_DT
group_NN
acquired_VBD
100_CD
%_NN
of_PIN
the_DT
issued_VBN
share_NN
capital_NN
of_PIN
two_CD
ltration_NOMZ
companies_NN
,_,
AG_NN
Technology_NN
Corp_NN
and_PHC
InnovaSep_NN
Technology_NN
Corp._NN
._.
The_DT
fair_JJ
value_NN
of_PIN
the_DT
total_JJ
consideration_NOMZ
is_VPRT [BEMA]
38.1_CD
m_NN
,_,
of_PIN
which_WDT [PIRE]
11.8_CD
m_NN
is_VPRT [PASS]
deferred_VBN
consideration_NOMZ
and_CC
6.7_CD
m_NN
is_VPRT [BEMA]
the_DT
groups_NN
best_JJ
estimate_NN
of_PIN
deferred_VBN
contingent_JJ
consideration_NOMZ
._.
The_DT
deferred_JJ
contingent_JJ
consideration_NOMZ
is_VPRT [BEMA]
dependent_PRED
on_PIN
the_DT
acquired_VBN
companies_NN
reaching_VBG [WZPRES]
technological_JJ
milestones_NN
and_CC
on_PIN
performance_NN
conditions_NOMZ
._.
The_DT
ultimate_JJ
amount_NN
of_PIN
deferred_VBN
and_CC
contingent_JJ
consideration_NOMZ
payable_JJ
is_VPRT [PASS]
expected_VBN [PRIV]
to_TO
be_VB [BEMA]
in_PIN
the_DT
range_NN
of_PIN
$_$
15-33m_CD
._.
Goodwill_NN
arising_VBG [WZPRES]
of_PIN
36.9_CD
m_NN
is_VPRT
being_VBG [PASS]
amortised_VBN
over_IN
10_CD
years_NN
._.
On_PIN
29_CD
April_NN
2002_CD
,_,
the_DT
group_NN
acquired_VBD
100_CD
%_NN
of_PIN
the_DT
issued_VBN
share_NN
capital_NN
of_PIN
Synthia_NN
Lab_NN
Systems_NN
Sweden_NN
AB_NN
._.
Goodwill_NN
arising_VBG [WZPRES]
of_PIN
0.5_CD
m_NN
is_VPRT
being_VBG [PASS]
amortised_VBN
over_IN
seven_CD
years_NN
._.
On_PIN
10_CD
May_POMD
2002_CD
,_,
the_DT
group_NN
acquired_VBD
a_DT
further_JJ
16_CD
%_NN
holding_GER
in_PIN
Cimarron_NN
Software_NN
Inc_NN
,_,
taking_VBG [PRESP]
the_DT
groups_NN
total_VPRT
holding_VBG [PRIV]
at_PIN
acquisition_NOMZ
to_PIN
35_CD
%_NN
._.
Cimarron_NN
Software_NN
Inc_NN
is_VPRT
being_VBG [PASS]
consolidated_VBN
as_IN
a_DT
subsidiary_NN
undertaking_GER
as_IN
the_DT
group_NN
controls_VPRT
the_DT
company_NN
through_PIN
a_DT
shareholders_NN
agreement_NOMZ
._.
Goodwill_NN
arising_VBG [WZPRES]
of_PIN
6.3_CD
m_NN
is_VPRT
being_VBG [PASS]
amortised_VBN
over_IN
seven_CD
years_NN
._.
Since_OSUB
10_CD
May_POMD
2002_CD
,_,
the_DT
group_NN
has_VPRT [PEAS]
subscribed_VBN
for_PIN
additional_JJ
allotted_JJ
share_NN
capital_NN
in_PIN
Cimarron_NN
Software_NN
Inc_NN
,_,
taking_VBG [PRESP]
its_PIT
holding_GER
at_PIN
the_DT
year_NN
end_NN
to_PIN
44_CD
%_NN
._.
Goodwill_NN
recognized_VBN [PRIV] [WZPAST]
on_PIN
the_DT
post-acquisition_JJ
allotments_NOMZ
of_PIN
share_NN
capital_NN
amounts_NN
to_PIN
1.7_CD
m._FW
The_DT
group_NN
has_VPRT
obligations_NOMZ
to_TO
subscribe_VB
for_PIN
a_DT
further_JJ
7_CD
%_NN
of_PIN
share_NN
capital_NN
over_IN
the_DT
next_JJ
three_CD
years_NN
,_,
and_ANDC
has_VPRT
options_NOMZ
to_TO
acquire_VB
the_DT
remaining_VBG
49_CD
%_NN
of_PIN
the_DT
company_NN
for_PIN
a_DT
maximum_JJ
consideration_NOMZ
of_PIN
$_$
33m_CD
,_,
the_DT
total_JJ
consideration_NOMZ
payable_JJ
being_VBG [BEMA]
contingent_PRED
on_PIN
performance_NN
conditions_NOMZ
._.
On_PIN
11_CD
July_NN
2002_CD
,_,
the_DT
group_NN
acquired_VBD
the_DT
net_JJ
assets_NN
of_PIN
Motorolas_NN
CodeLink_NN
pre-arrayed_JJ
slide_NN
business_NOMZ
._.
Goodwill_NN
arising_VBG [WZPRES]
of_PIN
6.8_CD
m_NN
is_VPRT
being_VBG [PASS]
amortised_VBN
over_IN
10_CD
years_NN
._.
All_QUAN
transactions_NOMZ
were_VBD [PASS]
accounted_VBN
for_PIN
using_VBG
acquisition_NOMZ
accounting_GER
._.
The_DT
groups_NN
estimated_VBN [PRIV]
useful_JJ
life_NN
for_PIN
these_DEMO
acquisitions_NOMZ
reects_VPRT
the_DT
period_NN
over_IN
which_WDT
the_DT
group_NN
expects_VPRT [PRIV]
to_TO
receive_VB
benefit_NN
based_VBN [WZPAST]
on_PIN
acquired_VBN
patents_NN
and_PHC
technology_NN
._.
Set_VBN [PASTP]
out_PIN
below_PLACE
is_VPRT [BEMA]
a_DT
summary_NN
of_PIN
the_DT
net_JJ
assets_NN
acquired_VBN
and_CC
provisional_JJ
fair_JJ
value_NN
adjustments_NOMZ
:_:
Book_NN
value_NN
Revaluation_NOMZ
Fair_NN
value_NN
m_NN
m_FW
m_FW [PASS]
Fixed_VBN
assets_NN
6.2_CD
3.9_CD
10.1_CD
Net_JJ
current_JJ
assets_NN
1.8_CD
2.8_CD
1.0_CD
Net_JJ
assets_NN
8.0_CD
1.1_CD
9.1_CD
Net_JJ
assets_NN
acquired_VBD
8.8_CD
Cost_NN
of_PIN
acquisition_NOMZ
:_:
Cash_NN
consideration_NOMZ
38.2_CD
Deferred_JJ
consideration_NOMZ
18.5_CD
Existing_VBG
trade_NN
investment_NOMZ
2.6_CD
59.3_CD
Goodwill_NN
arising_VBG [WZPRES]
on_PIN
acquisition_NOMZ
50.5_CD
Adjustments_NOMZ
to_PIN
xed_JJ
assets_NN
relate_VPRT
to_PIN
recognition_NOMZ
of_PIN
intangible_JJ
assets_NN
relating_VBG [WZPRES]
to_PIN
patented_JJ
technology_NN
acquired_VBN
and_CC
the_DT
adjustment_NOMZ
to_PIN
net_JJ
current_JJ
assets_NN
relates_VPRT
to_PIN
the_DT
recognition_NOMZ
of_PIN
liabilities_NOMZ
assumed_VBD [PRIV]
on_PIN
acquisition_NOMZ
._.
No_SYNE
accounting_GER
policy_NN
alignment_NOMZ
adjustments_NOMZ
have_VPRT [PEAS]
been_VBN [PASS]
recorded_VBN
as_IN
the_DT
acquired_VBN
entities_NOMZ
accounting_VBG [WZPRES]
policies_NN
are_VPRT [BEMA]
consistent_PRED
with_PIN
those_DEMO
of_PIN
the_DT
Amersham_NN
group_NN
._.
76_CD
Amersham_NN
plc_NN
Annual_JJ
Report_NN
&_CC
Accounts_NN
2002_CD
24_CD
Acquisitions_NOMZ
continued_VBD
As_IN
discussed_VBN
above_PLACE
,_,
goodwill_NN
of_PIN
1.7_CD
m_NN [PASS]
arose_VBD
on_PIN
the_DT
acquisition_NOMZ
of_PIN
additional_JJ
holdings_GER
in_PIN
Cimarron_NN
Software_NN
Inc._NN
._.
Total_JJ
goodwill_NN
arising_VBG [WZPRES]
on_PIN
other_JJ
acquisitions_NOMZ
during_PIN
the_DT
year_NN
was_VBD [BEMA]
52.2_CD
m._FW
Included_VBN
within_PIN
cash_NN
paid_VBN [WZPAST]
for_PIN
acquisitions_NOMZ
during_PIN
the_DT
year_NN
of_PIN
40.6_CD
m_NN [BEMA]
in_PIN
the_DT
group_NN
cash_NN
ow_NN
statement_NOMZ
is_VPRT [BEMA]
2.4_CD
m_NN [BEMA]
for_PIN
milestone_NN
payments_NOMZ
relating_VBG [WZPRES]
to_PIN
prior_JJ
year_NN
acquisitions_NOMZ
._.
25_CD
Called_VBN
up_RP
share_NN
capital_NN
Ordinary_NN
5p_CD
shares_NN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
m_FW
m_FW
Authorised_NN
:_:
Value_NN
45.0_CD
45.0_CD
Number_NN
900.0_CD
900.0_CD
Issued_VBN
,_,
called_VBN [PASTP]
up_RB
and_PHC
fully_AMP
paid_VBN
:_:
Value_NN
35.1_CD
32.1_CD
Number_NN
701.8_CD
641.7_CD
During_PIN
the_DT
year_NN
a_DT
total_NN
of_PIN
60,101,551_CD
ordinary_JJ
shares_NN
of_PIN
5p_JJ
each_QUAN
nominal_JJ
value_NN
3m_NN
were_VBD [PASS]
issued_VBN
for_PIN
an_DT
aggregate_JJ
net_JJ
cash_NN
consideration_NOMZ
of_PIN
407.7_CD
m._FW
Of_PIN
these_DEMP
,_,
57,500,000_CD
shares_NN
were_VBD [PASS]
issued_VBN
on_PIN
18_CD
March_NN
2002_CD
,_,
in_PIN
connection_NOMZ
with_PIN
the_DT
placing_GER
of_PIN
shares_NN
on_PIN
12_CD
March_NN
2002_CD
,_,
to_TO
finance_VB
the_DT
purchase_NN
of_PIN
the_DT
outstanding_JJ
shares_NN
in_PIN
Amersham_NN
Biosciences_NN
Limited_NN
for_PIN
cash_NN
consideration_NOMZ
of_PIN
397.0_CD
m_NN
,_,
net_NN
of_PIN
issue_NN
costs_NN
of_PIN
5.5_CD
m._FW
The_DT
shares_NN
were_VBD [PASS]
issued_VBN
at_PIN
a_DT
price_NN
of_PIN
7.00_CD
per_PIN
share_NN
,_,
and_ANDC
the_DT
market_NN
price_NN
on_PIN
the_DT
12_CD
March_NN
2002_CD
was_VBD [BEMA]
7.365_CD
per_PIN
share_NN
._.
The_DT
57,500,000_CD
shares_NN
were_VBD [PASS]
allotted_VBN
,_,
as_IN
follows_VPRT
:_:
50,000,000_CD
placing_VBG
shares_NN
to_PIN
persons_NN
nominated_VBN [WZPAST]
by_PIN
Morgan_NN
Stanley_NN
Securities_NOMZ
Limited_NN
and_PHC
Hoare_NN
Govett_NN
Limited_NN
:_:
7,500,000_CD
shares_NN
issued_VBN [WZPAST]
to_PIN
Morgan_NN
Stanley_NN
Securities_NOMZ
Limited_NN
,_,
pursuant_JJ
to_PIN
the_DT
exercise_NN
of_PIN
an_DT
over-allotment_NOMZ
option_NOMZ
._.
The_DT
50,000,000_CD
placing_VBG
shares_NN
were_VBD [SPAU] [PASS]
ultimately_RB
allotted_VBN
to_PIN
institutional_JJ
investors_NN
._.
A_DT
further_JJ
438,890_CD
shares_NN
were_VBD [PASS]
issued_VBN
to_PIN
the_DT
Qualifying_VBG
Employee_NN
Share_NN
Ownership_NN
Trust_NN
QUEST_NN
for_PIN
an_DT
aggregate_JJ
net_JJ
cash_NN
consideration_NOMZ
of_PIN
2.5_CD
m._FW
The_DT
remaining_VBG
2,162,661_CD
ordinary_JJ
shares_NN
of_PIN
5p_JJ
each_QUAN
were_VBD [PASS]
issued_VBN
in_PIN
connection_NOMZ
with_PIN
employee_NN
share_NN
option_NOMZ
schemes_NN
for_PIN
an_DT
aggregate_JJ
net_JJ
cash_NN
consideration_NOMZ
of_PIN
8.2_CD
m._FW
Share_NN
option_NOMZ
schemes_NN
The_DT
following_JJ
options_NOMZ
remained_VBD
exercisable_JJ
at_PIN
the_DT
year_NN
end_NN
._.
The_DT
exercise_NN
of_PIN
options_NOMZ
granted_VBN [SUAV] [WZPAST]
to_PIN
Executive_NN
Directors_NN
is_VPRT [BEMA]
subject_PRED
to_PIN
performance_NN
conditions_NOMZ
._.
Options_NOMZ
for_PIN
All_QUAN
6.35_CD
October_NN
2004_CD
to_PIN
October_NN
2007_CD
8,581,352_CD
9,150,000_CD
78_CD
Amersham_NN
plc_NN
Annual_JJ
Report_NN
&_CC
Accounts_NN
2002_CD
26_CD
Share_NN
premium_NN
account_NN
and_PHC
reserves_NN
Share_NN
profit_NN
premium_NN
and_PHC
loss_NN
Merger_NN
Other_JJ
Revaluation_NOMZ
account_NN
account_NN
reserve_NN
reserves_NN
reserve_NN
m_NN
m_FW
m_FW
m_FW
m_FW
Group_NN
At_PIN
1_CD
January_NN
2002_CD
as_IN
previously_TIME
stated_VBN [PUBV]
64.3_CD
401.5_CD
73.0_CD
21.0_CD
Prior_RB
year_NN
adjustment_NOMZ
4.4_CD
At_PIN
1_CD
January_NN
2002_CD
as_IN
restated_VBN
64.3_CD
405.9_CD
73.0_CD
21.0_CD
Foreign_JJ
currency_NN
translation_NOMZ
47.8_CD
Issue_NN
costs_NN
5.5_CD
Shares_NN
issued_VBN [WZPAST]
in_PIN
the_DT
year_NN
410.2_CD
Loss_NN
relating_VBG [WZPRES]
to_TO
Qualifying_VBG
Employee_NN
Share_NN
Ownership_NN
Trust_NN
QUEST_NN
1.2_CD
Retained_VBN
profit_NN
for_PIN
the_DT
year_NN
121.4_CD
At_PIN
31_CD
December_NN
2002_CD
469.0_CD
573.9_CD
73.0_CD
21.0_CD
Company_NN
At_PIN
1_CD
January_NN
2002_CD
as_IN
previously_TIME
stated_VBN [PUBV]
64.3_CD
59.8_CD
13.5_CD
Issue_NN
costs_NN
5.5_CD
Shares_NN
issued_VBN [WZPAST]
in_PIN
the_DT
year_NN
410.2_CD
Loss_NN
relating_VBG [WZPRES]
to_TO
Qualifying_VBG
Employee_NN
Share_NN
Ownership_NN
Trust_NN
QUEST_NN
1.2_CD
Revaluation_NOMZ
of_PIN
xed_JJ
asset_NN
investment_NOMZ
3.6_CD
Retained_VBN
profit_NN
for_PIN
the_DT
year_NN
15.5_CD
At_PIN
31_CD
December_NN
2002_CD
469.0_CD
74.1_CD
17.1_CD
The_DT
amounts_NN
included_VBD
in_PIN
other_JJ
reserves_NN
relate_VPRT
to_PIN
foreign_JJ
subsidiary_NN
undertakings_GER
and_CC
represent_VPRT
amounts_NN
which_WDT [WHSUB]
can_POMD
not_XX0
be_VB [PASS]
distributed_VBN
under_IN
local_JJ
company_NN
law_NN
,_,
plus_PIN
negative_JJ
goodwill_NN
arising_VBG [WZPRES]
on_PIN
the_DT
acquisition_NOMZ
of_PIN
Pharmacia_NN
Biotech_NN
._.
The_DT
cumulative_JJ
value_NN
of_PIN
goodwill_NN
written_VBN [PUBV] [WZPAST]
off_PIN
amounts_NN
to_PIN
1,439.9_CD
m_NN [BEMA]
2001_CD
1,439.9_CD
m._NN
The_DT
companys_NN
profit_NN
attributable_JJ
to_PIN
shareholders_NN
is_VPRT [BEMA]
72.8_CD
m_NN [BEMA]
2001_CD
66.0_CD
m._NN
In_PIN
accordance_NN
with_PIN
the_DT
groups_NN
accounting_VBG [WZPRES]
policy_NN
,_,
an_DT
exchange_NN
gain_NN
of_PIN
46.4_CD
m_NN [BEMA]
2001_CD
6.4_CD
m_NN [BEMA]
on_PIN
the_DT
foreign_JJ
currency_NN
loans_NN
hedging_VBG [WZPRES]
group_NN
investments_NOMZ
has_VPRT [PEAS]
been_VBN [PASS]
matched_VBN
with_PIN
the_DT
exchange_NN
loss_NN
on_PIN
those_DEMO
investments_NOMZ
in_PIN
reserves_NN
._.
A_DT
related_JJ
tax_NN
charge_NN
of_PIN
5.4_CD
m_NN [BEMA]
2001_CD
0.3_CD
m_NN
credit_NN
has_VPRT [SPAU] [PEAS]
also_RB
been_VBN [PASS]
offset_VBN
in_PIN
reserves_NN
._.
27_CD
Capital_NN
commitments_NOMZ
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Group_NN
Group_NN
Company_NN
Company_NN
m_FW
m_FW
m_FW
m_FW [PASS]
Expenditure_NN
contracted_VBD
41.3_CD
22.7_CD
13.2_CD
10.3_CD
28_CD
Operating_GER
and_PHC
finance_NN
lease_NN
commitments_NOMZ
Payments_NOMZ
which_WDT [WHOBJ]
the_DT
group_NN
and_CC
the_DT
company_NN
are_VPRT [PASS]
committed_VBN
to_TO
make_VB
during_PIN
the_DT
following_JJ
year_NN
against_PIN
operating_VBG
leases_NN
are_VPRT
as_IN
follows_VPRT
:_:
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Group_NN
Group_NN
Company_NN
Company_NN
Operating_GER
leases_VPRT
m_FW
m_FW
m_FW
m_FW
Land_NN
and_PHC
buildings_GER
:_:
Expiring_VBG [PRESP]
within_PIN
one_CD
year_NN
1.3_CD
1.9_CD
0.3_CD
Expiring_VBG
between_PIN
two_CD
and_CC
five_CD
years_NN
inclusive_JJ
10.3_CD
7.6_CD
1.6_CD
0.8_CD
Expiring_VBG
after_IN
more_EMPH
than_PIN
five_CD
years_NN
3.1_CD
4.3_CD
1.3_CD
14.7_CD
13.8_CD
1.9_CD
2.1_CD
Other_JJ
leases_NN
:_:
Expiring_VBG [PRESP]
within_PIN
one_CD
year_NN
1.4_CD
1.8_CD
0.7_CD
0.5_CD
Expiring_VBG
between_PIN
two_CD
and_CC
five_CD
years_NN
inclusive_JJ
12.9_CD
13.8_CD
2.4_CD
3.6_CD
Expiring_VBG
after_IN
more_EMPH
than_PIN
five_CD
years_NN
0.3_CD
14.6_CD
15.6_CD
3.1_CD
4.1_CD
Amersham_NN
plc_NN
79_CD
Notes_NN
to_PIN
the_DT
financial_JJ
statements_NOMZ
continued_VBD
28_CD
Operating_GER
and_PHC
finance_NN
lease_NN
commitments_NOMZ
continued_VBD
The_DT
finance_NN
lease_NN
obligations_NOMZ
to_PIN
which_WDT [PIRE]
the_DT
group_NN
and_CC
the_DT
company_NN
are_VPRT [PASS]
committed_VBN
are_VPRT
as_IN
follows_VPRT
:_:
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Group_NN
Group_NN
Company_NN
Company_NN
Finance_NN
lease_NN
commitments_NOMZ
m_VPRT
m_FW
m_FW
m_FW [BEMA]
Payable_PRED
within_PIN
one_CD
year_NN
0.5_CD
0.4_CD
Payable_JJ
between_PIN
two_CD
and_CC
five_CD
years_NN
1.4_CD
1.5_CD
Payable_JJ
after_IN
five_CD
years_NN
1.9_CD
2.1_CD
3.8_CD
4.0_CD
Less_RB
finance_NN
charges_NN
allocated_VBN [WZPAST]
to_PIN
future_JJ
periods_NN
1.0_CD
1.0_CD
2.8_CD
3.0_CD
29_CD
Pensions_NN
UK_NN
schemes_NN
The_DT
company_NN
participates_VPRT
in_PIN
a_DT
variety_NN
of_PIN
pension_NN
arrangements_NOMZ
on_PIN
behalf_NN
of_PIN
its_PIT
UK_NN
employees_NN
._.
The_DT
principal_JJ
scheme_NN
is_VPRT [BEMA]
the_DT
Amersham_NN
Pension_NN
Scheme_NN
,_,
which_WDT [SERE]
is_VPRT [BEMA]
a_DT
dened_JJ
benefit_NN
arrangement_NOMZ
,_,
the_DT
assets_NN
of_PIN
which_WDT [PIRE]
are_VPRT [PASS]
held_VBN [PRIV]
in_PIN
a_DT
separate_JJ
trustee_NN
administered_VBN
fund_NN
._.
An_DT
actuarial_JJ
valuation_NOMZ
of_PIN
this_DEMO
scheme_NN
as_IN
at_PIN
31_CD
March_NN
2000_CD
was_VBD [BYPA]
made_VBN
by_PIN
Watson_NN
Wyatt_NN
,_,
an_DT
independent_JJ
rm_NN
of_PIN
actuaries_NN
,_,
using_VBG [PRESP]
the_DT
projected_VBN
unit_NN
method_NN
._.
The_DT
main_JJ
assumptions_NOMZ
adopted_VBN [WZPAST]
in_PIN
that_DEMO
valuation_NOMZ
for_PIN
the_DT
purposes_NN
of_PIN
the_DT
UK_NN
Statement_NOMZ
of_PIN
Standard_NN
Accounting_GER
Practice_NN
SSAP_NN
24_CD
,_,
Accounting_GER
for_PIN
Pension_NN
Costs_NN
,_,
were_VBD
that_DEMO
over_IN
the_DT
long_JJ
term_NN
the_DT
rate_NN
of_PIN
return_NN
on_PIN
investments_NOMZ
would_PRMD
be_VB [BEMA]
6.9_CD
%_NN
pa_NN
,_,
the_DT
increase_NN
in_PIN
pensionable_JJ
pay_NN
5_CD
%_NN
pa_NN
and_PHC
pensions_NN
in_PIN
payment_NOMZ
3_CD
%_NN
pa._NN
._.
On_PIN
the_DT
basis_NN
of_PIN
these_DEMO
assumptions_NOMZ
the_DT
market_NN
value_NN
of_PIN
the_DT
schemes_NN
assets_NN
as_IN
at_PIN
31_CD
March_NN
2000_CD
represented_VBD
112_CD
%_NN
of_PIN
the_DT
value_NN
of_PIN
the_DT
benets_NN
to_PIN
members_NN
at_PIN
that_DEMO
date_NN
including_VBG [WZPRES]
allowance_NN
for_PIN
future_JJ
salary_NN
and_PHC
pension_NN
increases_NN
._.
The_DT
market_NN
value_NN
of_PIN
the_DT
schemes_NN
assets_NN
on_PIN
31_CD
March_NN
2000_CD
was_VBD [BEMA]
209m_PRED
._.
The_DT
pension_NN
cost_NN
in_PIN
the_DT
companys_NN
financial_JJ
statements_NOMZ
and_CC
the_DT
associated_VBN
amounts_NN
of_PIN
prepayment_NOMZ
are_VPRT [PASS]
set_VBN
out_PIN
below_PLACE
:_:
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
m_FW
m_FW
Prepayment_NOMZ
at_PIN
start_NN
of_PIN
year_NN
8.7_CD
6.8_CD
Regular_JJ
cost_NN
10.3_CD
9.0_CD
Variation_NOMZ
from_PIN
regular_JJ
cost_NN
1.6_CD
1.6_CD
Contributions_NOMZ
paid_VBN
10.7_CD
9.3_CD
Prepayment_NOMZ
at_PIN
end_NN
of_PIN
year_NN
10.7_CD
8.7_CD
Overseas_PLACE
schemes_NN
The_DT
group_NN
operates_VPRT
a_DT
number_NN
of_PIN
pension_NN
schemes_NN
overseas_PLACE
,_,
which_WDT [SERE]
have_VPRT [PEAS]
been_VBN [PASS]
developed_VBN
in_PIN
line_NN
with_PIN [STPR]
,_,
and_ANDC
are_VPRT [PASS]
funded_VBN
under_IN
,_,
local_JJ
practices_NN
._.
The_DT
principal_JJ
overseas_PLACE
schemes_NN
are_VPRT [BEMA]
in_PIN
the_DT
US_FPP1
,_,
Norway_NN
and_PHC
Sweden_NN
and_CC
are_VPRT [BEMA]
mainly_RB
of_PIN
the_DT
dened_VBN
benefit_NN
type_NN
funded_VBN [WZPAST]
via_PIN
separately_RB
administered_VBN
trusts_NN
or_CC
guaranteed_VBN [PUBV]
by_PIN
insurance_NN
policies_NN
._.
The_DT
scheme_NN
in_PIN
Sweden_NN
is_VPRT [BEMA]
an_DT
unfunded_JJ
arrangement_NOMZ
and_CC
there_EX
is_VPRT
an_DT
unfunded_JJ
arrangement_NOMZ
in_PIN
Norway_NN
in_CONJ
addition_NULL
to_PIN
the_DT
funded_JJ
scheme_NN
._.
These_DEMP
are_VPRT [PASS]
provided_VBN
for_PIN
in_PIN
the_DT
group_NN
financial_JJ
statements_NOMZ
and_CC
secured_VBN
on_PIN
the_DT
ongoing_JJ
business_NOMZ
._.
Watson_NN
Wyatt_NN
have_VPRT [PEAS]
prepared_VBN
pension_NN
costs_NN
using_VBG [WZPRES]
actuarial_JJ
valuations_NOMZ
carried_VBD
out_PIN
in_PIN
accordance_NN
with_PIN
local_JJ
requirements_NOMZ
,_,
for_PIN
the_DT
purposes_NN
of_PIN
group_NN
reporting_VBG [PUBV] [WZPRES]
under_IN
SSAP_NN
24_CD
,_,
Accounting_GER
for_PIN
Pension_NN
Costs_NN
._.
A_DT
surplus_NN
or_CC
deficit_NN
is_VPRT [PASS]
amortised_VBN
over_IN
the_DT
average_JJ
remaining_VBG
service_NN
lives_NN
of_PIN
the_DT
relevant_JJ
employees_NN
using_VBG [WZPRES]
the_DT
straight-line_JJ
method_NN
._.
The_DT
review_NN
was_VBD [PASS]
made_VBN
as_IN
at_PIN
1_CD
January_NN
2002_CD
,_,
using_VBG [PRESP]
the_DT
projected_VBN
unit_NN
method_NN
and_CC
using_VBG
the_DT
following_VBG
principal_NN
assumptions_NOMZ
._.
US_FPP1
Norway_NN
Sweden_NN
%_NN
%_NN
%_NN
Return_NN
on_PIN
investment_NOMZ
7.5_CD
6.5_CD
7.0_CD
Increase_VPRT
in_PIN
pensionable_JJ
salary_NN
4.5_CD
3.5_CD
4.0_CD
Increase_VPRT
in_PIN
pensions_NN
in_PIN
payment_NOMZ
2.0_CD
2.5_CD
The_DT
pension_NN
cost_NN
in_PIN
the_DT
groups_NN
financial_JJ
statements_NOMZ
and_CC
associated_VBN
amounts_NN
of_PIN
provision_NN
are_VPRT [PASS]
set_VBN
out_PIN
below_PLACE
,_,
in_PIN
aggregate_NN
,_,
for_PIN
these_DEMO
principal_JJ
overseas_PLACE
funded_VBN
and_CC
unfunded_JJ
schemes_NN
._.
80_CD
Amersham_NN
plc_NN
Annual_JJ
Report_NN
&_CC
Accounts_NN
2002_CD
29_CD
Pensions_NN
continued_VBD
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Funded_VBN
Unfunded_JJ
Funded_VBN
Unfunded_JJ
schemes_NN
schemes_NN
schemes_NN
schemes_NN
m_VPRT
m_FW
m_FW
m_FW
Provision_NN
at_PIN
start_NN
of_PIN
year_NN
18.6_CD
43.2_CD
18.8_CD
41.5_CD
Foreign_JJ
currency_NN
translation_NOMZ
1.6_CD
2.3_CD
0.5_CD
1.6_CD
Pension_NN
cost_NN
7.2_CD
4.6_CD
5.3_CD
4.0_CD
Contributions_NOMZ
pensions_NN
paid_VBD
8.2_CD
1.3_CD
6.0_CD
0.7_CD
Provision_NN
at_PIN
end_NN
of_PIN
year_NN
16.0_CD
48.8_CD
18.6_CD
43.2_CD
On_PIN
the_DT
basis_NN
of_PIN
the_DT
above_PLACE
assumptions_NOMZ
the_DT
actuarial_JJ
value_NN
of_PIN
the_DT
scheme_NN
assets_NN
for_PIN
the_DT
principal_JJ
overseas_PLACE
funded_JJ
schemes_NN
was_VBD [BEMA]
76.0_CD
m_NN [BEMA]
2001_CD
76.5_CD
m_NN
and_CC
represents_VPRT
80_CD
%_NN
2001_CD
87_CD
%_NN
of_PIN
the_DT
actuarial_JJ
value_NN
of_PIN
benets_NN
to_PIN
members_NN
as_IN
at_PIN
1_CD
January_NN
2002_CD
,_,
including_VBG
allowance_NN
for_PIN
future_JJ
salary_NN
and_PHC
pension_NN
increases_NN
._.
In_CONJ
addition_NULL
to_PIN
the_DT
schemes_NN
included_VBD
in_PIN
the_DT
above_PLACE
analysis_NN
the_DT
group_NN
also_RB
operates_VPRT
dened_VBN
benefit_NN
schemes_NN
in_PIN
other_JJ
territories_NN
,_,
principally_RB
Japan_NN
and_PHC
Germany_NN
._.
FRS_NN
17_CD
In_PIN
November_NN
2000_CD
,_,
the_DT
Accounting_GER
Standards_NN
Board_NN
published_VBD
FRS_NN
17_CD
Retirement_NOMZ
Benets_NN
to_TO
replace_VB
the_DT
existing_VBG
standard_JJ
SSAP_NN
24_CD
Accounting_GER
for_PIN
Pension_NN
costs_NN
._.
Although_CONC
the_DT
new_JJ
standard_NN
does_VPRT
not_XX0
become_VB
mandatory_JJ
until_IN
accounting_GER
periods_NN
beginning_VBG [WZPRES]
on_PIN
or_CC
after_IN
1_CD
January_NN
2005_CD
,_,
it_PIT
sets_VPRT
down_RP
transitional_JJ
arrangements_NOMZ
which_WDT [WHSUB]
require_VPRT [SUAV]
footnote_NN
disclosures_NN
in_PIN
the_DT
interim_JJ
period_NN
up_IN
to_PIN
full_JJ
adoption_NOMZ
._.
The_DT
most_EMPH
recent_JJ
actuarial_JJ
valuations_NOMZ
have_VPRT [PEAS]
been_VBN [BYPA]
updated_VBN
by_PIN
Watson_NN
Wyatt_NN
to_TO
take_VB
account_NN
of_PIN
the_DT
requirements_NOMZ
of_PIN
FRS_NN
17_CD
in_PIN
order_NN
to_TO
assess_VB
the_DT
liabilities_NOMZ
of_PIN
the_DT
schemes_NN
at_PIN
31_CD
December_NN
2002_CD
._.
For_PIN
the_DT
principal_JJ
overseas_PLACE
schemes_NN
this_DEMO
latest_JJ
valuation_NOMZ
was_VBD [BEMA]
at_PIN
31_CD
December_NN
2001_CD
including_VBG
both_DT
the_DT
US_FPP1
and_PHC
Norway_NN
and_CC
at_PIN
31_CD
December_NN
1999_CD
for_PIN
Sweden_NN
._.
Scheme_NN
assets_NN
are_VPRT [PASS]
stated_VBN [PUBV]
at_PIN
their_TPP3
market_NN
value_NN
at_PIN
31_CD
December_NN
2002_CD
._.
The_DT
future_JJ
agreed_VBD [SUAV] [PUBV]
contribution_NOMZ
rate_NN
for_PIN
the_DT
UK_NN
scheme_NN
is_VPRT [BEMA]
currently_RB
15.2_CD
%_NN
._.
This_DEMP
is_VPRT [BEMA]
subject_PRED
to_TO
review_VB
during_PIN
2003_CD
._.
For_PIN
the_DT
overseas_PLACE
schemes_NN
the_DT
contribution_NOMZ
rate_NN
will_PRMD
be_VB [PASS]
assessed_VBN
on_PIN
year_NN
on_PIN
year_NN
basis_NN
._.
All_QUAN
of_PIN
the_DT
group_NN
pension_NN
schemes_NN
are_VPRT [BEMA]
open_PRED
as_IN
at_PIN
31_CD
December_NN
2002_CD
._.
Main_NN
assumptions_NOMZ
for_PIN
FRS_NN
17_CD
purposes_NN
UK_NN
US_FPP1
Norway_NN
Other_JJ
31_CD
December_NN
2002_CD
%_NN
pa_CD
%_NN
pa_CD
%_NN
pa_CD
%_NN
pa_NN
Rate_NN
of_PIN
increase_NN
in_PIN
salaries_NN
4.25_CD
4.25_CD
3.50_CD
3.75_CD
Rate_NN
of_PIN
increase_NN
in_PIN
pensions_NN
in_PIN
payment_NOMZ
2.25_CD
0.00_CD
2.00_CD
2.00_CD
Discount_NN
rate_NN
5.50_CD
6.75_CD
6.50_CD
5.50_CD
Ination_NOMZ
2.25_CD
3.00_CD
2.50_CD
2.50_CD
UK_NN
US_FPP1
Norway_NN
Other_JJ
31_CD
December_NN
2001_CD
%_NN
pa_CD
%_NN
pa_CD
%_NN
pa_CD
%_NN
pa_NN
Rate_NN
of_PIN
increase_NN
in_PIN
salaries_NN
4.25_CD
4.25_CD
3.50_CD
3.25_CD
Rate_NN
of_PIN
increase_NN
in_PIN
pensions_NN
in_PIN
payment_NOMZ
2.25_CD
0.00_CD
2.00_CD
2.25_CD
Discount_NN
rate_NN
5.75_CD
7.25_CD
7.00_CD
5.00_CD
Ination_NOMZ
2.25_CD
3.00_CD
2.50_CD
2.50_CD
The_DT
market_NN
value_NN
of_PIN
assets_NN
in_PIN
the_DT
schemes_NN
at_PIN
31_CD
December_NN
2002_CD
and_CC
the_DT
long_JJ
term_NN
expected_VBN [PRIV]
rates_NN
of_PIN
return_NN
at_PIN
that_DEMO
date_NN
were_VBD
:_:
31_CD
December_NN
2002_CD
Equities_NOMZ
Bonds_NN
Other_JJ
Total_JJ
Long_JJ
term_NN
rate_NN
of_PIN
return_NN
expected_VBN [PRIV] [WZPAST]
at_PIN
31_CD
December_NN
2002_CD
%_NN
pa_NN
UK_NN
8.50_CD
5.00_CD
6.00_CD
US_FPP1
8.75_CD
6.25_CD
4.50_CD
Norway_NN
8.75_CD
6.00_CD
5.00_CD
Other_JJ
5.50_CD
2.50_CD
2.00_CD
Value_NN
at_PIN
31_CD
December_NN
2002_CD
m_NN
UK_NN
127.3_CD
34.5_CD
8.4_CD
170.2_CD
US_FPP1
29.4_CD
16.4_CD
0.7_CD
46.5_CD
Norway_NN
2.9_CD
16.7_CD
9.0_CD
28.6_CD
Other_JJ
4.9_CD
3.4_CD
0.7_CD
9.0_CD
Total_JJ
164.5_CD
71.0_CD
18.8_CD
254.3_CD
Amersham_NN
plc_NN
81_CD
Notes_NN
to_PIN
the_DT
financial_JJ
statements_NOMZ
continued_VBD
29_CD
Pensions_NN
continued_VBD
The_DT
market_NN
value_NN
of_PIN
assets_NN
in_PIN
the_DT
schemes_NN
at_PIN
31_CD
December_NN
2001_CD
and_CC
the_DT
long_JJ
term_NN
expected_VBN [PRIV]
rates_NN
of_PIN
return_NN
at_PIN
that_DEMO
date_NN
were_VBD
:_:
31_CD
December_NN
2001_CD
Equities_NOMZ
Bonds_NN
Other_JJ
Total_JJ
Long_JJ
term_NN
rate_NN
of_PIN
return_NN
expected_VBN [PRIV] [WZPAST]
at_PIN
31_CD
December_NN
2001_CD
%_NN
pa_NN
UK_NN
8.00_CD
5.50_CD
5.00_CD
US_FPP1
8.75_CD
7.00_CD
4.50_CD
Norway_NN
8.25_CD
6.75_CD
6.00_CD
Other_JJ
6.25_CD
3.00_CD
2.00_CD
Value_NN
at_PIN
31_CD
December_NN
2001_CD
m_NN
UK_NN
136.5_CD
26.7_CD
27.4_CD
190.6_CD
US_FPP1
32.0_CD
21.7_CD
0.7_CD
54.4_CD
Norway_NN
4.8_CD
15.2_CD
2.7_CD
22.7_CD
Other_JJ
4.4_CD
3.2_CD
0.7_CD
8.3_CD
Total_JJ
177.7_CD
66.8_CD
31.5_CD
276.0_CD
The_DT
following_JJ
amounts_NN
at_PIN
31_CD
December_NN
2002_CD
were_VBD [PASS]
measured_VBN
in_PIN
accordance_NN
with_PIN
the_DT
requirements_NOMZ
of_PIN
FRS17_NN
:_:
UK_NN
US_FPP1
Norway_NN
Other_JJ
Total_NN
m_FW
m_FW
m_FW
m_FW
m_FW [BEMA]
Total_JJ
market_NN
value_NN
of_PIN
assets_NN
170.2_CD
46.5_CD
28.6_CD
9.0_CD
254.3_CD
Present_JJ
value_NN
of_PIN
scheme_NN
liabilities_NOMZ
268.3_CD
102.2_CD
33.8_CD
58.3_CD
462.6_CD
deficit_NN
in_PIN
the_DT
scheme_NN
98.1_CD
55.7_CD
5.2_CD
49.3_CD
208.3_CD
Related_VBN
deferred_VBN
tax_NN
asset_NN
7.5_CD
22.3_CD
1.4_CD
15.4_CD
46.6_CD
Net_JJ
pension_NN
liabilities_NOMZ
90.6_CD
33.4_CD
3.8_CD
33.9_CD
161.7_CD
The_DT
following_JJ
amounts_NN
at_PIN
31_CD
December_NN
2001_CD
were_VBD [PASS]
measured_VBN
in_PIN
accordance_NN
with_PIN
the_DT
requirements_NOMZ
of_PIN
FRS17_NN
:_:
UK_NN
US_FPP1
Norway_NN
Other_JJ
Total_NN
m_FW
m_FW
m_FW
m_FW
m_FW [BEMA]
Total_JJ
market_NN
value_NN
of_PIN
assets_NN
190.6_CD
54.4_CD
22.7_CD
8.3_CD
276.0_CD
Present_JJ
value_NN
of_PIN
scheme_NN
liabilities_NOMZ
212.4_CD
92.2_CD
26.3_CD
48.7_CD
379.6_CD
deficit_NN
in_PIN
the_DT
scheme_NN
21.8_CD
37.8_CD
3.6_CD
40.4_CD
103.6_CD
Related_VBN
deferred_VBN
tax_NN
asset_NN
15.1_CD
1.0_CD
12.5_CD
28.6_CD
Net_JJ
pension_NN
liabilities_NOMZ
21.8_CD
22.7_CD
2.6_CD
27.9_CD
75.0_CD
If_COND
the_DT
above_PLACE
amounts_NN
had_VBD [PEAS]
been_VBN [PASS]
recognized_VBN [PRIV]
in_PIN
the_DT
financial_JJ
statements_NOMZ
,_,
the_DT
groups_NN
net_JJ
assets_NN
and_PHC
reserves_NN
at_PIN
31_CD
December_NN
2002_CD
would_PRMD
be_VB
as_IN
follows_VPRT
:_:
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
Restated_VBN
m_FW
m_FW [BEMA]
Net_JJ
assets_NN
Net_JJ
assets_NN
1,176.9_CD
658.9_CD
Add_VB [PUBV]
back_RB
SSAP_NN
24_CD
net_JJ
pension_NN
liability_NOMZ
and_PHC
prepayments_NOMZ
80.8_CD
79.5_CD
Less_RB
effect_NN
of_PIN
NMP_NN
joint_JJ
venture_NN
scheme_NN
0.2_CD
0.1_CD
Less_RB
FRS_NN
17_CD
net_JJ
pension_NN
liability_NOMZ
,_,
including_VBG
NMP_NN
208.3_CD
103.6_CD
Net_JJ
effect_NN
on_PIN
related_JJ
deferred_JJ
tax_NN
asset_NN
19.6_CD
2.2_CD
Impact_NN
on_PIN
minority_NOMZ
interest_NN
0.2_CD
Net_JJ
assets_NN
including_VBG [WZPRES]
FRS_NN
17_CD
pension_NN
liability_NOMZ
1,068.8_CD
636.7_CD
Reserves_NN
Reserves_NN
1,136.9_CD
564.2_CD
Add_VB [PUBV]
back_RB
SSAP_NN
24_CD
net_JJ
pension_NN
liability_NOMZ
and_PHC
prepayments_NOMZ
80.8_CD
79.5_CD
Less_RB
effect_NN
of_PIN
NMP_NN
joint_JJ
venture_NN
scheme_NN
0.2_CD
0.1_CD
Less_RB
FRS_NN
17_CD
net_JJ
pension_NN
liability_NOMZ
,_,
including_VBG
NMP_NN
208.3_CD
103.6_CD
Net_JJ
effect_NN
on_PIN
related_JJ
deferred_JJ
tax_NN
asset_NN
19.6_CD
2.2_CD
Impact_NN
on_PIN
minority_NOMZ
interest_NN
0.2_CD
Reserves_NN
including_VBG [WZPRES]
FRS_NN
17_CD
pension_NN
liability_NOMZ
1,028.8_CD
542.0_CD
82_CD
Amersham_NN
plc_NN
Annual_JJ
Report_NN
&_CC
Accounts_NN
2002_CD
29_CD
Pensions_NN
continued_VBD
The_DT
amounts_NN
charged_VBN
to_TO
operating_VBG
profit_NN
under_IN
FRS17_NN
would_PRMD
have_VB [PEAS]
been_VBN
:_:
UK_NN
US_FPP1
Norway_NN
Other_JJ
Total_NN
m_FW
m_FW
m_FW
m_FW
m_FW [BEMA]
Current_JJ
service_NN
cost_NN
10.7_CD
4.8_CD
1.6_CD
2.9_CD
20.0_CD
Past_JJ
service_NN
cost_NN
0.3_CD
0.3_CD
Total_JJ
operating_VBG
charge_NN
10.7_CD
5.1_CD
1.6_CD
2.9_CD
20.3_CD
The_DT
amounts_NN
charged_VBN
to_TO
nancing_VBG
under_IN
FRS17_NN
would_PRMD
have_VB [PEAS]
been_VBN
:_:
UK_NN
US_FPP1
Norway_NN
Other_JJ
Total_NN
m_FW
m_FW
m_FW
m_FW
m_FW [PASS]
Expected_VBN [PRIV]
return_NN
on_PIN
pension_NN
scheme_NN
assets_NN
14.1_CD
4.3_CD
1.8_CD
0.4_CD
20.6_CD
Interest_NN
on_PIN
pension_NN
scheme_NN
liabilities_NOMZ
12.1_CD
6.3_CD
2.0_CD
2.8_CD
23.2_CD
Total_JJ
nancing_VBG
charge_NN
income_NN
2.0_CD
2.0_CD
0.2_CD
2.4_CD
2.6_CD
The_DT
total_JJ
pension_NN
charge_NN
for_PIN
the_DT
group_NN
,_,
including_VBG
NMP_NN
,_,
is_VPRT [BEMA]
23.8_CD
m._FW
Excluding_VBG
items_NN
outside_PLACE
the_DT
scope_NN
of_PIN
SSAP_NN
24_CD
of_PIN
0.6_CD
m_NN
,_,
the_DT
charge_NN
for_PIN
the_DT
year_NN
is_VPRT [BEMA]
23.1_CD
m._FW
The_DT
effect_NN
on_PIN
the_DT
charge_NN
of_PIN
adopting_VBG
FRS_NN
17_CD
would_PRMD [SPAU]
therefore_CONJ
be_VB [BEMA]
a_DT
decrease_NN
of_PIN
0.2_CD
m._FW
Analysis_NN
of_PIN
the_DT
amount_NN
that_TSUB
would_PRMD
have_VB [PEAS]
been_VBN [PASS]
included_VBN
within_PIN
the_DT
statement_NOMZ
of_PIN
total_JJ
recognized_VBN [PRIV]
gains_NN
and_PHC
losses_NN
under_IN
FRS17_NN
:_:
UK_NN
US_FPP1
Norway_NN
Other_JJ
Total_NN
m_FW
m_FW
m_FW
m_FW
m_FW [BEMA]
Actual_JJ
return_NN
less_RB
expected_JJ
return_NN
on_PIN
pension_NN
scheme_NN
assets_NN
44.8_CD
10.1_CD
1.4_CD
1.4_CD
57.7_CD
Experience_NN
gains_NN
losses_NN
arising_VBG [WZPRES]
on_PIN
the_DT
scheme_NN
liabilities_NOMZ
4.2_CD
2.7_CD
2.3_CD
1.3_CD
5.1_CD
Changes_NN
in_PIN
assumptions_NOMZ
underlying_VBG [WZPRES]
the_DT
present_JJ
value_NN
1_CD
of_PIN
scheme_NN
liabilities_NOMZ
37.7_CD
8.8_CD
2.9_CD
3.1_CD
52.5_CD
Actuarial_JJ
loss_NN
recognized_VBN [PRIV] [WZPAST]
in_PIN
group_NN
statement_NOMZ
of_PIN
total_JJ
recognized_VBN [PRIV]
gains_NN
and_PHC
losses_NN
78.3_CD
21.6_CD
2.0_CD
3.2_CD
105.1_CD
1_CD
Includes_VPRT
the_DT
impact_NN
of_PIN
adopting_VBG
Urgent_NN
Issues_NN
Task_NN
Force_NN
UITF_NN
No_NN
35_CD
Death-in-service_NN
and_PHC
incapacity_NOMZ
benets_NN
._.
The_DT
analysis_NN
of_PIN
experience_NN
gains_NN
and_PHC
losses_NN
,_,
recognized_VBN [PRIV] [PASTP]
in_PIN
the_DT
statement_NOMZ
of_PIN
total_JJ
recognized_VBN [PRIV]
gains_NN
and_PHC
losses_NN
,_,
is_VPRT
as_IN
follows_VPRT
:_:
UK_NN
US_FPP1
Norway_NN
Other_JJ
Total_JJ
Actual_JJ
return_NN
less_RB
expected_JJ
return_NN
on_PIN
pension_NN
scheme_NN
assets_NN
m_VPRT [BEMA]
44.8_CD
10.1_CD
1.4_CD
1.4_CD
57.7_CD
Percentage_NN
of_PIN
scheme_NN
assets_NN
at_PIN
end_NN
of_PIN
year_NN
%_NN
26_CD
22_CD
5_CD
16_CD
23_CD
Experience_NN
gains_NN
losses_NN
arising_VBG [WZPRES]
on_PIN
the_DT
scheme_NN
liabilities_NOMZ
m_VPRT [BEMA]
4.2_CD
2.7_CD
2.3_CD
1.3_CD
5.1_CD
Percentage_NN
of_PIN
scheme_NN
liabilities_NOMZ
at_PIN
end_NN
of_PIN
year_NN
%_NN
2_CD
3_CD
7_CD
2_CD
1_CD
Total_JJ
actuarial_JJ
loss_NN
recognized_VBN [PRIV] [WZPAST]
in_PIN
statement_NOMZ
of_PIN
total_JJ
recognized_VBN [PRIV]
gains_NN
and_PHC
losses_NN
m_VPRT [BEMA]
78.3_CD
21.6_CD
2.0_CD
3.2_CD
105.1_CD
Percentage_NN
of_PIN
scheme_NN
liabilities_NOMZ
at_PIN
end_NN
of_PIN
year_NN
%_NN
29_CD
21_CD
6_CD
5_CD
23_CD
The_DT
movement_NOMZ
in_PIN
the_DT
deficit_NN
during_PIN
the_DT
year_NN
under_IN
FRS_NN
17_CD
would_PRMD
have_VB [PEAS]
been_VBN
:_:
UK_NN
US_FPP1
Norway_NN
Other_JJ
Total_NN
m_FW
m_FW
m_FW
m_FW
m_FW
deficit_NN
in_PIN
the_DT
scheme_NN
at_PIN
the_DT
beginning_GER
of_PIN
the_DT
year_NN
21.8_CD
37.8_CD
3.6_CD
40.4_CD
103.6_CD
Movement_NOMZ
in_PIN
the_DT
year_NN
:_:
Foreign_JJ
currency_NN
translation_NOMZ
5.2_CD
0.8_CD
2.9_CD
1.5_CD
Current_JJ
service_NN
cost_NN
10.7_CD
4.8_CD
1.6_CD
2.9_CD
20.0_CD
Past_NN
service_NN
costs_VPRT
0.3_CD
0.3_CD
Contributions_NOMZ
10.7_CD
5.6_CD
3.0_CD
2.5_CD
21.8_CD
Other_JJ
finance_NN
income_NN
charge_NN
2.0_CD
2.0_CD
0.2_CD
2.4_CD
2.6_CD
Actuarial_JJ
loss_NN
78.3_CD
21.6_CD
2.0_CD
3.2_CD
105.1_CD
deficit_NN
in_PIN
the_DT
scheme_NN
at_PIN
the_DT
end_NN
of_PIN
the_DT
year_NN
98.1_CD
55.7_CD
5.2_CD
49.3_CD
208.3_CD
Opening_GER
related_VBN
deferred_VBN
tax_NN
asset_NN
15.1_CD
1.0_CD
12.5_CD
28.6_CD
Movement_NOMZ
in_PIN
the_DT
year_NN
7.5_CD
7.2_CD
0.4_CD
2.9_CD
18.0_CD
Closing_GER
related_VBN
deferred_VBN
tax_NN
asset_NN
7.5_CD
22.3_CD
1.4_CD
15.4_CD
46.6_CD
Amersham_NN
plc_NN
83_CD
Notes_NN
to_PIN
the_DT
financial_JJ
statements_NOMZ
continued_VBD
30_CD
Shares_NN
in_PIN
group_NN
undertakings_GER
Information_NOMZ
relating_VBG [WZPRES]
to_PIN
subsidiary_NN
,_,
joint_JJ
venture_NN
and_CC
associated_VBN
undertakings_GER
is_VPRT [PASS]
given_VBN
on_PIN
those_DEMO
that_DEMP
,_,
in_PIN
the_DT
opinion_NN
of_PIN
the_DT
Directors_NN
,_,
principally_RB
affected_VBD
the_DT
profits_NN
or_CC
assets_NN
of_PIN
the_DT
group_NN
._.
The_DT
primary_JJ
activity_NOMZ
of_PIN
the_DT
majority_NOMZ
of_PIN
the_DT
undertakings_GER
shown_VBN [PRIV]
below_PLACE
is_VPRT [BEMA]
the_DT
development_NOMZ
and_PHC
manufacture_NN
and_CC
or_CC
sale_NN
of_PIN
specialised_JJ
products_NN
for_PIN
research-based_JJ
biotechnology_NN
supply_NN
and_CC
the_DT
diagnosis_NN
and_PHC
treatment_NOMZ
of_PIN
disease_NN
._.
Subsidiary_NN
,_,
joint_JJ
venture_NN
,_,
and_ANDC
associated_VBN
undertakings_GER
are_VPRT [PASS]
listed_VBN
under_IN
the_DT
relevant_JJ
business_NOMZ
operation_NOMZ
._.
Where_RB
the_DT
relevant_JJ
company_NN
serves_VPRT
more_EMPH
than_PIN
one_CD
business_NOMZ
it_PIT
is_VPRT [PASS]
listed_VBN
under_IN
the_DT
dominant_JJ
business_NOMZ
operation_NOMZ
._.
With_PIN
the_DT
exception_NOMZ
of_PIN
Amersham_NN
Buchler_NN
GmbH_NN
&_CC
Co._NN
._.
KG_NN
and_PHC
Amersham_NN
Biosciences_NN
Limited_NN
,_,
the_DT
companys_NN
holdings_GER
in_PIN
the_DT
following_VBG
undertakings_GER
are_VPRT [BYPA]
represented_VBN
by_PIN
ordinary_JJ
shares_NN
._.
Amersham_NN
Buchler_NN
GmbH_NN
&_CC
Co._NN
._.
KG_NN
is_VPRT [BEMA]
a_DT
partnership_NN
in_PIN
which_WDT [PIRE]
the_DT
groups_NN
interest_NN
is_VPRT [BEMA]
in_PIN
limited_JJ
liability_NOMZ
form_NN
._.
The_DT
company_NN
holds_VPRT [PRIV]
ordinary_JJ
and_PHC
non-voting_JJ
preference_NN
shares_NN
in_PIN
Amersham_NN
Biosciences_NN
Limited_NN
in_PIN
the_DT
proportion_NOMZ
stated_VBN [PUBV]
below_PLACE
._.
All_QUAN
of_PIN
the_DT
companies_NN
listed_VBN
below_PLACE
operate_VPRT
principally_RB
in_PIN
their_TPP3
country_NN
of_PIN
incorporation_NOMZ
or_CC
registration_NOMZ
and_CC
have_VPRT
coterminous_JJ
year_NN
ends_VPRT
._.
Proportion_NOMZ
of_PIN
nominal_JJ
value_NN
of_PIN
issued_VBN
shares_NN
held_VBD [PRIV]
Country_NN
of_PIN
By_PIN
the_DT
By_PIN
subsidiary_NN
incorporation_NOMZ
company_NN
undertakings_GER
or_CC
registration_NOMZ
%_NN
%_NN
Holding_VBG [PRIV] [WZPRES]
companies_NN
Amersham_NN
Health_NN
Norge_NN
AS_NN
Norway_NN
100_CD
Acam_NN
Overseas_NN
Holdings_GER
Ltd_NN
UK_NN
100_CD
Acam_NN
Holdings_GER
UK_NN
Ltd_NN
UK_NN
100_CD
Amersham_NN
Benelux_NN
BV_NN
Netherlands_NN
100_CD
Amersham_NN
Biosystems_NN
AB_NN
Sweden_NN
100_CD
Amersham_NN
Biosciences_NN
Amersham_NN
Biosciences_NN
Ltd_NN
UK_NN
61_CD
39_CD
Amersham_NN
Biosciences_NN
Corp_NN
USA_NN
100_CD
Amersham_NN
Biosciences_NN
UK_NN
Ltd_NN
UK_NN
100_CD
Amersham_NN
Biosciences_NN
Europe_NN
GmbH_NN
Germany_NN
100_CD
Amersham_NN
Biosciences_NN
AB_NN
Sweden_NN
100_CD
Amersham_NN
Biosciences_NN
SV_NN
Corp_NN
USA_NN
100_CD
Amersham_NN
Biosciences_NN
KK_NN
Japan_NN
100_CD
Amersham_NN
Biosciences_NN
Ltd_NN
Hong_NN
Kong_NN
100_CD
AG_NN
Technology_NN
Corp_NN
USA_NN
100_CD
InnovaSep_NN
Technology_NN
Corporation_NOMZ
USA_NN
100_CD
Amersham_NN
Health_NN
Amersham_NN
Buchler_NN
GmbH_NN
&_CC
Co._NN
._.
KG_NN
Germany_NN
60_CD
Amersham_NN
Health_NN
AS_NN
Norway_NN
100_CD
Amersham_NN
Health_NN
Ireland_NN
100_CD
Amersham_NN
Health_NN
Inc_NN
USA_NN
100_CD
Amersham_NN
Health_NN
Pte_NN
Ltd_NN
Singapore_NN
100_CD
Nycomed_NN
Amersham_NN
Sorin_NN
Srl_NN
Italy_NN
100_CD
Amersham_NN
Health_NN
Ltd_NN
China_NN
80_CD
Amersham_NN
Health_NN
Holdings_GER
Inc_NN
USA_NN
100_CD
Joint_NN
venture_NN
Amersham_NN
Health_NN
Nihon_NN
Medi-Physics_NN
Company_NN
Ltd_NN
Japan_NN
29_CD
21_CD
The_DT
investment_NOMZ
in_PIN
Nihon_NN
Medi-Physics_NN
Company_NN
Ltd_NN
relates_VPRT
to_PIN
ordinary_JJ
shares_NN
._.
The_DT
shares_NN
carry_VPRT
standard_JJ
pre-emption_NOMZ
rights_NN
._.
A_DT
full_JJ
list_NN
of_PIN
all_QUAN
group_NN
undertakings_GER
will_PRMD
be_VB [PASS]
appended_VBN
to_PIN
the_DT
annual_JJ
return_NN
._.
84_CD
Amersham_NN
plc_NN
Annual_JJ
Report_NN
&_CC
Accounts_NN
2002_CD
31_CD
Net_JJ
cash_NN
ow_NN
from_PIN
operating_VBG
activities_NOMZ
12_CD
months_NN
to_PIN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
m_NN
m_NN [BEMA]
Total_JJ
operating_GER
profit_NN
before_IN
exceptional_JJ
items_NN
273.2_CD
280.8_CD
Share_NN
of_PIN
operating_GER
profit_NN
of_PIN
joint_JJ
venture_NN
and_PHC
associates_NN
23.2_CD
26.1_CD
Depreciation_NOMZ
and_PHC
amortisation_NOMZ
116.4_CD
80.0_CD
Loss_NN
on_PIN
sale_NN
of_PIN
tangible_JJ
xed_JJ
assets_NN
1.5_CD
0.3_CD
Decrease_NN
increase_NN
in_PIN
provisions_NN
6.8_CD
1.3_CD
Increase_VPRT
in_PIN
stocks_NN
19.9_CD
12.1_CD
Decrease_NN
increase_NN
in_PIN
debtors_NN
5.3_CD
16.8_CD
Decrease_NN
increase_NN
in_PIN
creditors_NN
1.0_CD
34.9_CD
Net_JJ
cash_NN
inow_NN
from_PIN
operating_VBG
activities_NOMZ
before_IN
exceptional_JJ
items_NN
345.5_CD
342.3_CD
Exceptional_JJ
items_NN
12.0_CD
Net_JJ
cash_NN
inow_NN
from_PIN
operating_VBG
activities_NOMZ
345.5_CD
354.3_CD
32_CD
Analysis_NN
of_PIN
net_JJ
debt_NN
As_IN
at_PIN
Exchange_NN
As_IN
at_PIN
1_CD
Jan_NN
2002_CD
Cash_NN
ow_NN
movements_NOMZ
31_CD
Dec_NN
2002_CD
m_FW
m_FW
m_FW
m_FW
Cash_NN
at_PIN
bank_NN
and_CC
in_PIN
hand_NN
56.9_CD
30.3_CD
6.1_CD
32.7_CD
Overdrafts_NN
11.1_CD
4.0_CD
0.1_CD
7.2_CD
45.8_CD
26.3_CD
6.0_CD
25.5_CD
Liquid_NN
resources_NN
96.5_CD
74.5_CD
0.1_CD
22.1_CD
Loans_NN
due_JJ
within_PIN
one_CD
year_NN
19.7_CD
14.7_CD
3.0_CD
37.4_CD
Loans_NN
due_JJ
after_IN
more_EMPH
than_PIN
one_CD
year_NN
148.0_CD
133.6_CD
89.1_CD
192.5_CD
Net_JJ
debt_NN
25.4_CD
249.1_CD
92.2_CD
182.3_CD
33_CD
Reconciliation_NOMZ
of_PIN
net_JJ
cash_NN
ow_NN
to_PIN
movement_NOMZ
in_PIN
net_JJ
debt_NN
31_CD
Dec_NN
2002_CD
31_CD
Dec_NN
2001_CD
m_FW
m_FW
Decrease_NN
increase_NN
in_PIN
cash_NN
in_PIN
the_DT
period_NN
26.3_CD
7.8_CD
Cash_NN
inow_NN
outow_NN
from_PIN
liquid_JJ
resources_NN
74.5_CD
91.4_CD
Cash_NN
inow_NN
outow_NN
from_PIN
increase_NN
reduction_NOMZ
in_PIN
loans_NN
and_PHC
lease_NN
finance_NN
148.3_CD
205.3_CD
Change_NN
in_PIN
net_JJ
debt_NN
resulting_VBG [WZPRES]
from_PIN
cash_NN
ows_NN
249.1_CD
304.5_CD
Exchange_NN
movements_NOMZ
92.2_CD
6.4_CD
Movement_NOMZ
in_PIN
net_JJ
debt_NN
in_PIN
the_DT
period_NN
156.9_CD
298.1_CD
Net_JJ
debt_NN
at_PIN
1_CD
January_NN
25.4_CD
323.5_CD
Net_JJ
debt_NN
at_PIN
31_CD
December_NN
182.3_CD
25.4_CD
34_CD
Related_VBN
party_NN
disclosures_NN
Apart_RB
from_PIN
the_DT
transactions_NOMZ
noted_VBD [PRIV]
below_PLACE
there_EX
were_VBD
no_SYNE
other_JJ
material_NN
items_NN
requiring_VBG [SUAV] [WZPRES]
disclosure_NN
._.
Transactions_NOMZ
with_PIN
Nihon_NN
Medi-Physics_NN
Company_NN
Limited_NN
NMP_NN
During_PIN
2002_CD
the_DT
group_NN
made_VBD
sales_NN
to_PIN
NMP_NN
of_PIN
7.6_CD
m_NN [BEMA]
2001_CD
6.6_CD
m_NN
and_PHC
purchases_NN
of_PIN
0.1_CD
m_NN [BEMA]
2001_CD
0.1_CD
m._NN
At_PIN
the_DT
year_NN
end_NN
the_DT
group_NN
was_VBD [PASS]
owed_VBN
1.0_CD
m_NN [BEMA]
2001_CD
1.3_CD
m_NN [BEMA]
in_PIN
respect_NN
of_PIN
trading_GER
balances_NN
and_CC
the_DT
group_NN
owed_VBD
NMP_NN
26.2_CD
m_NN [BEMA]
2001_CD
nil_NN
relating_VBG [WZPRES]
to_PIN
a_DT
short_JJ
term_NN
loan_NN
balance_NN
._.
Transactions_NOMZ
with_PIN
Reviss_NN
Services_NN
Limited_NN
RSL_NN
During_PIN
1996_CD
the_DT
group_NN
disposed_VBD
of_PIN
its_PIT
Puridec_JJ
business_NOMZ
to_PIN
RSL_NN
,_,
then_RB
an_DT
associated_VBN
undertaking_GER
,_,
for_PIN
a_DT
consideration_NOMZ
of_PIN
5.9_CD
m_NN [BEMA]
payable_PRED
within_PIN
a_DT
seven_CD
year_NN
period_NN
._.
At_PIN
31_CD
December_NN
2002_CD
the_DT
group_NN
held_VBD [PRIV]
a_DT
10_CD
%_NN
trade_NN
investment_NOMZ
in_PIN
RSL_NN
._.
During_PIN
2002_CD
the_DT
group_NN
recharged_VBD
RSL_NN
in_PIN
relation_NOMZ
to_PIN
the_DT
provision_NN
of_PIN
payroll_NN
and_CC
other_JJ
services_NN
0.8_CD
m_NN [BEMA]
2001_CD
1.1_CD
m_NN
and_CC
made_VBD
purchases_NN
of_PIN
2.9_CD
m_NN [BEMA]
2001_CD
4.7_CD
m_NN [BEMA]
in_PIN
respect_NN
of_PIN
normal_JJ
trading_GER
activities_NOMZ
._.
At_PIN
31_CD
December_NN
2002_CD
the_DT
group_NN
owed_VBD
RSL_NN
0.2_CD
m_NN [BEMA]
2001_CD
0.1_CD
m_NN
and_CC
was_VBD [PASS]
owed_VBN
0.6_CD
m_NN [BEMA]
2001_CD
1.3_CD
m_NN
,_,
comprising_VBG [PRESP]
0.6_CD
m_NN [BEMA]
2001_CD
0.6_CD
m_NN [BEMA]
in_PIN
respect_NN
of_PIN
other_JJ
services_NN
and_PHC
nil_NN
2001_CD
-_:
0.7_CD
m_NN [BEMA]
in_PIN
relation_NOMZ
to_PIN
the_DT
sale_NN
of_PIN
the_DT
Puridec_NN
business_NOMZ
._.
Amersham_NN
plc_NN
85_CD
Notes_NN
to_PIN
the_DT
financial_JJ
statements_NOMZ
continued_VBD
34_CD
Related_VBN
party_NN
disclosures_NN
continued_VBD
Transactions_NOMZ
with_PIN
Gyros_NN
AB_NN
During_PIN
the_DT
year_NN
the_DT
group_NN
made_VBD
milestone_NN
payments_NOMZ
of_PIN
nil_NN
2001_CD
1.0_CD
m_NN [BEMA]
to_PIN
Gyros_NN
AB_NN
._.
The_DT
group_NN
holds_VPRT [PRIV]
a_DT
9.7_CD
%_NN
interest_NN
in_PIN
Gyros_NN
AB_NN
._.
At_PIN
31_CD
December_NN
2002_CD
the_DT
group_NN
owed_VBD
Gyros_NN
AB_NN
nil_NN
2001_CD
nil_NN
._.
Transactions_NOMZ
with_PIN
Cimarron_NN
Software_NN
Inc_NN
From_PIN
1_CD
January_NN
2002_CD
to_PIN
10_CD
May_POMD
2002_CD
the_DT
group_NN
held_VBD [PRIV]
a_DT
trade_NN
investment_NOMZ
in_PIN
Cimarron_NN
Software_NN
Inc_NN
representing_VBG [WZPRES]
19_CD
%_NN
of_PIN
that_DEMP
companys_VPRT
equity_NOMZ
._.
During_PIN
the_DT
period_NN
to_PIN
10_CD
May_POMD
2002_CD
the_DT
group_NN
paid_VBD
0.5_CD
m_NN [BEMA]
2001_CD
1.1_CD
m_NN [BEMA]
to_PIN
Cimarron_NN
Software_NN
Inc._NN
in_PIN
respect_NN
of_PIN
normal_JJ
trading_GER
activities_NOMZ
._.
From_PIN
10_CD
May_POMD
2002_CD
onwards_NN
Cimarron_NN
Software_NN
Inc_NN
has_VPRT [PEAS]
been_VBN [PASS]
consolidated_VBN
as_IN
a_DT
subsidiary_NN
undertaking_GER
._.
Transactions_NOMZ
with_PIN
Molecular_NN
Staging_GER
Inc_NN
The_NN
group_NN
holds_VPRT [PRIV]
a_DT
trade_NN
investment_NOMZ
in_PIN
Molecular_NN
Staging_GER
Inc._NN
._.
During_PIN
2002_CD
,_,
the_DT
group_NN
made_VBD
sales_NN
of_PIN
nil_NN
2001_CD
0.2_CD
m_NN [BEMA]
to_PIN
Molecular_NN
Staging_GER
Inc_NN
,_,
and_ANDC
made_VBD
purchases_NN
of_PIN
0.8_CD
m_NN [BEMA]
2001_CD
0.4_CD
m_NN
,_,
in_PIN
respect_NN
of_PIN
normal_JJ
trading_GER
activities_NOMZ
._.
Transactions_NOMZ
with_PIN
MU_NN
Bioteknik_NN
AB_NN
During_PIN
the_DT
year_NN
,_,
the_DT
group_NN
made_VBD
royalty_NN
payments_NOMZ
to_PIN
MU_NN
Bioteknik_NN
AB_NN
,_,
a_DT
company_NN
of_PIN
which_WDT [PIRE]
Professor_NN
Uhln_NN
is_VPRT [BEMA]
the_DT
sole_JJ
Director_NN
and_PHC
shareholder_NN
,_,
of_PIN
SEK_NN
800,000_CD
,_,
with_PIN
an_DT
additional_JJ
SEK_NN
400,000_CD
accrued_VBN
payments_NOMZ
at_PIN
December_NN
2002_CD
._.
These_DEMO
payments_NOMZ
were_VBD [PASS]
made_VBN
in_PIN
respect_NN
of_PIN
royalty_NN
agreements_NOMZ
entered_VBD
into_PIN
prior_RB
to_PIN
the_DT
appointment_NOMZ
of_PIN
Professor_NN
Uhln_NN
as_IN
a_DT
Non-Executive_JJ
Director_NN
._.
Loan_NN
to_PIN
Dr_NN
A_NN
Carr_NN
In_PIN
2000_CD
,_,
the_DT
group_NN
provided_VBD
an_DT
interest_NN
free_JJ
,_,
secured_JJ
loan_NN
facility_NOMZ
to_PIN
Dr_NN
A_NN
Carr_NN
,_,
the_DT
Chief_NN
Executive_NN
of_PIN
Amersham_NN
Biosciences_NN
,_,
of_PIN
$_$
300,000_CD
to_TO
assist_VB
in_PIN
the_DT
purchase_NN
of_PIN
a_DT
house_NN
following_VBG [WZPRES]
his_TPP3
relocation_NOMZ
to_PIN
the_DT
US_FPP1
._.
The_DT
loan_NN
was_VBD [BEMA]
repayable_PRED
over_IN
five_CD
years_NN
in_PIN
equal_JJ
fortnightly_RB
instalments_NOMZ
or_CC
on_PIN
his_TPP3
ceasing_VBG
to_TO
be_VB [BYPA]
employed_VBN
by_PIN
the_DT
group_NN
,_,
if_COND
earlier_TIME
._.
The_DT
maximum_NN
balance_NN
on_PIN
this_DEMO
loan_NN
in_PIN
the_DT
year_NN
was_VBD
$_$
291,000_CD
._.
The_DT
loan_NN
has_VPRT [PEAS]
been_VBN [PASS]
repaid_VBN
since_OSUB
the_DT
year_NN
end_NN
._.
35_CD
Contingent_JJ
liabilities_NOMZ
The_DT
group_NN
is_VPRT [PASS]
involved_VBN
in_PIN
various_JJ
negotiations_NOMZ
or_CC
disputes_NN
of_PIN
a_DT
nature_NN
considered_VBN [PRIV]
typical_JJ
for_PIN
its_PIT
businesses_NOMZ
,_,
including_VBG [PRESP]
those_DEMP
relating_VBG
to_PIN
product_NN
liability_NOMZ
and_PHC
infringements_NOMZ
and_PHC
claims_NN
of_PIN
intellectual_JJ
property_NN
rights_NN
,_,
validity_NOMZ
of_PIN
patents_NN
and_PHC
taxation_NOMZ
._.
Although_CONC
there_EX
can_POMD
be_VB
no_SYNE
assurance_NN
regarding_VBG [WZPRES]
the_DT
outcome_NN
of_PIN
any_QUAN
of_PIN
these_DEMO
negotiations_NOMZ
or_CC
disputes_NN
,_,
the_DT
group_NN
believes_VPRT [PRIV]
that_THVC
on_PIN
the_DT
basis_NN
of_PIN
current_JJ
available_JJ
information_NOMZ
they_TPP3
will_PRMD
not_XX0
have_VB
a_DT
material_NN
adverse_JJ
impact_NN
on_PIN
the_DT
groups_NN
financial_JJ
position_NOMZ
._.
36_CD
Restatement_NOMZ
of_PIN
prior_JJ
periods_NN
Following_VBG [WZPRES]
the_DT
introduction_NOMZ
of_PIN
Financial_NN
Reporting_GER
Standard_NN
19_CD
,_,
Deferred_NN
Taxation_NOMZ
in_PIN
2002_CD
,_,
the_DT
group_NN
has_VPRT [PEAS]
changed_VBN
its_PIT
accounting_GER
policy_NN
with_PIN
respect_NN
to_TO
deferred_VBN
taxation_NOMZ
._.
Under_IN
the_DT
previous_JJ
policy_NN
,_,
provision_NN
was_VBD [PASS]
made_VBN
for_PIN
deferred_VBN
taxation_NOMZ
,_,
using_VBG [PRESP]
the_DT
liability_NOMZ
method_NN
,_,
on_PIN
all_QUAN
material_NN
timing_NN
differences_NN
to_PIN
the_DT
extent_NN
that_TOBJ
it_PIT
was_VBD [BEMA]
probable_PRED
that_THAC
an_DT
asset_NN
or_CC
liability_NOMZ
would_PRMD
crystallise_VB
._.
Under_IN
the_DT
revised_VBN
accounting_GER
policy_NN
,_,
liabilities_NOMZ
will_PRMD
be_VB [PASS]
recognized_VBN [PRIV]
for_PIN
most_EMPH
types_NN
of_PIN
timing_NN
differences_NN
regardless_RB
of_PIN
whether_IN
they_TPP3
are_VPRT [PASS]
anticipated_VBN [PRIV]
to_TO
reverse_VB
in_PIN
the_DT
foreseeable_JJ
future_NN
._.
Deferred_JJ
taxation_NOMZ
assets_NN
will_PRMD
be_VB [PASS]
recognized_VBN [PRIV]
to_PIN
the_DT
extent_NN
that_TOBJ
it_PIT
is_VPRT [BEMA]
more_EMPH
likely_PRED
than_PIN
not_XX0
that_DEMO
they_TPP3
will_PRMD
reverse_VB
._.
The_DT
adjustments_NOMZ
required_VBN [SUAV] [WZPAST]
to_PIN
shareholders_NN
funds_NN
are_VPRT [PASS]
set_VBN
out_PIN
below_PLACE
:_:
12_CD
months_NN
12_CD
months_NN
to_PIN
31_CD
Dec_NN
to_PIN
31_CD
Dec_NN
2001_CD
2001_CD
m_NN
m_NN
Adjustment_NOMZ
to_TO
opening_VBG
shareholders_NN
funds_NN
8.5_CD
Effect_NN
of_PIN
adoption_NOMZ
of_PIN
FRS19_CD
at_PIN
1_CD
January_NN
2001_CD
12.3_CD
Reverse_VB
deferred_VBN
tax_NN
provision_NN
under_IN
SSAP_NN
15_CD
4.5_CD
Deferred_JJ
tax_NN
provision_NN
under_IN
FRS_NN
19_CD
9.0_CD
Attributable_JJ
to_PIN
minority_NOMZ
interest_NN
FRS_NN
19_CD
0.4_CD
3.8_CD
Adjustment_NOMZ
to_TO
closing_VBG
shareholders_NN
funds_NN
4.4_CD
8.5_CD
In_PIN
the_DT
year_NN
ended_VBD
31_CD
December_NN
2001_CD
,_,
deferred_VBN
tax_NN
charged_VBN
under_IN
FRS_NN
19_CD
amounted_VBD
to_PIN
9.0_CD
m_NN
:_:
this_DEMP
would_PRMD
have_VB [PEAS]
been_VBN [BEMA]
4.5_CD
m_NN
under_IN
SSAP_NN
15_CD
._.
For_PIN
the_DT
year_NN
ended_VBD
31_CD
December_NN
2002_CD
,_,
deferred_VBN
tax_NN
charged_VBN
under_IN
FRS_NN
19_CD
amounted_VBD
to_PIN
23.1_CD
m_NN
:_:
this_DEMP
would_PRMD
have_VB [PEAS]
been_VBN [BEMA]
18.9_CD
m_NN
under_IN
SSAP_NN
15_CD
._.
37_CD
Post_NN
balance_NN
sheet_NN
events_NN
On_PIN
26_CD
February_NN
2003_CD
the_DT
group_NN
announced_VBD [PUBV]
a_DT
restructuring_GER
of_PIN
its_PIT
discovery_NN
systems_NN
business_NOMZ
area_NN
._.
The_DT
restructuring_GER
program_NN
,_,
which_WDT [SERE]
will_PRMD
deliver_VB
a_DT
more_EMPH
efficient_JJ
manufacturing_GER
cost_NN
base_NN
and_PHC
focus_NN
research_NN
and_PHC
development_NOMZ
on_PIN
fewer_JJ
sites_NN
,_,
will_PRMD
result_VB
in_PIN
the_DT
loss_NN
of_PIN
approximately_RB
400_CD
jobs_NN
._.
The_DT
group_NN
will_PRMD
incur_VB
one_CD
off_PIN
costs_NN
in_PIN
the_DT
range_NN
of_PIN
45-50m_JJ
,_,
which_WDT [SERE]
is_VPRT [PASS]
expected_VBN [PRIV]
to_TO
result_VB
in_PIN
savings_GER
running_VBG [WZPRES]
at_PIN
the_DT
rate_NN
of_PIN
30-35m_JJ
per_PIN
annum_NN
by_PIN
the_DT
end_NN
of_PIN
2004_CD
._.
86_CD
Amersham_NN
plc_NN
Annual_JJ
Report_NN
&_CC
Accounts_NN
2002_CD
